Christel Daniel David Ouagne PATHLEX Generic-Infiltrating malignant neoplasm-Specimen weight Specimen weight Generic-Infiltrating malignant neoplasm-Lesion size, largest dimension Lesion size, largest dimension Histologic grade Ancillary techniques Histologic grade Target site Specimen collection procedure Generic-Infiltrating malignant neoplasm Generic-In situ neoplasm Generic-Lesion Generic-Specimen Prostate-Infiltrating malignant neoplasm-Histologic type-Adenocarcinoma (acinar, not otherwise specified) Adenocarcinoma (acinar, not otherwise specified) Prostate-Infiltrating malignant neoplasm-Histologic type-Prostatic duct adenocarcinoma Prostatic duct adenocarcinoma Prostate-Infiltrating malignant neoplasm-Histologic type-Mucinous (colloid) adenocarcinoma Mucinous (colloid) adenocarcinoma Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Primary (Predominant) Pattern)-Grade 1 Grade 1 Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Primary (Predominant) Pattern)-Grade 2 Grade 2 Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Primary (Predominant) Pattern)-Grade 3 Grade 3 Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Primary (Predominant) Pattern)-Grade 4 Grade 4 Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Primary (Predominant) Pattern)-Grade 5 Grade 5 Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Secondary (Worst Remaining) Pattern)-Grade 1 Grade 1 Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Secondary (Worst Remaining) Pattern)-Grade 2 Grade 2 Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Secondary (Worst Remaining) Pattern)-Grade 3 Grade 3 Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Secondary (Worst Remaining) Pattern)-Grade 4 Grade 4 Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Secondary (Worst Remaining) Pattern)-Grade 5 Grade 5 Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Tertiary Pattern)-Grade 3 Grade 3 Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Tertiary Pattern)-Grade 4 Grade 4 Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Tertiary Pattern)-Grade 5 Grade 5 Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Total Gleason Score)-2 2 Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Total Gleason Score)-3 3 Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Total Gleason Score)-4 4 Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Total Gleason Score)-5 5 Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Total Gleason Score)-6 6 Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Total Gleason Score)-7 7 Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Total Gleason Score)-8 8 Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Total Gleason Score)-9 9 Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Total Gleason Score)-10 10 Prostate-Infiltrating malignant neoplasm-pT-pT2: Organ confined pT2: Organ confined Prostate-Infiltrating malignant neoplasm-pT-pT2a: Unilateral, involving one-half of 1 side or less pT2a: Unilateral, involving one-half of 1 side or less Prostate-Infiltrating malignant neoplasm-pT-pT2b: Unilateral, involving more than one-half of 1 side but not both sides pT2b: Unilateral, involving more than one-half of 1 side but not both sides Prostate-Infiltrating malignant neoplasm-pT-pT2c: Bilateral disease pT2c: Bilateral disease Prostate-Infiltrating malignant neoplasm-pT-pT3: Extraprostatic extension pT3: Extraprostatic extension Prostate-Infiltrating malignant neoplasm-pT-pT3a: Extraprostatic extension or microscopic invasion of bladder neck pT3a: Extraprostatic extension or microscopic invasion of bladder neck Prostate-Infiltrating malignant neoplasm-pT-pT3b: Seminal vesicle invasion pT3b: Seminal vesicle invasion Prostate-Infiltrating malignant neoplasm-pT-pT4: Invasion of rectum, levator muscles and/or pelvic wall (Note J) pT4: Invasion of rectum, levator muscles and/or pelvic wall (Note J) Prostate-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis pN0: No regional lymph node metastasis Prostate-Infiltrating malignant neoplasm-pN-pN1: Metastasis in regional lymph node or nodes pN1: Metastasis in regional lymph node or nodes Testis-Specimen-Target site-Testis Testis Testis-Specimen-Specimen collection procedure-Radical Orchiectomy Radical Orchiectomy Testis-Infiltrating malignant neoplasm-Histologic type-Teratoma Teratoma Testis-Infiltrating malignant neoplasm-Histologic type-Intratubular germ cell neoplasia, unclassified only Intratubular germ cell neoplasia, unclassified only Testis-Infiltrating malignant neoplasm-Histologic type-Seminoma, classic type Seminoma, classic type Testis-Infiltrating malignant neoplasm-Histologic type-Mixed germ cell tumor Mixed germ cell tumor Testis-Infiltrating malignant neoplasm-Histologic type-Yolk sac tumor Yolk sac tumor Testis-Infiltrating malignant neoplasm-Histologic type-Testicular scar only Testicular scar only Testis-Infiltrating malignant neoplasm-Margin site-Spermatic Cord Margin Spermatic Cord Margin Testis-Infiltrating malignant neoplasm-pT-pT0: No evidence of primary tumor pT0: No evidence of primary tumor Testis-Infiltrating malignant neoplasm-pT-pTis: Intratubular germ cell neoplasia (carcinoma in situ) pTis: Intratubular germ cell neoplasia (carcinoma in situ) Testis-Infiltrating malignant neoplasm-pT-pT1: Tumor limited to the testis and epididymis without vascular/lymphatic invasion; tumor may invade tunica albuginea but not tunica vaginalis pT1: Tumor limited to the testis and epididymis without vascular/lymphatic invasion; tumor may invade tunica albuginea but not tunica vaginalis Testis-Infiltrating malignant neoplasm-pT-pT2: Tumor limited to the testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis pT2: Tumor limited to the testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis Testis-Infiltrating malignant neoplasm-pT-pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion Testis-Infiltrating malignant neoplasm-pT-pTX: Cannot be assessed pT0: No evidence of primary tumor pTis: Intratubular germ cell neoplasia (carcinoma in situ) pT1: Tumor limited to the testis and epididymis without vascular/lymphatic invasion; tumor may invade tunica albuginea but not tunica vaginalis pT2: Tumor limited to the testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion pT4: Tumor invades the scrotum with or without vascular/lymphatic invasion pTX: Cannot be assessed pT0: No evidence of primary tumor pTis: Intratubular germ cell neoplasia (carcinoma in situ) pT1: Tumor limited to the testis and epididymis without vascular/lymphatic invasion; tumor may invade tunica albuginea but not tunica vaginalis pT2: Tumor limited to the testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion pT4: Tumor invades the scrotum with or without vascular/lymphatic invasion Testis-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis pN0: No regional lymph node metastasis Testis-Infiltrating malignant neoplasm-pN-pN1: Metastasis with a lymph node mass 2 cm or less in greatest dimension, or 5 or fewer positive nodes, none more than 2 cm in greatest dimension pN1: Metastasis with a lymph node mass 2 cm or less in greatest dimension, or 5 or fewer positive nodes, none more than 2 cm in greatest dimension Testis-Infiltrating malignant neoplasm-pN-pN2: Metastasis with a lymph node mass greater than 2 cm but not more than 5 cm in greatest dimension; or more than 5 nodes positive, none greater than 5 cm; or evidence of extranodal extension of tumor pN2: Metastasis with a lymph node mass greater than 2 cm but not more than 5 cm in greatest dimension; or more than 5 nodes positive, none greater than 5 cm; or evidence of extranodal extension of tumor Testis-Infiltrating malignant neoplasm-pN-pN3: Metastasis with a lymph node mass greater than 5 cm in greatest dimension pN3: Metastasis with a lymph node mass greater than 5 cm in greatest dimension Kidney-Specimen-Specimen collection procedure-Partial nephrectomy Partial nephrectomy Kidney-Specimen-Specimen collection procedure-Radical nephrectomy Radical nephrectomy Kidney-Infiltrating malignant neoplasm-Lesion site-Upper pole Upper pole Kidney-Infiltrating malignant neoplasm-Lesion site-Middle Middle Kidney-Infiltrating malignant neoplasm-Lesion site-Lower pole Lower pole Kidney-Infiltrating malignant neoplasm-Lesion site-Kidney Kidney Kidney-Infiltrating malignant neoplasm-Histologic type-Clear cell renal cell carcinoma Clear cell renal cell carcinoma Kidney-Infiltrating malignant neoplasm-Histologic type-Chromophobe renal cell carcinoma Chromophobe renal cell carcinoma Kidney-Infiltrating malignant neoplasm-Histologic type-Carcinoma of the collecting ducts of Bellini Carcinoma of the collecting ducts of Bellini Kidney-Infiltrating malignant neoplasm-Histologic type-Renal medullary carcinoma Renal medullary carcinoma Kidney-Infiltrating malignant neoplasm-Histologic grade (Fuhrman Nuclear Grade)-G1: Nuclei round, uniform, approximately 10 mm; nucleoli inconspicuous or absent G1: Nuclei round, uniform, approximately 10 mm; nucleoli inconspicuous or absent Kidney-Infiltrating malignant neoplasm-Histologic grade (Fuhrman Nuclear Grade)-G2: Nuclei slightly irregular, approximately 15 mm; nucleoli evident G2: Nuclei slightly irregular, approximately 15 mm; nucleoli evident Kidney-Infiltrating malignant neoplasm-Histologic grade (Fuhrman Nuclear Grade)-G3: Nuclei very irregular, approximately 20 mm; nucleoli large and proeminent G3: Nuclei very irregular, approximately 20 mm; nucleoli large and proeminent Kidney-Infiltrating malignant neoplasm-Histologic grade (Fuhrman Nuclear Grade)-G4: Nuclei bizarre and multilobated, 20 mm or greater, nucleoli prominent, chromatin clumped G4: Nuclei bizarre and multilobated, 20 mm or greater, nucleoli prominent, chromatin clumped Kidney-Infiltrating malignant neoplasm-Margin site-Renal parenchymal margin (partial nephrectomy only) Renal parenchymal margin (partial nephrectomy only) Kidney-Infiltrating malignant neoplasm-Margin site-Renal vein margin Renal vein margin Kidney-Infiltrating malignant neoplasm-pT-pT0: No evidence of primary tumor pT0: No evidence of primary tumor Kidney-Infiltrating malignant neoplasm-pT-pT1: Tumor 7 cm or less in greatest dimension, limited to the kidney pT1: Tumor 7 cm or less in greatest dimension, limited to the kidney Kidney-Infiltrating malignant neoplasm-pT-pT1a: Tumor 4 cm or less in greatest dimension, limited to the kidney pT1a: Tumor 4 cm or less in greatest dimension, limited to the kidney Kidney-Infiltrating malignant neoplasm-pT-pT1b: Tumor more than 4 cm but not more than 7 cm in greatest dimension, limited to the kidney pT1b: Tumor more than 4 cm but not more than 7 cm in greatest dimension, limited to the kidney Kidney-Infiltrating malignant neoplasm-pT-pT2: Tumor more than 7 cm in greatest dimension, limited to the kidney pT2: Tumor more than 7 cm in greatest dimension, limited to the kidney Generic-Infiltrating malignant neoplasm-Lesion size, additional dimension Lesion size, additional dimension Kidney-Infiltrating malignant neoplasm-pT-pT2a: Tumor more than 7 cm but less than or equal to 10 cm in greatest dimension, limited to the kidney pT2a: Tumor more than 7 cm but less than or equal to 10 cm in greatest dimension, limited to the kidney Kidney-Infiltrating malignant neoplasm-pT-pT2b: Tumor more than 10 cm, limited to the kidney pT2b: Tumor more than 10 cm, limited to the kidney Kidney-Infiltrating malignant neoplasm-pT-pT3: Tumor extends into major veins or perinephric tissues but not into the ipsilateral adrenal gland and not beyond Gerota’s fascia pT3: Tumor extends into major veins or perinephric tissues but not into the ipsilateral adrenal gland and not beyond Gerota’s fascia Kidney-Infiltrating malignant neoplasm-pT-pT3a: Tumor grossly extends into the renal vein or its segmental (muscle containing) branches, or tumor invades perirenal and/or renal sinus fat but not beyond Gerota’s fascia pT3a: Tumor grossly extends into the renal vein or its segmental (muscle containing) branches, or tumor invades perirenal and/or renal sinus fat but not beyond Gerota’s fascia Kidney-Infiltrating malignant neoplasm-pT-pT3b: Tumor grossly extends into the vena cava below the diaphragm pT3b: Tumor grossly extends into the vena cava below the diaphragm Kidney-Infiltrating malignant neoplasm-pT-pT3c: Tumor grossly extends into vena cava above diaphragm or invades the wall of the vena cava pT3c: Tumor grossly extends into vena cava above diaphragm or invades the wall of the vena cava Kidney-Infiltrating malignant neoplasm-pT-pT4: Tumor invades beyond Gerota’s fascia (including contiguous extension into the ipsilateral adrenal gland) pT4: Tumor invades beyond Gerota’s fascia (including contiguous extension into the ipsilateral adrenal gland) Kidney-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis pN0: No regional lymph node metastasis Kidney-Infiltrating malignant neoplasm-pN-pN1: Metastasis in regional lymph node(s) pN1: Metastasis in regional lymph node(s) Urinary bladder-Infiltrating malignant neoplasm-Histologic type-Urothelial (transitional cell) carcinoma Urothelial (transitional cell) carcinoma Urinary bladder-Infiltrating malignant neoplasm-Histologic type-Small cell carcinoma Small cell carcinoma Urinary bladder-Infiltrating malignant neoplasm-pT-pT0: No evidence of primary tumor pT0: No evidence of primary tumor Urinary bladder-Infiltrating malignant neoplasm-pT-pTa: Noninvasive papillary carcinoma pTa: Noninvasive papillary carcinoma Urinary bladder-Infiltrating malignant neoplasm-pT-pTis: Carcinoma in situ: “flat tumor” pTis: Carcinoma in situ: “flat tumor” Urinary bladder-Infiltrating malignant neoplasm-pT-pT1: Tumor invades subepithelial connective tissue (lamina propria) pT1: Tumor invades subepithelial connective tissue (lamina propria) Urinary bladder-Infiltrating malignant neoplasm-pT-pT2: Tumor invades muscularis propria (detrusor muscle) pT2: Tumor invades muscularis propria (detrusor muscle) Urinary bladder-Infiltrating malignant neoplasm-pT-pT2a: Tumor invades superficial muscularis propria (inner half) pT2a: Tumor invades superficial muscularis propria (inner half) Urinary bladder-Infiltrating malignant neoplasm-pT-pT2b: Tumor invades deep muscularis propria (outer half) pT2b: Tumor invades deep muscularis propria (outer half) Urinary bladder-Infiltrating malignant neoplasm-pT-pT3: Tumor invades perivesical tissue pT3: Tumor invades perivesical tissue Urinary bladder-Infiltrating malignant neoplasm-pT-pT3a: Microscopically pT3a: Microscopically Urinary bladder-Infiltrating malignant neoplasm-pT-pT3b: Macroscopically (extravesicular mass) pT3b: Macroscopically (extravesicular mass) Urinary bladder-Infiltrating malignant neoplasm-pT-pT4: Tumor invades any of the following: prostatic stroma, seminal vesicles, uterus,vagina, pelvic wall, abdominal wall pT4: Tumor invades any of the following: prostatic stroma, seminal vesicles, uterus,vagina, pelvic wall, abdominal wall Urinary bladder-Infiltrating malignant neoplasm-pT-pT4a: Tumor invades prostatic stroma or uterus or vagina pT4a: Tumor invades prostatic stroma or uterus or vagina Urinary bladder-Infiltrating malignant neoplasm-pT-pT4b: Tumor invades pelvic wall or abdominal wall pT4b: Tumor invades pelvic wall or abdominal wall Urinary bladder-Infiltrating malignant neoplasm-pN-pN1: Single regional lymph node metastasis in the true pelvis (hypogastric, obturator, external iliac or presacral lymph node) pN1: Single regional lymph node metastasis in the true pelvis (hypogastric, obturator, external iliac or presacral lymph node) Urinary bladder-Infiltrating malignant neoplasm-pN-pN2: Multiple regional lymph node metastasis in the true pelvis (hypogastric, obrutrator, external iliac or presacral lymph node metastasis) pN2: Multiple regional lymph node metastasis in the true pelvis (hypogastric, obrutrator, external iliac or presacral lymph node metastasis) Urinary bladder-Infiltrating malignant neoplasm-pN-pN3: Lymph node metastasis to the common iliac lymph nodes pN3: Lymph node metastasis to the common iliac lymph nodes Skin (melanoma)-Infiltrating malignant neoplasm-Lesion site-Body Body Skin (melanoma)-Specimen-Specimen collection procedure-Excision Excision Skin (melanoma)-Infiltrating malignant neoplasm-Histologic type-Superficial spreading melanoma Superficial spreading melanoma Skin (melanoma)-Infiltrating malignant neoplasm-Histologic type-Nodular melanoma Nodular melanoma Skin (melanoma)-Infiltrating malignant neoplasm-Histologic grade (Clark)-I (Melanoma in situ) I (Melanoma in situ) Skin (melanoma)-Infiltrating malignant neoplasm-Histologic grade (Clark)-II (Melanoma present in but does not fill and expand papillary dermis) II (Melanoma present in but does not fill and expand papillary dermis) Skin (melanoma)-Infiltrating malignant neoplasm-Histologic grade (Clark)-III (Melanoma fills and expands papillary dermis) III (Melanoma fills and expands papillary dermis) Skin (melanoma)-Infiltrating malignant neoplasm-Histologic grade (Clark)-IV (Melanoma invades reticular dermis) IV (Melanoma invades reticular dermis) Skin (melanoma)-Infiltrating malignant neoplasm-Histologic grade (Clark)-V (Melanoma invades subcutaneum) V (Melanoma invades subcutaneum) Skin (melanoma)-Infiltrating malignant neoplasm-Margin site-Deep margin Deep margin Skin (melanoma)-Infiltrating malignant neoplasm-Margin site-Peripheral margins Peripheral margins Skin (melanoma)-Infiltrating malignant neoplasm-pT-pT0: No evidence of primary tumor pT0: No evidence of primary tumor Skin (melanoma)-Infiltrating malignant neoplasm-pT-pTis: Melanoma in situ (ie, not an invasive tumor: anatomic level I) pTis: Melanoma in situ (ie, not an invasive tumor: anatomic level I) Skin (melanoma)-Infiltrating malignant neoplasm-pT-pT1: Melanoma 1.0 mm or less in thickness, with or without ulceration (see Note D) pT1: Melanoma 1.0 mm or less in thickness, with or without ulceration (see Note D) Skin (melanoma)-Infiltrating malignant neoplasm-pT-pT1a: Melanoma 1.0 mm or less in thickness, no ulceration, <1 mitoses/mm2 pT1a: Melanoma 1.0 mm or less in thickness, no ulceration, <1 mitoses/mm2 Skin (melanoma)-Infiltrating malignant neoplasm-pT-pT1b: Melanoma 1.0 mm or less in thickness with ulceration and/or 1 or more mitoses/mm2 pT1b: Melanoma 1.0 mm or less in thickness with ulceration and/or 1 or more mitoses/mm2 Skin (melanoma)-Infiltrating malignant neoplasm-pT-pT2: Melanoma 1.01 to 2 mm in thickness, with or without ulceration pT2: Melanoma 1.01 to 2 mm in thickness, with or without ulceration Skin (melanoma)-Infiltrating malignant neoplasm-pT-pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration Skin (melanoma)-Infiltrating malignant neoplasm-pT-pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration Skin (melanoma)-Infiltrating malignant neoplasm-pT-pT3: Melanoma 2.01 to 4.0 mm in thickness, with or without ulceration pT3: Melanoma 2.01 to 4.0 mm in thickness, with or without ulceration Skin (melanoma)-Infiltrating malignant neoplasm-pT-pT3a: Melanoma 2.01 to 4.0 mm in thickness, no ulceration pT3a: Melanoma 2.01 to 4.0 mm in thickness, no ulceration Skin (melanoma)-Infiltrating malignant neoplasm-pT-pT3b: Melanoma 2.01 to 4.0 mm in thickness, with ulceration pT3b: Melanoma 2.01 to 4.0 mm in thickness, with ulceration Skin (melanoma)-Infiltrating malignant neoplasm-pT-pT4: Melanoma greater than 4.0 mm in thickness, with or without ulceration pT4: Melanoma greater than 4.0 mm in thickness, with or without ulceration Skin (melanoma)-Infiltrating malignant neoplasm-pT-pT4a: Melanoma greater than 4.0 mm in thickness, no ulceration pT4a: Melanoma greater than 4.0 mm in thickness, no ulceration Skin (melanoma)-Infiltrating malignant neoplasm-pT-pT4b: Melanoma greater than 4.0 mm in thickness, with ulceration pT4b: Melanoma greater than 4.0 mm in thickness, with ulceration Skin (melanoma)-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis pN0: No regional lymph node metastasis Skin (melanoma)-Infiltrating malignant neoplasm-pN-pN1: Metastasis in 1 regional lymph node pN1: Metastasis in 1 regional lymph node Skin (melanoma)-Infiltrating malignant neoplasm-pN-pN1a: Clinically occult (microscopic) metastasis pN1a: Clinically occult (microscopic) metastasis Skin (melanoma)-Infiltrating malignant neoplasm-pN-pN1b: Clinically apparent (macroscopic) metastasis pN1b: Clinically apparent (macroscopic) metastasis Skin (melanoma)-Infiltrating malignant neoplasm-pN-pN2: Metastasis in 2 to 3 regional nodes or intralymphatic regional metastasis without nodal metastasis pN2: Metastasis in 2 to 3 regional nodes or intralymphatic regional metastasis without nodal metastasis Skin (melanoma)-Infiltrating malignant neoplasm-pN-pN2a: Clinically occult (microscopic) metastasis pN2a: Clinically occult (microscopic) metastasis Skin (melanoma)-Infiltrating malignant neoplasm-pN-pN2b: Clinically apparent (macroscopic) metastasis pN2b: Clinically apparent (macroscopic) metastasis Skin (melanoma)-Infiltrating malignant neoplasm-pN-pN2c: Satellite or in-transit metastasis without nodal metastasis pN2c: Satellite or in-transit metastasis without nodal metastasis Skin (melanoma)-Infiltrating malignant neoplasm-pN-pN3: Metastasis in 4 or more regional lymph nodes, or matted metastatic nodes, or in-transit metastasis or satellites(s) with metastasis in regional node(s) pN3: Metastasis in 4 or more regional lymph nodes, or matted metastatic nodes, or in-transit metastasis or satellites(s) with metastasis in regional node(s) Thyroid-Infiltrating malignant neoplasm-Lesion site-Thyroid Thyroid Thyroid-Specimen-Specimen collection procedure-Thyroid lobectomy Thyroid lobectomy Thyroid-Specimen-Specimen collection procedure-Partial thyroidectomy (anything less than a lobectomy) Partial thyroidectomy (anything less than a lobectomy) Thyroid-Specimen-Specimen collection procedure-Hemithyroidectomy (lobe and part or all of isthmus) Hemithyroidectomy (lobe and part or all of isthmus) Thyroid-Specimen-Specimen collection procedure-Total thyroidectomy Total thyroidectomy Margins involvement Cervix-Infiltrating malignant neoplasm-Margins involvement Cervix-Margins involvement Thyroid-Infiltrating malignant neoplasm-Histologic type-Papillary carcinoma Papillary carcinoma Thyroid-Infiltrating malignant neoplasm-Histologic type-Follicular carcinoma Follicular carcinoma Thyroid-Infiltrating malignant neoplasm-Histologic type-Poorly differentiated thyroid Carcinoma, including insular carcinoma Poorly differentiated thyroid Carcinoma, including insular carcinoma Thyroid-Infiltrating malignant neoplasm-Histologic type-Medullary carcinoma Medullary carcinoma Thyroid-Infiltrating malignant neoplasm-Histologic type-Undifferentiated (anaplastic) carcinoma Undifferentiated (anaplastic) carcinoma Thyroid-Infiltrating malignant neoplasm-pT-pT0: No evidence of primary tumor pT0: No evidence of primary tumor Margins involvement Cervix-In situ neoplasm-Margins involvement Cervix-Margins involvement Thyroid-Infiltrating malignant neoplasm-pT-pT1: Tumor size 2 cm or less, limited to thyroid pT1: Tumor size 2 cm or less, limited to thyroid Thyroid-Infiltrating malignant neoplasm-pT-pT1a: Tumor 1 cm or less in greatest dimension limited to the thyroid. pT1a: Tumor 1 cm or less in greatest dimension limited to the thyroid. Thyroid-Infiltrating malignant neoplasm-pT-pT1b: Tumor more than 1 cm but not more than 2 cm in greatest dimension, limited to the thyroid pT1b: Tumor more than 1 cm but not more than 2 cm in greatest dimension, limited to the thyroid Thyroid-Infiltrating malignant neoplasm-pT-pT2: Tumor more than 2 cm, but not more than 4 cm, limited to thyroid pT2: Tumor more than 2 cm, but not more than 4 cm, limited to thyroid Thyroid-Infiltrating malignant neoplasm-pT-pT3: Tumor more than 4 cm limited to thyroid or any tumor with minimal extrathyroid extension (eg, extension to sternothyroid muscle or perithyroid soft tissues) pT3: Tumor more than 4 cm limited to thyroid or any tumor with minimal extrathyroid extension (eg, extension to sternothyroid muscle or perithyroid soft tissues) Thyroid-Infiltrating malignant neoplasm-pT-pT4a: Moderately advanced disease. Tumor of any size extending beyond the thyroid capsule to invade subcutaneous soft tissues, larynx, trachea, esophagus or recurrent laryngeal nerve pT4a: Moderately advanced disease. Tumor of any size extending beyond the thyroid capsule to invade subcutaneous soft tissues, larynx, trachea, esophagus or recurrent laryngeal nerve Thyroid-Infiltrating malignant neoplasm-pT-pT4b: Very advanced disease. Tumor invades prevertebral fascia or encases carotid artery or mediastinal vessels pT4b: Very advanced disease. Tumor invades prevertebral fascia or encases carotid artery or mediastinal vessels Thyroid-Infiltrating malignant neoplasm-pT-pT0: No evidence of primary tumor pT0: No evidence of primary tumor Thyroid-Infiltrating malignant neoplasm-pT-pT1: Tumor size 2 cm or less, limited to thyroid pT1: Tumor size 2 cm or less, limited to thyroid Thyroid-Infiltrating malignant neoplasm-pT-pT1a: Tumor 1 cm or less in greatest dimension limited to the thyroid. pT1a: Tumor 1 cm or less in greatest dimension limited to the thyroid. Cervix-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin Distance of lesion from closest uninvolved margin Thyroid-Infiltrating malignant neoplasm-pT-pT1b: Tumor more than 1 cm but not more than 2 cm in greatest dimension, limited to the thyroid pT1b: Tumor more than 1 cm but not more than 2 cm in greatest dimension, limited to the thyroid Thyroid-Infiltrating malignant neoplasm-pT-pT2: Tumor more than 2 cm, but not more than 4 cm, limited to thyroid pT2: Tumor more than 2 cm, but not more than 4 cm, limited to thyroid Thyroid-Infiltrating malignant neoplasm-pT-pT3: Tumor more than 4 cm limited to thyroid or any tumor with minimal extrathyroid extension (eg, extension to sternothyroid muscle or perithyroid soft tissues) pT3: Tumor more than 4 cm limited to thyroid or any tumor with minimal extrathyroid extension (eg, extension to sternothyroid muscle or perithyroid soft tissues) Thyroid-Infiltrating malignant neoplasm-pT-pT4a: Intrathyroidal anaplastic carcinoma—surgically resectable pT4a: Intrathyroidal anaplastic carcinoma—surgically resectable Thyroid-Infiltrating malignant neoplasm-pT-pT4b: Extrathyroidal anaplastic carcinoma—surgically unresectable pT4b: Extrathyroidal anaplastic carcinoma—surgically unresectable Thyroid-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis pN0: No regional lymph node metastasis Thyroid-Infiltrating malignant neoplasm-pN-pN1a: Nodal metastases to Level VI (pretracheal, paratracheal and prelaryngeal/Delphian) lymph nodes pN1a: Nodal metastases to Level VI (pretracheal, paratracheal and prelaryngeal/Delphian) lymph nodes Thyroid-Infiltrating malignant neoplasm-pN-pN1b: Metastases to unilateral, bilateral or contralateral cervical (Levels I, II, III, IV,V) or retropharyngeal or superior mediastinal lymph nodes (Level VII). pN1b: Metastases to unilateral, bilateral or contralateral cervical (Levels I, II, III, IV,V) or retropharyngeal or superior mediastinal lymph nodes (Level VII). Cervix-In situ neoplasm-Distance of lesion from closest uninvolved margin Distance of lesion from closest uninvolved margin Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Squamous cell carcinoma, conventional Squamous cell carcinoma, conventional Lymph-vascular invasion Cervix-Infiltrating malignant neoplasm-Lymph-vascular invasion Cervix-Lymph-vascular invasion Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Basaloid squamous cell carcinoma Basaloid squamous cell carcinoma Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Spindle cell squamous carcinoma Spindle cell squamous carcinoma Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Verrucous carcinoma Verrucous carcinoma Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Adenosquamous carcinoma Adenosquamous carcinoma Lymph node sampling Cervix-Infiltrating malignant neoplasm-Lymph node sampling Cervix-Lymph node sampling Lip, oral cavity-Infiltrating malignant neoplasm-pT carcinoma-pT0: No evidence of primary tumor pT0: No evidence of primary tumor Lip, oral cavity-Infiltrating malignant neoplasm-pT carcinoma-pTis: Carcinoma in situ pTis: Carcinoma in situ Extent Cervix-Infiltrating malignant neoplasm-Extent Cervix-Extent Lip, oral cavity-Infiltrating malignant neoplasm-pT carcinoma-pT1: Tumor 2 cm or less in greatest dimension pT1: Tumor 2 cm or less in greatest dimension Lip, oral cavity-Infiltrating malignant neoplasm-pT carcinoma-pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension Lip, oral cavity-Infiltrating malignant neoplasm-pT carcinoma-pT3: Tumor more than 4 cm in greatest dimension - Oropharynx : or extension to lingual surface of epiglottis pT3: Tumor more than 4 cm in greatest dimension - Oropharynx : or extension to lingual surface of epiglottis Lip, oral cavity-Infiltrating malignant neoplasm-pT carcinoma-pT4a: Moderately advanced local disease. Lip: Tumor invades through cortical bone, inferior alveolar nerve, floor of mouth, or skin of face, ie, chin or nose - Oral cavity: Tumor invades adjacent structures only (eg, through cortical bone [mandible, maxilla], into deep [extrinsic] muscle of tongue [genioglossus, hyoglossus, palatoglossus, and styloglossus], maxillary sinus, skin of face) - Oropharynx : Tumor invades larynx, deep/extrinsic muscle of tongue, medial pterygoid muscles, hard palate, or mandible pT4a: Moderately advanced local disease. Lip: Tumor invades through cortical bone, inferior alveolar nerve, floor of mouth, or skin of face, ie, chin or nose - Oral cavity: Tumor invades adjacent structures only (eg, through cortical bone [mandible, maxilla], into deep [extrinsic] muscle of tongue [genioglossus, hyoglossus, palatoglossus, and styloglossus], maxillary sinus, skin of face) - Oropharynx : Tumor invades larynx, deep/extrinsic muscle of tongue, medial pterygoid muscles, hard palate, or mandible Lip, oral cavity-Infiltrating malignant neoplasm-pT carcinoma-pT4b: Very advanced local disease. Tumor invades masticator space, pterygoid plates, or skull base, and/or encases internal carotid artery - Oropharynx: Tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base, or encases carotid artery pT4b: Very advanced local disease. Tumor invades masticator space, pterygoid plates, or skull base, and/or encases internal carotid artery - Oropharynx: Tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base, or encases carotid artery Lip, oral cavity-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis pN0: No regional lymph node metastasis Lip, oral cavity-Infiltrating malignant neoplasm-pN-pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension Lip, oral cavity-Infiltrating malignant neoplasm-pN-pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension Lip, oral cavity-Infiltrating malignant neoplasm-pN-pN2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension pN2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension Lip, oral cavity-Infiltrating malignant neoplasm-pN-pN2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension pN2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension Cervix-Lesion-Identification of pathogen agents Identification of pathogen agents Lip, oral cavity-Infiltrating malignant neoplasm-pN-pN3: Metastasis in a lymph node more than 6 cm in greatest dimension pN3: Metastasis in a lymph node more than 6 cm in greatest dimension Pharynx-Specimen-Target site-Nasopharynx Nasopharynx Pharynx-Specimen-Target site-Hypopharynx Hypopharynx Pharynx-Specimen-Specimen collection procedure-Laryngopharyngectomy Laryngopharyngectomy Lesion site Cervix-Infiltrating malignant neoplasm-Lesion site Cervix-Lesion site Pharynx-Infiltrating malignant neoplasm-Lesion site-Hypopharynx: Piriform sinus Hypopharynx: Piriform sinus Pharynx-Infiltrating malignant neoplasm-Lesion site-Hypopharynx: Postcricoid Hypopharynx: Postcricoid Pharynx-Infiltrating malignant neoplasm-Lesion site-Hypopharynx: Pharyngeal wall (posterior and/or lateral) Hypopharynx: Pharyngeal wall (posterior and/or lateral) Lymph node site Cervix-Infiltrating malignant neoplasm-Lymph node site Cervix-Lymph node site Number of lymph nodes involved Cervix-Infiltrating malignant neoplasm-Number of lymph nodes involved Cervix-Number of lymph nodes involved Number of lymph nodes examined Cervix-Infiltrating malignant neoplasm-Number of lymph nodes examined Cervix-Number of lymph nodes examined Salivary gland-Specimen-Target site-Total parotid gland (qualifier : right, left) Total parotid gland (qualifier : right, left) Salivary gland-Infiltrating malignant neoplasm-Lesion site-Submandibular gland Submandibular gland Salivary gland-Infiltrating malignant neoplasm-Lesion site-Sublingual gland Sublingual gland Salivary gland-Specimen-Specimen collection procedure-Superficial parotidectomy (qualifier: right, left) Superficial parotidectomy (qualifier: right, left) Salivary gland-Specimen-Specimen collection procedure-Total parotidectomy (qualifier: right, left) Total parotidectomy (qualifier: right, left) Salivary gland-Infiltrating malignant neoplasm-Histologic type-Adenoid cystic carcinoma Adenoid cystic carcinoma Salivary gland-Infiltrating malignant neoplasm-Histologic type-Adenocarcinoma, not otherwise specified (NOS) Adenocarcinoma, not otherwise specified (NOS) Salivary gland-Infiltrating malignant neoplasm-Histologic type-Basal cell adenocarcinoma Basal cell adenocarcinoma Salivary gland-Infiltrating malignant neoplasm-Histologic type-Carcinoma ex pleomorphic adenoma (malignant mixed tumor) Carcinoma ex pleomorphic adenoma (malignant mixed tumor) Salivary gland-Infiltrating malignant neoplasm-Histologic type-Carcinosarcoma (true malignant mixed tumor) Carcinosarcoma (true malignant mixed tumor) Salivary gland-Infiltrating malignant neoplasm-Histologic type-Mucoepidermoid carcinoma Mucoepidermoid carcinoma pN Cervix-Infiltrating malignant neoplasm-pN Cervix-Infiltrating malignant neoplasm-pN Salivary gland-Infiltrating malignant neoplasm-Histologic type-Sebaceous adenocarcinoma Sebaceous adenocarcinoma Salivary gland-Infiltrating malignant neoplasm-Histologic type-Small cell (neuroendocrine) carcinoma Small cell (neuroendocrine) carcinoma Salivary gland-Infiltrating malignant neoplasm-Histologic type-Undifferentiated carcinoma, large cell type Undifferentiated carcinoma, large cell type Salivary gland-Infiltrating malignant neoplasm-pT-pTX: Cannot be assessed pTX: Cannot be assessed Salivary gland-Infiltrating malignant neoplasm-pT-pT0: No evidence of primary tumor pT0: No evidence of primary tumor Salivary gland-Infiltrating malignant neoplasm-pT-pT1: Tumor 2 cm or less in greatest dimension without extraparenchymal extension pT1: Tumor 2 cm or less in greatest dimension without extraparenchymal extension Salivary gland-Infiltrating malignant neoplasm-pT-pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension without extraparenchymal extension pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension without extraparenchymal extension Salivary gland-Infiltrating malignant neoplasm-pT-pT3: Tumor more than 4 cm and/or tumor having extraparenchymal extension pT3: Tumor more than 4 cm and/or tumor having extraparenchymal extension Salivary gland-Infiltrating malignant neoplasm-pT-pT4a: Moderately advanced disease. Tumor invades skin, mandible, ear canal, and/or facial nerve. pT4a: Moderately advanced disease. Tumor invades skin, mandible, ear canal, and/or facial nerve. Salivary gland-Infiltrating malignant neoplasm-pT-pT4b: Very advanced local disease. Tumor invades skull base and/or pterygoid plates and/or encases carotid artery pT4b: Very advanced local disease. Tumor invades skull base and/or pterygoid plates and/or encases carotid artery Salivary gland-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis pN0: No regional lymph node metastasis Salivary gland-Infiltrating malignant neoplasm-pN-pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension Salivary gland-Infiltrating malignant neoplasm-pN-pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension pT Cervix-Infiltrating malignant neoplasm-pT Cervix-Infiltrating malignant neoplasm-pT Salivary gland-Infiltrating malignant neoplasm-pN-pN2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension pN2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension Salivary gland-Infiltrating malignant neoplasm-pN-pN2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension pN2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension Salivary gland-Infiltrating malignant neoplasm-pN-pN3: Metastasis in a lymph node, more than 6 cm in greatest dimension pN3: Metastasis in a lymph node, more than 6 cm in greatest dimension Larynx-Specimen-Specimen collection procedure-Partial laryngectomy (specify type) Partial laryngectomy (specify type) Larynx-Specimen-Specimen collection procedure-Total laryngectomy Total laryngectomy Lesion size, largest dimension Cervix-Infiltrating malignant neoplasm-Lesion size, largest dimension Cervix-Lesion size, largest dimension Larynx-Infiltrating malignant neoplasm-Histologic type-Squamous cell carcinoma, conventional Squamous cell carcinoma, conventional Larynx-Infiltrating malignant neoplasm-Histologic type-Adenosquamous carcinoma Adenosquamous carcinoma Larynx-Infiltrating malignant neoplasm-Histologic type-Verrucous carcinoma Verrucous carcinoma Larynx-Infiltrating malignant neoplasm-Histologic type-Lymphoepithelial carcinoma (non-nasopharyngeal) Lymphoepithelial carcinoma (non-nasopharyngeal) Larynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands Carcinoma of Minor Salivary Glands Cervix-In situ neoplasm-Cytologic type Cytologic type Larynx-Infiltrating malignant neoplasm-pT supra glottis carcinoma-pT0: No evidence of primary tumor pT0: No evidence of primary tumor Larynx-Infiltrating malignant neoplasm-pT supra glottis carcinoma-pTis: Carcinoma in situ pTis: Carcinoma in situ Larynx-Infiltrating malignant neoplasm-pT supra glottis carcinoma-pT1: Tumor limited to one subsite of supraglottis with normal vocal cord mobility pT1: Tumor limited to one subsite of supraglottis with normal vocal cord mobility Larynx-Infiltrating malignant neoplasm-pT supra glottis carcinoma-pT2: Tumor invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (eg, mucosa of base of tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx pT2: Tumor invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (eg, mucosa of base of tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx Cervix-Infiltrating malignant neoplasm-Cytologic type Cytologic type Larynx-Infiltrating malignant neoplasm-pT supra glottis carcinoma-pT3: Tumor limited to larynx with vocal cord fixation and/or invades any of the following: postcricoid area, preepiglottic space, paraglottic space, and/or inner cortex of thyroid cartilage pT3: Tumor limited to larynx with vocal cord fixation and/or invades any of the following: postcricoid area, preepiglottic space, paraglottic space, and/or inner cortex of thyroid cartilage Larynx-Infiltrating malignant neoplasm-pT supra glottis carcinoma-pT4a: Moderately advanced local disease. Tumor invades through the thyroid cartilage and/or invades tissues beyond the larynx (eg, trachea, soft tissues of neck including deep extrinsic muscle of tongue, strap muscles, thyroid, or esophagus) pT4a: Moderately advanced local disease. Tumor invades through the thyroid cartilage and/or invades tissues beyond the larynx (eg, trachea, soft tissues of neck including deep extrinsic muscle of tongue, strap muscles, thyroid, or esophagus) Larynx-Infiltrating malignant neoplasm-pT supra glottis carcinoma-pT4b: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures pT4b: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures Larynx-Infiltrating malignant neoplasm-pT glottis carcinoma-pT0: No evidence of primary tumor pT0: No evidence of primary tumor Larynx-Infiltrating malignant neoplasm-pT glottis carcinoma-pTis: Carcinoma in situ pTis: Carcinoma in situ Larynx-Infiltrating malignant neoplasm-pT glottis carcinoma-pT1: Tumor limited to the vocal cord(s) (may involve anterior or posterior commissure) with normal mobility pT1: Tumor limited to the vocal cord(s) (may involve anterior or posterior commissure) with normal mobility Larynx-Infiltrating malignant neoplasm-pT glottis carcinoma-pT1a: Tumor limited to one vocal cord pT1a: Tumor limited to one vocal cord Larynx-Infiltrating malignant neoplasm-pT glottis carcinoma-pT1b: Tumor involves both vocal cords pT1b: Tumor involves both vocal cords Larynx-Infiltrating malignant neoplasm-pT glottis carcinoma-pT2: Tumor extends to supraglottis and/or subglottis and/or with impaired vocal cord mobility pT2: Tumor extends to supraglottis and/or subglottis and/or with impaired vocal cord mobility Larynx-Infiltrating malignant neoplasm-pT glottis carcinoma-pT3: Tumor limited to the larynx with vocal cord fixation and/or invades paraglottic space and/or minor thyroid cartilage erosion (eg, inner cortex) (Note H) pT3: Tumor limited to the larynx with vocal cord fixation and/or invades paraglottic space and/or minor thyroid cartilage erosion (eg, inner cortex) (Note H) Histologic type Cervix-Lesion-Histologic type Cervix-Histologic type Larynx-Infiltrating malignant neoplasm-pT glottis carcinoma-pT4a: Moderately advanced local disease. Tumor invades through the outer cortex of the thyroid cartilage and/or invades tissues beyond the larynx (eg, trachea, soft tissues of neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus) (Note H) pT4a: Moderately advanced local disease. Tumor invades through the outer cortex of the thyroid cartilage and/or invades tissues beyond the larynx (eg, trachea, soft tissues of neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus) (Note H) Larynx-Infiltrating malignant neoplasm-pT glottis carcinoma-pT4b: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures pT4b: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures Larynx-Infiltrating malignant neoplasm-pT sub glottis carcinoma-pT0: No evidence of primary tumor pT0: No evidence of primary tumor Larynx-Infiltrating malignant neoplasm-pT sub glottis carcinoma-pTis: Carcinoma in situ pTis: Carcinoma in situ Larynx-Infiltrating malignant neoplasm-pT sub glottis carcinoma-pT1: Tumor limited to subglottis pT1: Tumor limited to subglottis Larynx-Infiltrating malignant neoplasm-pT sub glottis carcinoma-pT2: Tumor extends to vocal cord(s) with normal or impaired mobility pT2: Tumor extends to vocal cord(s) with normal or impaired mobility Larynx-Infiltrating malignant neoplasm-pT sub glottis carcinoma-pT3: Tumor limited to larynx with vocal cord fixation pT3: Tumor limited to larynx with vocal cord fixation Larynx-Infiltrating malignant neoplasm-pT sub glottis carcinoma-pT4a: Moderately advanced local disease. Tumor invades cricoid or thyroid cartilage and/or invades tissues beyond the larynx (eg, trachea, soft tissues of neck including deep extrinsic muscles of the tongue, strap muscles, thyroid, or esophagus) pT4a: Moderately advanced local disease. Tumor invades cricoid or thyroid cartilage and/or invades tissues beyond the larynx (eg, trachea, soft tissues of neck including deep extrinsic muscles of the tongue, strap muscles, thyroid, or esophagus) Larynx-Infiltrating malignant neoplasm-pT sub glottis carcinoma-pT4b: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures pT4b: Very advanced local disease. Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures Larynx-Infiltrating malignant neoplasm-pT mucosal malignant melanoma-pT0: No evidence of primary tumor pT0: No evidence of primary tumor Prostate-Infiltrating malignant neoplasm-Lesion size, largest dimension Lesion size, largest dimension Histologic type Cervix-In situ neoplasm-Histologic type Cervix-Histologic type Larynx-Infiltrating malignant neoplasm-pT mucosal malignant melanoma-pTis: Carcinoma in situ pTis: Carcinoma in situ Larynx-Infiltrating malignant neoplasm-pT mucosal malignant melanoma-pT3: Mucosal disease pT3: Mucosal disease Larynx-Infiltrating malignant neoplasm-pT mucosal malignant melanoma-pT4a: Moderately advanced disease. Tumor involving deep soft tissue, cartilage, bone, or overlying skin pT4a: Moderately advanced disease. Tumor involving deep soft tissue, cartilage, bone, or overlying skin Larynx-Infiltrating malignant neoplasm-pT mucosal malignant melanoma-pT4b: Very advanced disease. Tumor involving brain, dura, skull base, lower cranial nerves (IX, X, XI, XII), masticator space, carotid artery, prevertebral space, or mediastinal structures pT4b: Very advanced disease. Tumor involving brain, dura, skull base, lower cranial nerves (IX, X, XI, XII), masticator space, carotid artery, prevertebral space, or mediastinal structures Larynx-Infiltrating malignant neoplasm-pN carcinoma-pN0: No regional lymph node metastasis pN0: No regional lymph node metastasis Larynx-Infiltrating malignant neoplasm-pN carcinoma-pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension Larynx-Infiltrating malignant neoplasm-pN carcinoma-pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension Larynx-Infiltrating malignant neoplasm-pN carcinoma-pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension Larynx-Infiltrating malignant neoplasm-pN carcinoma-pN2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension pN2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension Larynx-Infiltrating malignant neoplasm-pN carcinoma-pN2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension pN2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension Histologic type Cervix-Infiltrating malignant neoplasm-Histologic type Cervix-Histologic type Larynx-Infiltrating malignant neoplasm-pN carcinoma-pN3: Metastasis in a lymph node more than 6 cm in greatest dimension pN3: Metastasis in a lymph node more than 6 cm in greatest dimension Larynx-Infiltrating malignant neoplasm-pN mucosal malignant melanoma-pN0: No regional lymph node metastases pN0: No regional lymph node metastases Larynx-Infiltrating malignant neoplasm-pN mucosal malignant melanoma-pN1: Regional lymph node metastases present pN1: Regional lymph node metastases present Esophagus-Specimen-Specimen collection procedure-Endoscopic resection Endoscopic resection Urinary bladder-Specimen-Target site-Urinary bladder Urinary bladder Concept pT UICC TNM 7ème édition Generic-Infiltrating malignant neoplasm-pT-Concept pT UICC TNM 7ème édition pT-Concept pT UICC TNM 7ème édition Concept pN UICC TNM 7ème édition Generic-Infiltrating malignant neoplasm-pN-Concept pN UICC TNM 7ème édition pN-Concept pN UICC TNM 7ème édition Concept pM UICC TNM 7ème édition Generic-Infiltrating malignant neoplasm-pM-Concept pM UICC TNM 7ème édition pM-Concept pM UICC TNM 7ème édition Cervix-Infiltrating malignant neoplasm-Cytologic type-Squamous cell carcinoma Squamous cell carcinoma Cervix-Infiltrating malignant neoplasm-Cytologic type-Adenocarcinoma Adenocarcinoma Cervix-In situ neoplasm-Cytologic type-Atypical squamous cells Atypical squamous cells Cervix-In situ neoplasm-Cytologic type-Atypical squamous cells of undetermined significance (ASC-US) Atypical squamous cells of undetermined significance (ASC-US) Cervix-In situ neoplasm-Cytologic type-Atypical squamous cells for which a high-grade lesion cannot be excluded (ASC-H) Atypical squamous cells for which a high-grade lesion cannot be excluded (ASC-H) Cervix-In situ neoplasm-Cytologic type-Low-grade squamous intraepithelial lesion encompassing HPV infection or mild dysplasia (CIN 1) Low-grade squamous intraepithelial lesion encompassing HPV infection or mild dysplasia (CIN 1) Cervix-In situ neoplasm-Cytologic type-High-grade squamous intraepithelial lesion encompassing moderate (CIN 2) and severe dysplasia (CIN 3/CIS); whether the lesion has features suggesting invasion is noted High-grade squamous intraepithelial lesion encompassing moderate (CIN 2) and severe dysplasia (CIN 3/CIS); whether the lesion has features suggesting invasion is noted Cervix-In situ neoplasm-Cytologic type-Atypical glandular cells Atypical glandular cells Cervix-In situ neoplasm-Cytologic type-Atypical endocervical cells Atypical endocervical cells Cervix-In situ neoplasm-Cytologic type-Atypical endometrial cells Atypical endometrial cells Cervix-In situ neoplasm-Cytologic type-Atypical glandular cells likely to be cancerous Atypical glandular cells likely to be cancerous Colon-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin Distance of lesion from closest uninvolved margin Cervix-In situ neoplasm-Cytologic type-Atypical endocervical cells likely to be cancerou Atypical endocervical cells likely to be cancerou Cervix-In situ neoplasm-Cytologic type-Adenocarcinoma endocervical in situ Adenocarcinoma endocervical in situ Cervix-Lesion-Histologic type-Inflammation Inflammation Colon-Infiltrating malignant neoplasm-Lymph-vascular invasion Lymph-vascular invasion Breast-Infiltrating malignant neoplasm-HER2/neu (immunoperoxidase study)-Positive (Score 3+) Positive (Score 3+) Breast-Infiltrating malignant neoplasm-HER2/neu (immunoperoxidase study)-Negative (Score 0) Negative (Score 0) Colon-Infiltrating malignant neoplasm-Extent Extent Colon-Infiltrating malignant neoplasm-Perineural invasion Perineural invasion Prostate-Infiltrating malignant neoplasm-Lesion size, largest dimension Lesion size, largest dimension Colon-Infiltrating malignant neoplasm-Lesion site Lesion site Colon-Infiltrating malignant neoplasm-Margin site Margin site Colon-Infiltrating malignant neoplasm-Number of lymph nodes involved Number of lymph nodes involved Colon-Infiltrating malignant neoplasm-Number of lymph nodes examined Number of lymph nodes examined Colon-Infiltrating malignant neoplasm-pN pN Colon-Infiltrating malignant neoplasm-pT pT Colon-Infiltrating malignant neoplasm-Lesion size, largest dimension Lesion size, largest dimension Colon-Infiltrating malignant neoplasm-Specimen size, largest dimension Specimen size, largest dimension Generic-Infiltrating malignant neoplasm-TNM Descriptors -Multiple primary tumors Multiple primary tumors Generic-Infiltrating malignant neoplasm-TNM Descriptors -Recurrent Recurrent Generic-Infiltrating malignant neoplasm-TNM Descriptors -Post-treatment Post-treatment Skin (melanoma)-Infiltrating malignant neoplasm-Lesion size, largest dimension Lesion size, largest dimension Colon-Infiltrating malignant neoplasm-Histologic type Histologic type Breast-Infiltrating malignant neoplasm-Estrogen receptor-No immunoreactive tumor cells present No immunoreactive tumor cells present Endometrium-Infiltrating malignant neoplasm-Margins involvement Margins involvement Pharynx-Infiltrating malignant neoplasm-pN hypopharynx carcinoma-pN0: No regional lymph node metastasis pN0: No regional lymph node metastasis Endometrium-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin Distance of lesion from closest uninvolved margin Pharynx-Infiltrating malignant neoplasm-pN hypopharynx carcinoma-pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension Pharynx-Infiltrating malignant neoplasm-pN hypopharynx carcinoma-pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension Pharynx-Infiltrating malignant neoplasm-pN hypopharynx carcinoma-pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension Pharynx-Infiltrating malignant neoplasm-pN hypopharynx carcinoma-pN2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension pN2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension Pharynx-Infiltrating malignant neoplasm-pN hypopharynx carcinoma-pN2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension pN2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension Pharynx-Infiltrating malignant neoplasm-pN hypopharynx carcinoma-pN3: Metastasis in a lymph node more than 6 cm in greatest dimension pN3: Metastasis in a lymph node more than 6 cm in greatest dimension Pharynx-Infiltrating malignant neoplasm-pN nasopharynx carcinoma-pN0: No regional lymph node metastasis pN0: No regional lymph node metastasis Pharynx-Infiltrating malignant neoplasm-pN nasopharynx carcinoma-pN1: Unilateral metastasis in lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa pN1: Unilateral metastasis in lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa Pharynx-Infiltrating malignant neoplasm-pN nasopharynx carcinoma-pN2: Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa pN2: Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa Pharynx-Infiltrating malignant neoplasm-pN nasopharynx carcinoma-pN3: Metastasis in a lymph node greater than 6 cm and/or to supraclavicular fossa pN3: Metastasis in a lymph node greater than 6 cm and/or to supraclavicular fossa Endometrium-Infiltrating malignant neoplasm-Lymph-vascular invasion Lymph-vascular invasion Pharynx-Infiltrating malignant neoplasm-pN nasopharynx carcinoma-pN3a: Greater than 6 cm in dimension pN3a: Greater than 6 cm in dimension Pharynx-Infiltrating malignant neoplasm-pN nasopharynx carcinoma-pN3b: Extension to the supraclavicular fossa pN3b: Extension to the supraclavicular fossa Pharynx-Infiltrating malignant neoplasm-pN mucosal malignant melanoma-pN0: No regional lymph node metastases pN0: No regional lymph node metastases Pharynx-Infiltrating malignant neoplasm-pN mucosal malignant melanoma-pN1: Regional lymph node metastases present pN1: Regional lymph node metastases present Pharynx-Infiltrating malignant neoplasm-pT hypopharynx carcinoma-pT0: No evidence of primary tumor pT0: No evidence of primary tumor Pharynx-Infiltrating malignant neoplasm-pT hypopharynx carcinoma-pTis: Carcinoma in situ pTis: Carcinoma in situ Pharynx-Infiltrating malignant neoplasm-pT hypopharynx carcinoma-pT1: Tumor limited to one subsite of hypopharynx and/or 2 cm or less in greatest dimension pT1: Tumor limited to one subsite of hypopharynx and/or 2 cm or less in greatest dimension Pharynx-Infiltrating malignant neoplasm-pT hypopharynx carcinoma-pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or measures more than 2 cm but not more than 4 cm in greatest dimension without fixation of hemilarynx pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or measures more than 2 cm but not more than 4 cm in greatest dimension without fixation of hemilarynx Pharynx-Infiltrating malignant neoplasm-pT hypopharynx carcinoma-pT3: Tumor measures more than 4 cm in greatest dimension or with fixation of hemilarynx or extension to esophagus pT3: Tumor measures more than 4 cm in greatest dimension or with fixation of hemilarynx or extension to esophagus Pharynx-Infiltrating malignant neoplasm-pT hypopharynx carcinoma-pT4a: Moderately advanced local disease. Tumor invades thyroid/cricoid cartilage, hyoid bone, thyroid gland, or central compartment soft tissue# pT4a: Moderately advanced local disease. Tumor invades thyroid/cricoid cartilage, hyoid bone, thyroid gland, or central compartment soft tissue# Endometrium-Infiltrating malignant neoplasm-Lymph node sampling Lymph node sampling Pharynx-Infiltrating malignant neoplasm-pT hypopharynx carcinoma-pT4b: Very advanced local disease. Tumor invades prevertebral pT4b: Very advanced local disease. Tumor invades prevertebral Pharynx-Infiltrating malignant neoplasm-pT mucosal malignant melanoma-pT3: Mucosal disease pT3: Mucosal disease Pharynx-Infiltrating malignant neoplasm-pT mucosal malignant melanoma-pT4a: Moderately advanced disease. Tumor involving deep soft tissue, cartilage,bone, or overlying skin. pT4a: Moderately advanced disease. Tumor involving deep soft tissue, cartilage,bone, or overlying skin. Pharynx-Infiltrating malignant neoplasm-pT mucosal malignant melanoma-pT4b: Very advanced disease. Tumor involving brain, dura, skull base, lower cranial nerves (IX, X, XI, XII), masticator space, carotid artery, prevertebral space, or mediastinal structures. pT4b: Very advanced disease. Tumor involving brain, dura, skull base, lower cranial nerves (IX, X, XI, XII), masticator space, carotid artery, prevertebral space, or mediastinal structures. Pharynx-Infiltrating malignant neoplasm-pT nasopharynx carcinoma-pT0: No evidence of primary tumor pT0: No evidence of primary tumor Pharynx-Infiltrating malignant neoplasm-pT nasopharynx carcinoma-pTis: Carcinoma in situ pTis: Carcinoma in situ Pharynx-Infiltrating malignant neoplasm-pT nasopharynx carcinoma-pT1: Tumor confined to nasopharynx, or tumor extends to oropharynx and/or nasal cavity without parapharyngeal extension# pT1: Tumor confined to nasopharynx, or tumor extends to oropharynx and/or nasal cavity without parapharyngeal extension# Pharynx-Infiltrating malignant neoplasm-pT nasopharynx carcinoma-pT2: Tumor with parapharyngeal extension pT2: Tumor with parapharyngeal extension Pharynx-Infiltrating malignant neoplasm-pT nasopharynx carcinoma-pT3: Tumor invades bony structures of skull base and/or paranasal sinuses pT3: Tumor invades bony structures of skull base and/or paranasal sinuses Pharynx-Infiltrating malignant neoplasm-pT nasopharynx carcinoma-pT4: Tumor with intracranial extension and/or involvement of cranial nerves, hypopharynx, orbit, or with extension to the infratemporal fossa/masticator space pT4: Tumor with intracranial extension and/or involvement of cranial nerves, hypopharynx, orbit, or with extension to the infratemporal fossa/masticator space Endometrium-Infiltrating malignant neoplasm-Extent Extent Larynx-Infiltrating malignant neoplasm-Lesion site-Epiglottis Epiglottis Larynx-Infiltrating malignant neoplasm-Lesion site-Aryepiglottic folds Aryepiglottic folds Larynx-Infiltrating malignant neoplasm-Lesion site-Arytenoid(s) Arytenoid(s) Larynx-Infiltrating malignant neoplasm-Lesion site-False vocal cord False vocal cord Larynx-Infiltrating malignant neoplasm-Lesion site-Ventricle Ventricle Larynx-Infiltrating malignant neoplasm-Lesion site-True vocal cord True vocal cord Larynx-Infiltrating malignant neoplasm-Lesion site-Posterior commissure Posterior commissure Larynx-Infiltrating malignant neoplasm-Lesion site-Anterior commissure Anterior commissure Larynx-Infiltrating malignant neoplasm-Lesion site-Larynx, subglottis Larynx, subglottis Endometrium-Infiltrating malignant neoplasm-Histologic grade (FIGO) Histologic grade (FIGO) Endometrium-Infiltrating malignant neoplasm-Lesion site Lesion site Endometrium-Infiltrating malignant neoplasm-Lymph node site Lymph node site Endometrium-Infiltrating malignant neoplasm-Number of lymph nodes involved Number of lymph nodes involved Breast-Infiltrating malignant neoplasm-Extensive intraductal component Extensive intraductal component Endometrium-Infiltrating malignant neoplasm-Number of lymph nodes examined Number of lymph nodes examined Endometrium-Infiltrating malignant neoplasm-pN pN Endometrium-Infiltrating malignant neoplasm-pT pT Endometrium-Infiltrating malignant neoplasm-Lesion size, largest dimension Lesion size, largest dimension Endometrium-Infiltrating malignant neoplasm-Histologic type Histologic type Larynx-Infiltrating malignant neoplasm-Histologic type-Basaloid squamous cell carcinoma Basaloid squamous cell carcinoma Larynx-Infiltrating malignant neoplasm-Histologic type-Spindle cell squamous cell carcinoma Spindle cell squamous cell carcinoma Stomach-Infiltrating malignant neoplasm-Margins involvement Margins involvement Stomach-Infiltrating malignant neoplasm-Margins involvement Margins involvement Stomach-Infiltrating malignant neoplasm-Margins involvement Margins involvement Stomach-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin Distance of lesion from closest uninvolved margin Stomach-Infiltrating malignant neoplasm-Lymph-vascular invasion Lymph-vascular invasion Lip, oral cavity-Infiltrating malignant neoplasm-pT mucosal malignant melanoma-pT3: Mucosal disease pT3: Mucosal disease Lip, oral cavity-Infiltrating malignant neoplasm-pT mucosal malignant melanoma-pT4a: Moderately advanced disease. Tumor involving deep soft tissue, cartilage, or overlying skin pT4a: Moderately advanced disease. Tumor involving deep soft tissue, cartilage, or overlying skin Lip, oral cavity-Infiltrating malignant neoplasm-pT mucosal malignant melanoma-pT4b: Very advanced disease. Tumor involving brain, dura, skull base, lower cranial nerves (IX, X, XI, XII), masticator space, carotid artery, prevertebral space, or mediastinal structures pT4b: Very advanced disease. Tumor involving brain, dura, skull base, lower cranial nerves (IX, X, XI, XII), masticator space, carotid artery, prevertebral space, or mediastinal structures Colon-Infiltrating malignant neoplasm-Histologic grade (Two-Tier Grading System) Histologic grade (Two-Tier Grading System) Colon-Infiltrating malignant neoplasm-pM pM Colon-Infiltrating malignant neoplasm-Histologic Features Suggestive of Microsatellite Instability Histologic Features Suggestive of Microsatellite Instability Colon-Infiltrating malignant neoplasm-Macroscopic type Macroscopic type Stomach-Infiltrating malignant neoplasm-Extent Extent Colon-Lesion-Histologic type Histologic type Colon-Lesion-Macroscopic type Macroscopic type Endometrium-Infiltrating malignant neoplasm-Histologic grade (WHO) Histologic grade (WHO) Endometrium-Infiltrating malignant neoplasm-pM pM Endometrium-Lesion-Histologic type Histologic type Endometrium-Lesion-Lesion site Lesion site Stomach-Infiltrating malignant neoplasm-pM pM Stomach-Lesion-Histologic type Histologic type Stomach-Infiltrating malignant neoplasm-Perineural invasion Perineural invasion Stomach-Lesion-Lesion site Lesion site Liver-Infiltrating malignant neoplasm-pM pM Liver-Lesion-Histologic type Histologic type Liver-Lesion-Lesion site Lesion site Generic-Infiltrating malignant neoplasm-TNM Descriptors TNM Descriptors Generic-Infiltrating malignant neoplasm-Margin site Margin site Stomach-Infiltrating malignant neoplasm-Lesion site Lesion site Generic-In situ neoplasm-Histologic type Histologic type Generic-In situ neoplasm-Lesion site Lesion site Salivary gland-Infiltrating malignant neoplasm-Lesion site Lesion site Salivary gland-Infiltrating malignant neoplasm-Macroscopic type Macroscopic type Salivary gland-Lesion-Histologic type Histologic type Salivary gland-Lesion-Lesion site Lesion site Larynx-Infiltrating malignant neoplasm-pM pM Larynx-Infiltrating malignant neoplasm-Macroscopic type Macroscopic type Stomach-Infiltrating malignant neoplasm-Margin site Margin site Larynx-Lesion-Histologic type Histologic type Larynx-Lesion-Lesion site Lesion site Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site Lesion site Lip, oral cavity-Lesion-Histologic type Histologic type Lip, oral cavity-Lesion-Lesion site Lesion site Esophagus-Infiltrating malignant neoplasm-Histologic grade (WHO) Histologic grade (WHO) Esophagus-Infiltrating malignant neoplasm-pM pM Esophagus-Lesion-Histologic type Histologic type Stomach-Infiltrating malignant neoplasm-Number of lymph nodes involved Number of lymph nodes involved Esophagus-Lesion-Lesion site Lesion site Ovary-Infiltrating malignant neoplasm-Histologic grade (WHO) Histologic grade (WHO) Ovary-Infiltrating malignant neoplasm-Lesion site Lesion site Ovary-Infiltrating malignant neoplasm-pM pM Ovary-Lesion-Histologic type Histologic type Ovary-Lesion-Lesion site Lesion site Pancreas-Infiltrating malignant neoplasm-pM pM Pancreas-Lesion-Histologic type Histologic type Stomach-Infiltrating malignant neoplasm-Number of lymph nodes examined Number of lymph nodes examined Pancreas-Lesion-Lesion site Lesion site Skin (melanoma)-Infiltrating malignant neoplasm-Lymph node site Lymph node site Skin (melanoma)-Infiltrating malignant neoplasm-pM pM Skin (melanoma)-Lesion-Histologic type Histologic type Skin (melanoma)-Lesion-Lesion site Lesion site Pharynx-Infiltrating malignant neoplasm-EBV (Epstein Barr virus encoded RNA [EBER], other) EBV (Epstein Barr virus encoded RNA [EBER], other) Pharynx-Infiltrating malignant neoplasm-HPV (p16 immunoreactivity, in situ) HPV (p16 immunoreactivity, in situ) Pharynx-Infiltrating malignant neoplasm-pM pM Pharynx-Infiltrating malignant neoplasm-pT oropharynx carcinoma pT oropharynx carcinoma Pharynx-Lesion-Histologic type Histologic type Pharynx-Lesion-Lesion site Lesion site Lung-Infiltrating malignant neoplasm-Epidermal growth factor receptor (EGFR) Epidermal growth factor receptor (EGFR) Lung-Infiltrating malignant neoplasm-KRAS mutational analysis KRAS mutational analysis Lung-Infiltrating malignant neoplasm-Histologic grade (WHO) Histologic grade (WHO) Lung-Infiltrating malignant neoplasm-Lesion site Lesion site Lung-Infiltrating malignant neoplasm-pM pM Stomach-Infiltrating malignant neoplasm-pN pN Lung-Lesion-Histologic type Histologic type Lung-Lesion-Lesion site Lesion site Prostate-Infiltrating malignant neoplasm-Margin site Margin site Prostate-Infiltrating malignant neoplasm-pM pM Prostate-Lesion-Histologic type Histologic type Prostate-Lesion-Lesion site Lesion site Kidney-Infiltrating malignant neoplasm-pM pM Kidney-Lesion-Histologic type Histologic type Kidney-Lesion-Lesion site Lesion site Breast-In situ neoplasm-Necrosis of ductal carcinoma in situ (DCIS) Necrosis of ductal carcinoma in situ (DCIS) pM Breast-Infiltrating malignant neoplasm-pM Breast-Infiltrating malignant neoplasm-pM Histologic type Breast-Lesion-Histologic type Breast-Histologic type Lesion site Breast-Lesion-Lesion site Breast-Lesion site Lesion site Breast-In situ neoplasm-Lesion site Breast-Lesion site Testis-Infiltrating malignant neoplasm-pM pM Testis-Lesion-Histologic type Histologic type Stomach-Infiltrating malignant neoplasm-pT pT Testis-Lesion-Lesion site Lesion site Thyroid-Infiltrating malignant neoplasm-Histologic grade (WHO) Histologic grade (WHO) Thyroid-Infiltrating malignant neoplasm-pM pM Thyroid-Lesion-Histologic type Histologic type Thyroid-Lesion-Lesion site Lesion site Urinary bladder-Infiltrating malignant neoplasm-pM pM Urinary bladder-Infiltrating malignant neoplasm-Macroscopic type Macroscopic type Urinary bladder-Lesion-Histologic type Histologic type Stomach-Infiltrating malignant neoplasm-Lesion size, largest dimension Lesion size, largest dimension Urinary bladder-Lesion-Lesion site Lesion site Pharynx-Infiltrating malignant neoplasm-Epstein-Barr virus (Epstein Barr virus encoded RNA [EBER], other)-Present Present Pharynx-Infiltrating malignant neoplasm-Epstein-Barr virus (Epstein Barr virus encoded RNA [EBER], other)-Negative Negative Pharynx-Infiltrating malignant neoplasm-Human papillomavirus (p16 immunoreactivity, in situ)-Present Present Pharynx-Infiltrating malignant neoplasm-Human papillomavirus (p16 immunoreactivity, in situ)-Negative Negative Breast-Infiltrating malignant neoplasm-HER2/neu (FISH method)-Equivocal (HER2 gene copy 4.0 to 6.0 or ratio 1.8 to 2.2) Equivocal (HER2 gene copy 4.0 to 6.0 or ratio 1.8 to 2.2) Breast-Infiltrating malignant neoplasm-HER2/neu (immunoperoxidase study)-Negative (Score 1+) Negative (Score 1+) Breast-Infiltrating malignant neoplasm-HER2/neu (immunoperoxidase study)-Equivocal (Score 2+) Equivocal (Score 2+) Colon-Infiltrating malignant neoplasm-Microsatellite instability-Stable Stable Colon-Infiltrating malignant neoplasm-Microsatellite instability-Low Low Stomach-Infiltrating malignant neoplasm-Histologic type Histologic type Colon-Infiltrating malignant neoplasm-Microsatellite instability-High High Lung-Infiltrating malignant neoplasm-Epidermal growth factor receptor (EGFR)-Positive Positive Lung-Infiltrating malignant neoplasm-Epidermal growth factor receptor (EGFR)-Negative Negative Colon-Infiltrating malignant neoplasm-Mismatch Repair Proteins-MLH1 (Immunohistochemistry Study)-Intact nuclear positivity, tumor cells Intact nuclear positivity, tumor cells Colon-Infiltrating malignant neoplasm-Mismatch Repair Proteins-MLH1 (Immunohistochemistry Study)-Loss of nuclear positivity, tumor cells Loss of nuclear positivity, tumor cells Colon-Infiltrating malignant neoplasm-Mismatch Repair Proteins-MLH2 (Immunohistochemistry Study)-Intact nuclear positivity, tumor cells Intact nuclear positivity, tumor cells Colon-Infiltrating malignant neoplasm-Mismatch Repair Proteins-MLH2 (Immunohistochemistry Study)-Loss of nuclear positivity, tumor cells Loss of nuclear positivity, tumor cells Colon-Infiltrating malignant neoplasm-Mismatch Repair Proteins-MLH6 (Immunohistochemistry Study)-Intact nuclear positivity, tumor cells Intact nuclear positivity, tumor cells Colon-Infiltrating malignant neoplasm-Mismatch Repair Proteins-MLH6 (Immunohistochemistry Study)-Loss of nuclear positivity, tumor cells Loss of nuclear positivity, tumor cells Colon-Infiltrating malignant neoplasm-BRAF V600E mutational analysis-Mutant detected Mutant detected Liver-Infiltrating malignant neoplasm-Margins involvement Margins involvement Colon-Infiltrating malignant neoplasm-BRAF V600E mutational analysis-No mutant detected No mutant detected Colon-Infiltrating malignant neoplasm-KRAS mutational analysis-Intact nuclear positivity, tumor cells Intact nuclear positivity, tumor cells Colon-Infiltrating malignant neoplasm-KRAS mutational analysis-Loss of nuclear positivity, tumor cells Loss of nuclear positivity, tumor cells Lung-Infiltrating malignant neoplasm-KRAS mutational analysis-Mutant detected Mutant detected Lung-Infiltrating malignant neoplasm-KRAS mutational analysis-No mutant detected No mutant detected Colon-Infiltrating malignant neoplasm-Mismatch Repair Proteins-PMS2 (Immunohistochemistry Study)-Intact nuclear positivity, tumor cells Intact nuclear positivity, tumor cells Colon-Infiltrating malignant neoplasm-Mismatch Repair Proteins-PMS2 (Immunohistochemistry Study)-Loss of nuclear positivity, tumor cells Loss of nuclear positivity, tumor cells Colon-Infiltrating malignant neoplasm-Extent-No evidence of primary tumor No evidence of primary tumor Colon-Infiltrating malignant neoplasm-Extent-Intramucosal carcinoma, invasion of lamina propria Intramucosal carcinoma, invasion of lamina propria Colon-Infiltrating malignant neoplasm-Extent-Tumor invades submucosa Tumor invades submucosa Liver-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin Distance of lesion from closest uninvolved margin Colon-Infiltrating malignant neoplasm-Extent-Tumor invades muscularis propria Tumor invades muscularis propria Colon-Infiltrating malignant neoplasm-Extent-Tumor invades through the muscularis propria into the subserosal adipose tissue or the nonperitonealized pericolic or perirectal soft tissues but does not extend to the serosal surface Tumor invades through the muscularis propria into the subserosal adipose tissue or the nonperitonealized pericolic or perirectal soft tissues but does not extend to the serosal surface Colon-Infiltrating malignant neoplasm-Extent-Tumor penetrates to the surface of the visceral peritoneum (serosa) Tumor penetrates to the surface of the visceral peritoneum (serosa) Colon-Infiltrating malignant neoplasm-Extent-Tumor is adherent to other organs or structures (specify: _________________) Tumor is adherent to other organs or structures (specify: _________________) Colon-Infiltrating malignant neoplasm-Extent-Tumor directly invades adjacent structures (specify: __________________) Tumor directly invades adjacent structures (specify: __________________) Colon-Infiltrating malignant neoplasm-Extent-Tumor penetrates to the surface of the visceral peritoneum (serosa) and directly invades adjacent structures (specify: _____________________) Tumor penetrates to the surface of the visceral peritoneum (serosa) and directly invades adjacent structures (specify: _____________________) Endometrium-Infiltrating malignant neoplasm-Extent-<50% myometrial invasion <50% myometrial invasion Endometrium-Infiltrating malignant neoplasm-Extent->=50% myometrial invasion >=50% myometrial invasion Colon-Infiltrating malignant neoplasm-Histologic grade (Two-Tier Grading System)-Low-grade (well-differentiated to moderately differentiated) Low-grade (well-differentiated to moderately differentiated) Liver-Infiltrating malignant neoplasm-Lymph-vascular invasion Lymph-vascular invasion Colon-Infiltrating malignant neoplasm-Histologic grade (Two-Tier Grading System)-High-grade (poorly differentiated to undifferentiated) High-grade (poorly differentiated to undifferentiated) Cervix-Infiltrating malignant neoplasm-Histologic grade (WHO)-G1: Well differentiated G1: Well differentiated Cervix-Infiltrating malignant neoplasm-Histologic grade (WHO)-G2: Moderately differentiated G2: Moderately differentiated Cervix-Infiltrating malignant neoplasm-Histologic grade (WHO)-G3: Poorly differentiated G3: Poorly differentiated Endometrium-Infiltrating malignant neoplasm-Histologic grade (WHO)-G1: Well differentiated G1: Well differentiated Endometrium-Infiltrating malignant neoplasm-Histologic grade (WHO)-G2: Moderately differentiated G2: Moderately differentiated Endometrium-Infiltrating malignant neoplasm-Histologic grade (WHO)-G3: Poorly differentiated G3: Poorly differentiated Esophagus-Infiltrating malignant neoplasm-Histologic grade (WHO)-G1: Well differentiated G1: Well differentiated Esophagus-Infiltrating malignant neoplasm-Histologic grade (WHO)-G2: Moderately differentiated G2: Moderately differentiated Esophagus-Infiltrating malignant neoplasm-Histologic grade (WHO)-G3: Poorly differentiated G3: Poorly differentiated Liver-Infiltrating malignant neoplasm-Extent Extent Esophagus-Infiltrating malignant neoplasm-Histologic grade (WHO)-G4: Undifferentiated G4: Undifferentiated Ovary-Infiltrating malignant neoplasm-Histologic grade (WHO)-G1: Well differentiated G1: Well differentiated Ovary-Infiltrating malignant neoplasm-Histologic grade (WHO)-G2: Moderately differentiated G2: Moderately differentiated Ovary-Infiltrating malignant neoplasm-Histologic grade (WHO)-G3: Poorly differentiated G3: Poorly differentiated Lung-Infiltrating malignant neoplasm-Histologic grade (WHO)-G1: Well differentiated G1: Well differentiated Lung-Infiltrating malignant neoplasm-Histologic grade (WHO)-G2: Moderately differentiated G2: Moderately differentiated Lung-Infiltrating malignant neoplasm-Histologic grade (WHO)-G3: Poorly differentiated G3: Poorly differentiated Lung-Infiltrating malignant neoplasm-Histologic grade (WHO)-G4: Undifferentiated G4: Undifferentiated Thyroid-Infiltrating malignant neoplasm-Histologic grade (WHO)-G1: Well differentiated G1: Well differentiated Thyroid-Infiltrating malignant neoplasm-Histologic grade (WHO)-G2: Moderately differentiated G2: Moderately differentiated Liver-Infiltrating malignant neoplasm-Perineural invasion Perineural invasion Thyroid-Infiltrating malignant neoplasm-Histologic grade (WHO)-G3: Poorly differentiated G3: Poorly differentiated Thyroid-Infiltrating malignant neoplasm-Histologic grade (WHO)-G4: Undifferentiated G4: Undifferentiated Skin (melanoma)-Infiltrating malignant neoplasm-Lymph node site-Subcapsular Subcapsular Skin (melanoma)-Infiltrating malignant neoplasm-Lymph node site-Intramedullary Intramedullary Skin (melanoma)-Infiltrating malignant neoplasm-Lymph node site-Subcapsular and intramedullary Subcapsular and intramedullary Breast-Infiltrating malignant neoplasm-Lymph node site-Supraclavicular Supraclavicular Cervix-Infiltrating malignant neoplasm-Margin site-Endocervical Margin Endocervical Margin Cervix-Infiltrating malignant neoplasm-Margin site-Exocervical Margin Exocervical Margin Liver-Infiltrating malignant neoplasm-Lesion site Lesion site Cervix-Infiltrating malignant neoplasm-Margin site-Deep Margin Deep Margin Colon-Infiltrating malignant neoplasm-Margin site-Deep Margin (Stalk Margin) Deep Margin (Stalk Margin) Colon-Infiltrating malignant neoplasm-Margin site-Mucosal/Lateral Margin (for non-circumferential transanal disk excision) Mucosal/Lateral Margin (for non-circumferential transanal disk excision) Colon-Infiltrating malignant neoplasm-Margin site-Circumferential (Radial) or Mesenteric Margin Circumferential (Radial) or Mesenteric Margin Stomach-Infiltrating malignant neoplasm-Margin site-Omental (Radial) Margins Omental (Radial) Margins Stomach-Infiltrating malignant neoplasm-Margin site-Deep Margin (applies to endoscopic resections) Deep Margin (applies to endoscopic resections) Liver-Infiltrating malignant neoplasm-Margin site-Parenchymal margin Parenchymal margin Liver-Infiltrating malignant neoplasm-Margin site-Other margin Other margin Esophagus-Infiltrating malignant neoplasm-Margin site-Circumferential (Adventitial) Margin (esophagectomy or esophagogastrectomy specimens) Circumferential (Adventitial) Margin (esophagectomy or esophagogastrectomy specimens) Esophagus-Infiltrating malignant neoplasm-Margin site-Deep Margin (endoscopic resection specimens) Deep Margin (endoscopic resection specimens) Generic-Infiltrating malignant neoplasm-Specimen size, largest dimension Specimen size, largest dimension Liver-Infiltrating malignant neoplasm-Margin site Margin site Lung-Infiltrating malignant neoplasm-Margin site-Parietal Pleural Margin Parietal Pleural Margin Lung-Infiltrating malignant neoplasm-Margin site-Chest Wall Margin Chest Wall Margin Kidney-Infiltrating malignant neoplasm-Margin site-Renal capsular margin (partial nephrectomy only) Renal capsular margin (partial nephrectomy only) Kidney-Infiltrating malignant neoplasm-Margin site-Perinephric fat margin (partial nephrectomy only) Perinephric fat margin (partial nephrectomy only) Liver-Infiltrating malignant neoplasm-Number of lymph nodes involved Number of lymph nodes involved Kidney-Infiltrating malignant neoplasm-Margin site-Gerota’s fascial margin Gerota’s fascial margin Kidney-Infiltrating malignant neoplasm-Margin site-Ureteral margin Ureteral margin Cervix-Infiltrating malignant neoplasm-Lesion site-Right superior quadrant (12 to 3 o’clock) Right superior quadrant (12 to 3 o’clock) Cervix-Infiltrating malignant neoplasm-Lesion site-Right inferior quadrant (3 to 6 o’clock) Right inferior quadrant (3 to 6 o’clock) Cervix-Infiltrating malignant neoplasm-Lesion site-Left inferior quadrant (6 to 9 o’clock) Left inferior quadrant (6 to 9 o’clock) Cervix-Infiltrating malignant neoplasm-Lesion site-Left superior quadrant (9 to 12 o’clock) Left superior quadrant (9 to 12 o’clock) Colon-Infiltrating malignant neoplasm-Lesion site-Cecum Cecum Colon-Infiltrating malignant neoplasm-Lesion site-Rectosigmoid Rectosigmoid Colon-Infiltrating malignant neoplasm-Lesion site-Colon, not otherwise specified Colon, not otherwise specified Colon-Infiltrating malignant neoplasm-Lesion site-Terminal ileum Terminal ileum Liver-Infiltrating malignant neoplasm-Number of lymph nodes examined Number of lymph nodes examined Colon-Infiltrating malignant neoplasm-Lesion site-Appendix Appendix Colon-Infiltrating malignant neoplasm-Lesion site-Anus Anus Endometrium-Infiltrating malignant neoplasm-Lesion site-Anterior endometrium Anterior endometrium Endometrium-Infiltrating malignant neoplasm-Lesion site-Posterior endometrium Posterior endometrium Stomach-Infiltrating malignant neoplasm-Lesion site-Body: Anterior wall Body: Anterior wall Stomach-Infiltrating malignant neoplasm-Lesion site-Body: Posterior wall Body: Posterior wall Stomach-Infiltrating malignant neoplasm-Lesion site-Body: Lesser curvature Body: Lesser curvature Stomach-Infiltrating malignant neoplasm-Lesion site-Body: Greater curvature Body: Greater curvature Stomach-Infiltrating malignant neoplasm-Lesion site-Antrum: Anterior wall Antrum: Anterior wall Stomach-Infiltrating malignant neoplasm-Lesion site-Antrum: Posterior wall Antrum: Posterior wall Stomach-Infiltrating malignant neoplasm-Lesion site-Antrum: Lesser curvature Antrum: Lesser curvature Stomach-Infiltrating malignant neoplasm-Lesion site-Antrum: Greater curvature Antrum: Greater curvature Stomach-Infiltrating malignant neoplasm-Lesion site-Fundus: Anterior wall Fundus: Anterior wall Stomach-Infiltrating malignant neoplasm-Lesion site-Fundus: Posterior wall Fundus: Posterior wall Liver-Infiltrating malignant neoplasm-Lesion site-Gallbladder Gallbladder Salivary gland-Infiltrating malignant neoplasm-Lesion site-Parotid gland Parotid gland Salivary gland-Infiltrating malignant neoplasm-Lesion site-Superficial lobe Superficial lobe Salivary gland-Infiltrating malignant neoplasm-Lesion site-Deep lobe Deep lobe Salivary gland-Infiltrating malignant neoplasm-Lesion site-Entire parotid gland Entire parotid gland Liver-Infiltrating malignant neoplasm-pN pN Salivary gland-Infiltrating malignant neoplasm-pM-pM1: Distant metastasis - Specify site(s) pM1: Distant metastasis - Specify site(s) Larynx-Infiltrating malignant neoplasm-Lesion site-Larynx, supraglottis Larynx, supraglottis Larynx-Infiltrating malignant neoplasm-Lesion site-Lingual aspect Lingual aspect Larynx-Infiltrating malignant neoplasm-Lesion site-Laryngeal aspect Laryngeal aspect Larynx-Infiltrating malignant neoplasm-Lesion site-Larynx, glottis Larynx, glottis Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Vermilion border upper lip (qualifier : right, left, medial) Vermilion border upper lip (qualifier : right, left, medial) Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Vermilion border lower lip (qualifier : right, left, medial) Vermilion border lower lip (qualifier : right, left, medial) Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Mucosa of lower lip (qualifier : right, left, medial) Mucosa of lower lip (qualifier : right, left, medial) Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Commissure of lip (qualifier : right, left, medial) Commissure of lip (qualifier : right, left, medial) Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Lateral border of tongue (qualifier : right, left, medial) Lateral border of tongue (qualifier : right, left, medial) Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Ventral surface of tongue, not otherwise specified (NOS) (qualifier : right, left, medial) Ventral surface of tongue, not otherwise specified (NOS) (qualifier : right, left, medial) Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Dorsal surface of tongue, NOS (qualifier : right, left, medial) Dorsal surface of tongue, NOS (qualifier : right, left, medial) Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Anterior two-thirds of tongue, NOS (qualifier : right, left, medial) Anterior two-thirds of tongue, NOS (qualifier : right, left, medial) Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Upper gingiva (gum) (qualifier : right, left, medial) Upper gingiva (gum) (qualifier : right, left, medial) Liver-Infiltrating malignant neoplasm-pT pT Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Lower gingiva (gum) (qualifier : right, left, medial) Lower gingiva (gum) (qualifier : right, left, medial) Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Anterior floor of mouth (qualifier : right, left, medial) Anterior floor of mouth (qualifier : right, left, medial) Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Floor of mouth, NOS (qualifier : right, left, medial) Floor of mouth, NOS (qualifier : right, left, medial) Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Hard palate (qualifier : right, left, medial) Hard palate (qualifier : right, left, medial) Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Buccal mucosa (inner cheek) (qualifier : right, left, medial) Buccal mucosa (inner cheek) (qualifier : right, left, medial) Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Upper vestibule of mouth (qualifier : right, left, medial) Upper vestibule of mouth (qualifier : right, left, medial) Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Lower vestibule of mouth (qualifier : right, left, medial) Lower vestibule of mouth (qualifier : right, left, medial) Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Upper alveolar process (qualifier : right, left, medial) Upper alveolar process (qualifier : right, left, medial) Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Lower alveolar process (qualifier : right, left, medial) Lower alveolar process (qualifier : right, left, medial) Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Mandible (qualifier : right, left, medial) Mandible (qualifier : right, left, medial) Liver-Infiltrating malignant neoplasm-Lesion size, largest dimension Lesion size, largest dimension Lip, oral cavity-Infiltrating malignant neoplasm-Lesion site-Maxilla (qualifier : right, left, medial) Maxilla (qualifier : right, left, medial) Lip, oral cavity-Infiltrating malignant neoplasm-pM-pM1: Distant metastasis - Specify site(s) pM1: Distant metastasis - Specify site(s) Esophagus-Infiltrating malignant neoplasm-Lesion site-Midesophagus: Upper thoracic esophagus Midesophagus: Upper thoracic esophagus Esophagus-Infiltrating malignant neoplasm-Lesion site-Midesophagus: Midthoracic esophagus Midesophagus: Midthoracic esophagus Esophagus-Infiltrating malignant neoplasm-Lesion site-Distal esophagus (lower thoracic esophagus) Distal esophagus (lower thoracic esophagus) Esophagus-Infiltrating malignant neoplasm-Lesion site-Proximal stomach and esophagogastric junction Proximal stomach and esophagogastric junction Pharynx-Infiltrating malignant neoplasm-Lesion site-Nasopharynx: Nasopharyngeal tonsils (adenoids) Nasopharynx: Nasopharyngeal tonsils (adenoids) Pharynx-Infiltrating malignant neoplasm-Lesion site-Oropharynx: Palatine tonsil Oropharynx: Palatine tonsil Pharynx-Infiltrating malignant neoplasm-Lesion site-Oropharynx: Base of tongue, including lingual tonsil Oropharynx: Base of tongue, including lingual tonsil Liver-Infiltrating malignant neoplasm-Histologic type Histologic type Pharynx-Infiltrating malignant neoplasm-Lesion site-Oropharynx: Soft palate Oropharynx: Soft palate Pharynx-Infiltrating malignant neoplasm-Lesion site-Oropharynx: Uvula Oropharynx: Uvula Pharynx-Infiltrating malignant neoplasm-Lesion site-Oropharynx: Pharyngeal wall (posterior) Oropharynx: Pharyngeal wall (posterior) Pharynx-Infiltrating malignant neoplasm-Lesion site-Oropharynx: Other Oropharynx: Other Lung-Infiltrating malignant neoplasm-Lesion site-Lung upper lobe Lung upper lobe Lung-Infiltrating malignant neoplasm-Lesion site-Lung middle lobe Lung middle lobe Lung-Infiltrating malignant neoplasm-Lesion site-Lung lower lobe Lung lower lobe Lung-Infiltrating malignant neoplasm-Lesion site-Bronchus (specify) Bronchus (specify) Prostate-Infiltrating malignant neoplasm-Lesion site-Prostate Prostate Generic-Infiltrating malignant neoplasm-Lymph node sampling Lymph node sampling Thyroid-Infiltrating malignant neoplasm-Lesion site-Lobe Lobe Cervix-Specimen-Target site-Fallopian tube (qualifier : right, left) Fallopian tube (qualifier : right, left) Cervix-Specimen-Target site-Vagina Vagina Cervix-Specimen-Target site-Urinary bladder Urinary bladder Generic-Infiltrating malignant neoplasm-Histologic type Histologic type Generic-Infiltrating malignant neoplasm-Histologic grade (Two-Tier Grading System) Histologic grade (Two-Tier Grading System) Colon-Specimen-Target site-Appendix Appendix Colon-Specimen-Target site-Anus Anus Endometrium-Specimen-Target site-Parametrium (qualifier : right, left) Parametrium (qualifier : right, left) Endometrium-Specimen-Target site-Vaginal cuff Vaginal cuff Endometrium-Specimen-Target site-Omentum Omentum Stomach-Specimen-Target site-Portion of stomach Portion of stomach Stomach-Specimen-Target site-Gastric body Gastric body Stomach-Specimen-Target site-Gastric antrum Gastric antrum Stomach-Specimen-Target site-Distal esophagus Distal esophagus Stomach-Specimen-Target site-Proximal duodenum Proximal duodenum Salivary gland-Specimen-Target site-Superficial lobe of parotid gland only (qualifier : right, left) Superficial lobe of parotid gland only (qualifier : right, left) Salivary gland-Specimen-Target site-Deep lobe of parotid gland only (qualifier : right, left) Deep lobe of parotid gland only (qualifier : right, left) Lip, oral cavity-Specimen-Target site-Dorsal surface of tongue, NOS (qualifier : right, left, medial) Dorsal surface of tongue, NOS (qualifier : right, left, medial) Lip, oral cavity-Specimen-Target site-Anterior two-thirds of tongue, NOS (qualifier : right, left, medial) Anterior two-thirds of tongue, NOS (qualifier : right, left, medial) Generic-Infiltrating malignant neoplasm-Macroscopic type Macroscopic type Lip, oral cavity-Specimen-Target site-Anterior floor of mouth (qualifier : right, left, medial) Anterior floor of mouth (qualifier : right, left, medial) Lip, oral cavity-Specimen-Target site-Buccal mucosa (inner cheek) (qualifier : right, left, medial) Buccal mucosa (inner cheek) (qualifier : right, left, medial) Lip, oral cavity-Specimen-Target site-Lower vestibule of mouth (qualifier : right, left, medial) Lower vestibule of mouth (qualifier : right, left, medial) Salivary gland-Infiltrating malignant neoplasm-Margins involvement Margins involvement Esophagus-Specimen-Target site-Proximal stomach Proximal stomach Ovary-Specimen-Target site-Cervix Cervix Ovary-Specimen-Target site-Peritoneum Peritoneum Pancreas-Specimen-Target site-Head of pancreas Head of pancreas Pancreas-Specimen-Target site-Body of pancreas Body of pancreas Pancreas-Specimen-Target site-Tail of pancreas Tail of pancreas Salivary gland-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin Distance of lesion from closest uninvolved margin Pancreas-Specimen-Target site-Duodenum Duodenum Pancreas-Specimen-Target site-Common bile duct Common bile duct Pancreas-Specimen-Target site-Spleen Spleen Pancreas-Specimen-Target site-Adjacent large vessels Adjacent large vessels Pancreas-Specimen-Target site-Portal vein Portal vein Pancreas-Specimen-Target site-Superior mesenteric vein Superior mesenteric vein Pharynx-Specimen-Target site-Oropharynx Oropharynx Salivary gland-Infiltrating malignant neoplasm-Lymph-vascular invasion Lymph-vascular invasion Lung-Specimen-Target site-Bronchus (specify) Bronchus (specify) Breast-Specimen-Target site-Partial breast Partial breast Breast-Infiltrating malignant neoplasm-Necrosis of ductal carcinoma in situ (DCIS)-Not identified Not identified Breast-Infiltrating malignant neoplasm-Necrosis of ductal carcinoma in situ (DCIS)-Present, focal (small foci or single cell necrosis) Present, focal (small foci or single cell necrosis) Salivary gland-Infiltrating malignant neoplasm-Extent Extent Breast-Infiltrating malignant neoplasm-Necrosis of ductal carcinoma in situ (DCIS)-Present, central (expansive “comedo” necrosis) Present, central (expansive “comedo” necrosis) Cervix-Infiltrating malignant neoplasm-pM-pM1 [IVB] - Distant metastasis site(s) pM1 [IVB] - Distant metastasis site(s) Colon-Infiltrating malignant neoplasm-pM-pM1: Distant metastasis pM1: Distant metastasis Colon-Infiltrating malignant neoplasm-pM-pM1a: Metastasis to single organ or site (eg, liver, lung, ovary, nonregional lymph node) pM1a: Metastasis to single organ or site (eg, liver, lung, ovary, nonregional lymph node) Colon-Infiltrating malignant neoplasm-pM-pM1b: Metastasis to more than one organ/site or to the peritoneum - Specify site(s) pM1b: Metastasis to more than one organ/site or to the peritoneum - Specify site(s) Endometrium-Infiltrating malignant neoplasm-pM-pM1 [IVB]: Distant metastasis (includes metastasis to inguinal lymph nodes, intraperitoneal disease, or lung, liver, or bone metastasis. It excludes metastasis to para-aortic lymph nodes, vagina, pelvic serosa, or adnexa) - Specify site(s) pM1 [IVB]: Distant metastasis (includes metastasis to inguinal lymph nodes, intraperitoneal disease, or lung, liver, or bone metastasis. It excludes metastasis to para-aortic lymph nodes, vagina, pelvic serosa, or adnexa) - Specify site(s) Stomach-Infiltrating malignant neoplasm-pM-pM1: Distant metastasis - Specify site(s) pM1: Distant metastasis - Specify site(s) Liver-Infiltrating malignant neoplasm-PM-pM1: Distant metastasis - Specify site(s) pM1: Distant metastasis - Specify site(s) Larynx-Infiltrating malignant neoplasm-pM-pM1: Distant metastasis - Specify site(s) pM1: Distant metastasis - Specify site(s) Esophagus-Infiltrating malignant neoplasm-pM-pM1: Distant metastasis. Specify site(s) pM1: Distant metastasis. Specify site(s) Salivary gland-Infiltrating malignant neoplasm-Perineural invasion Perineural invasion Ovary-Infiltrating malignant neoplasm-pM-pM1 [IV]: Distant metastases (includes extraperitoneal sites such as liver parenchyma, lung, skeletal metastases, and supraclavicular and axillary nodes) pM1 [IV]: Distant metastases (includes extraperitoneal sites such as liver parenchyma, lung, skeletal metastases, and supraclavicular and axillary nodes) Skin (melanoma)-Infiltrating malignant neoplasm-pM-pM1: Distant metastasis (documented in this specimen) pM1: Distant metastasis (documented in this specimen) Skin (melanoma)-Infiltrating malignant neoplasm-pM-pM1a: Metastasis in skin, subcutaneous tissues, or distant lymph nodes pM1a: Metastasis in skin, subcutaneous tissues, or distant lymph nodes Skin (melanoma)-Infiltrating malignant neoplasm-pM-pM1b: Metastasis to lung pM1b: Metastasis to lung Skin (melanoma)-Infiltrating malignant neoplasm-pM-pM1c: Metastasis to all other visceral sites or distant metastasis at any site associated with an elevated serum lactic dehydrogenase (LDH) pM1c: Metastasis to all other visceral sites or distant metastasis at any site associated with an elevated serum lactic dehydrogenase (LDH) Pharynx-Infiltrating malignant neoplasm-pM-pM1: Distant metastasis - Specify site(s) pM1: Distant metastasis - Specify site(s) Lung-Infiltrating malignant neoplasm-pM-pM1a: Separate tumor nodule(s) in contralateral lung; tumor with pleural nodules or malignant pleural (or pericardial) effusion (Note A) pM1a: Separate tumor nodule(s) in contralateral lung; tumor with pleural nodules or malignant pleural (or pericardial) effusion (Note A) Lung-Infiltrating malignant neoplasm-pM-pM1b: Distant metastases outside the lung/pleura pM1b: Distant metastases outside the lung/pleura Prostate-Infiltrating malignant neoplasm-pM-pM1: Distant metastasis pM1: Distant metastasis Salivary gland-Infiltrating malignant neoplasm-Lymph node capsule involvement Lymph node capsule involvement Prostate-Infiltrating malignant neoplasm-pM-pM1a: Nonregional lymph nodes(s) pM1a: Nonregional lymph nodes(s) Prostate-Infiltrating malignant neoplasm-pM-pM1b: Bone(s) pM1b: Bone(s) Prostate-Infiltrating malignant neoplasm-pM-pM1c: Other site(s) with or without bone disease pM1c: Other site(s) with or without bone disease Kidney-Infiltrating malignant neoplasm-pM-pM1: Distant metastasis pM1: Distant metastasis Breast-Infiltrating malignant neoplasm-pM-cM0(i+) - No clinical or radiographic evidence of distant metastasis, but deposits of molecularly or microscopically detected tumor cells in circulating blood, bone marrow, or other nonregional nodal tissue that are < = 0.2 mm in a patient without symptoms or signs of metastasis cM0(i+) - No clinical or radiographic evidence of distant metastasis, but deposits of molecularly or microscopically detected tumor cells in circulating blood, bone marrow, or other nonregional nodal tissue that are < = 0.2 mm in a patient without symptoms or signs of metastasis Breast-Infiltrating malignant neoplasm-pM-pM1 - Distant detectable metastasis as determined by classic clinical and radiographic means and/or histologically proven >0.2 mm pM1 - Distant detectable metastasis as determined by classic clinical and radiographic means and/or histologically proven >0.2 mm Thyroid-Infiltrating malignant neoplasm-pM-pM1: Distant metastasis pM1: Distant metastasis Generic-Infiltrating malignant neoplasm-Lymph node sampling-Performed Performed Salivary gland-Infiltrating malignant neoplasm-Lymph node site Lymph node site Generic-Infiltrating malignant neoplasm-Lymph node sampling-Sentinel lymph node(s) Sentinel lymph node(s) Generic-Infiltrating malignant neoplasm-Lymph node sampling-Not performed Not performed Cervix-Specimen-Specimen collection procedure-Pelvic Exenteration Pelvic Exenteration Cervix-Specimen-Specimen collection procedure-Cold knife cone excision Cold knife cone excision Cervix-Specimen-Specimen collection procedure-Loop electrical excision procedure (LEEP) Loop electrical excision procedure (LEEP) Cervix-Specimen-Specimen collection procedure-Large loop excision of the transformation zone (LLETZ) Large loop excision of the transformation zone (LLETZ) Cervix-Specimen-Specimen collection procedure-Radical trachelectomy Radical trachelectomy Colon-Specimen-Specimen collection procedure-Resection Resection Colon-Specimen-Specimen collection procedure-Excisional Biopsy (Polypectomy) Excisional Biopsy (Polypectomy) Colon-Specimen-Specimen collection procedure-Transanal Disk Excision of Rectal Neoplasms Transanal Disk Excision of Rectal Neoplasms Salivary gland-Infiltrating malignant neoplasm-Number of lymph nodes involved Number of lymph nodes involved Endometrium-Specimen-Specimen collection procedure-Simple hysterectomy Simple hysterectomy Endometrium-Specimen-Specimen collection procedure-Oophorectomy (Qualifier: laterality - Right,Left) Bilateral? Oophorectomy (Qualifier: laterality - Right,Left) Bilateral? Endometrium-Specimen-Specimen collection procedure-Salpingectomy (Qualifier: laterality - Right,Left) Bilateral? Salpingectomy (Qualifier: laterality - Right,Left) Bilateral? Endometrium-Specimen-Specimen collection procedure-Salpingo-oophorectomy (Qualifier: laterality - Right,Left, Bilateral) Salpingo-oophorectomy (Qualifier: laterality - Right,Left, Bilateral) Endometrium-Specimen-Specimen collection procedure-Omentectomy Omentectomy Endometrium-Specimen-Specimen collection procedure-Peritoneal biopsies Peritoneal biopsies Stomach-Specimen-Specimen collection procedure-Partial gastrectomy, Other Partial gastrectomy, Other Liver-Specimen-Specimen collection procedure-Wedge resection Wedge resection Liver-Specimen-Specimen collection procedure-Partial hepatectomy: Major hepatectomy (3 segments or more) Partial hepatectomy: Major hepatectomy (3 segments or more) Liver-Specimen-Specimen collection procedure-Partial hepatectomy: Minor hepatectomy (less than 3 segments) Partial hepatectomy: Minor hepatectomy (less than 3 segments) Salivary gland-Infiltrating malignant neoplasm-Number of lymph nodes examined Number of lymph nodes examined Salivary gland-Specimen-Specimen collection procedure-Incisional biopsy (qualifier: right, left) Incisional biopsy (qualifier: right, left) Salivary gland-Specimen-Specimen collection procedure-Excisional biopsy (qualifier: right, left) Excisional biopsy (qualifier: right, left) Salivary gland-Specimen-Specimen collection procedure-Resection, parotid gland (qualifier: right, left) Resection, parotid gland (qualifier: right, left) Salivary gland-Specimen-Specimen collection procedure-Resection, submandibular gland (qualifier: right, left) Resection, submandibular gland (qualifier: right, left) Salivary gland-Specimen-Specimen collection procedure-Resection, sublingual gland (qualifier: right, left) Resection, sublingual gland (qualifier: right, left) Salivary gland-Specimen-Specimen collection procedure-Neck (lymph node) dissection (specify) Neck (lymph node) dissection (specify) Larynx-Specimen-Specimen collection procedure-Incisional biopsy Incisional biopsy Larynx-Specimen-Specimen collection procedure-Excisional biopsy Excisional biopsy Larynx-Specimen-Specimen collection procedure-Resection Resection Larynx-Specimen-Specimen collection procedure-Stripping (glottis) Stripping (glottis) Larynx-Specimen-Specimen collection procedure-Transoral laser excision (glottis) Transoral laser excision (glottis) Larynx-Specimen-Specimen collection procedure-Supraglottic laryngectomy Supraglottic laryngectomy Larynx-Specimen-Specimen collection procedure-Supracricoid laryngectomy Supracricoid laryngectomy Larynx-Specimen-Specimen collection procedure-Vertical hemilaryngectomy (qualifier: right, left) Vertical hemilaryngectomy (qualifier: right, left) Larynx-Specimen-Specimen collection procedure-Neck (lymph node) dissection (specify) Neck (lymph node) dissection (specify) Esophagus-Specimen-Specimen collection procedure-Esophagogastrectomy Esophagogastrectomy Esophagus-Specimen-Specimen collection procedure-Esophagectomy Esophagectomy Ovary-Specimen-Specimen collection procedure-Subtotal oophorectomy Subtotal oophorectomy Ovary-Specimen-Specimen collection procedure-Supracervical hysterectomy Supracervical hysterectomy Salivary gland-Infiltrating malignant neoplasm-pN pN Ovary-Specimen-Specimen collection procedure-Hysterectomy Hysterectomy Ovary-Specimen-Specimen collection procedure-Peritoneal biopsies Peritoneal biopsies Pancreas-Specimen-Specimen collection procedure-Pancreaticoduodenectomy (Whipple resection), partial pancreatectomy Pancreaticoduodenectomy (Whipple resection), partial pancreatectomy Skin (melanoma)-Specimen-Specimen collection procedure-Biopsy, shave Biopsy, shave Skin (melanoma)-Specimen-Specimen collection procedure-Biopsy, punch Biopsy, punch Skin (melanoma)-Specimen-Specimen collection procedure-Biopsy, incisional Biopsy, incisional Skin (melanoma)-Specimen-Specimen collection procedure-Re-excision Re-excision Pharynx-Specimen-Specimen collection procedure-Incisional biopsy Incisional biopsy Pharynx-Specimen-Specimen collection procedure-Excisional biopsy Excisional biopsy Pharynx-Specimen-Specimen collection procedure-Resection Resection Pharynx-Specimen-Specimen collection procedure-Tonsillectomy Tonsillectomy Lung-Specimen-Specimen collection procedure-Major airway resection Major airway resection Lung-Specimen-Specimen collection procedure-Wedge resection Wedge resection Prostate-Specimen-Specimen collection procedure-Transurethral prostatic resection (enucleation) Transurethral prostatic resection (enucleation) Kidney-Specimen-Specimen collection procedure-Incisional biopsy, needle Incisional biopsy, needle Kidney-Specimen-Specimen collection procedure-Incisional biopsy, wedge Incisional biopsy, wedge Breast-Specimen-Specimen collection procedure-Excision without wire-guided localization Excision without wire-guided localization Breast-Specimen-Specimen collection procedure-Excision with wire-guided localization Excision with wire-guided localization Thyroid-Specimen-Specimen collection procedure-Total thyroidectomy with central compartment dissection Total thyroidectomy with central compartment dissection Thyroid-Specimen-Specimen collection procedure-Total thyroidectomy with neck dissection Total thyroidectomy with neck dissection Salivary gland-Infiltrating malignant neoplasm-pT pT Pharynx-Infiltrating malignant neoplasm-pT oropharynx carcinoma-pT0: No evidence of primary tumor pT0: No evidence of primary tumor Pharynx-Infiltrating malignant neoplasm-pT oropharynx carcinoma-pTis: Carcinoma in situ pTis: Carcinoma in situ Pharynx-Infiltrating malignant neoplasm-pT oropharynx carcinoma-pT1: Tumor 2 cm or less in greatest dimension pT1: Tumor 2 cm or less in greatest dimension Pharynx-Infiltrating malignant neoplasm-pT oropharynx carcinoma-pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension Pharynx-Infiltrating malignant neoplasm-pT oropharynx carcinoma-pT3: Tumor more than 4 cm in greatest dimension or extension to lingual surface of epiglottis pT3: Tumor more than 4 cm in greatest dimension or extension to lingual surface of epiglottis Pharynx-Infiltrating malignant neoplasm-pT oropharynx carcinoma-pT4a: Moderately advanced local disease. Tumor invades larynx, deep/extrinsic muscle of tongue, medial pterygoid muscles, hard palate, or mandible pT4a: Moderately advanced local disease. Tumor invades larynx, deep/extrinsic muscle of tongue, medial pterygoid muscles, hard palate, or mandible Pharynx-Infiltrating malignant neoplasm-pT oropharynx carcinoma-pT4b: Very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base, or encases carotid artery pT4b: Very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base, or encases carotid artery Breast-Infiltrating malignant neoplasm-Progesterone receptor-Immunoreactive tumor cells present (> = 1%) (Specify Quantitation) Immunoreactive tumor cells present (> = 1%) (Specify Quantitation) Breast-Infiltrating malignant neoplasm-Progesterone receptor-Less than 1% immunoreactive cells present Less than 1% immunoreactive cells present Breast-Infiltrating malignant neoplasm-Estrogen receptor-Immunoreactive tumor cells present (> = 1%) (Specify Quantitation) Immunoreactive tumor cells present (> = 1%) (Specify Quantitation) Salivary gland-Infiltrating malignant neoplasm-Lymph node metastasis size Lymph node metastasis size Breast-Infiltrating malignant neoplasm-Estrogen receptor-Less than 1% immunoreactive cells present Less than 1% immunoreactive cells present Generic-Infiltrating malignant neoplasm-Treatment effect-Marked response (grade 1, minimal residual cancer) Marked response (grade 1, minimal residual cancer) Colon-Infiltrating malignant neoplasm-Histologic Features Suggestive of Microsatellite Instability-No Intratumoral Lymphocytic Response (tumor-infiltrating lymphocytes) No Intratumoral Lymphocytic Response (tumor-infiltrating lymphocytes) Colon-Infiltrating malignant neoplasm-Histologic Features Suggestive of Microsatellite Instability-Mild to moderate (0-2 per high-power [X400] field) Intratumoral Lymphocytic Response (tumor-infiltrating lymphocytes) Mild to moderate (0-2 per high-power [X400] field) Intratumoral Lymphocytic Response (tumor-infiltrating lymphocytes) Colon-Infiltrating malignant neoplasm-Histologic Features Suggestive of Microsatellite Instability-Marked (3 or more per high-power field) Intratumoral Lymphocytic Response (tumor-infiltrating lymphocytes) Marked (3 or more per high-power field) Intratumoral Lymphocytic Response (tumor-infiltrating lymphocytes) Colon-Infiltrating malignant neoplasm-Histologic Features Suggestive of Microsatellite Instability-No Peritumor Lymphocytic Response (Crohn-like response) No Peritumor Lymphocytic Response (Crohn-like response) Colon-Infiltrating malignant neoplasm-Histologic Features Suggestive of Microsatellite Instability-Mild to moderate Peritumor Lymphocytic Response (Crohn-like response) Mild to moderate Peritumor Lymphocytic Response (Crohn-like response) Colon-Infiltrating malignant neoplasm-Histologic Features Suggestive of Microsatellite Instability-Marked Peritumor Lymphocytic Response (Crohn-like response) Marked Peritumor Lymphocytic Response (Crohn-like response) Colon-Infiltrating malignant neoplasm-Histologic Features Suggestive of Microsatellite Instability-Mucinous tumor component (specify percentage: ____) Mucinous tumor component (specify percentage: ____) Colon-Infiltrating malignant neoplasm-Histologic Features Suggestive of Microsatellite Instability-Medullary tumor component Medullary tumor component Salivary gland-Infiltrating malignant neoplasm-Lesion size, largest dimension Lesion size, largest dimension Colon-Infiltrating malignant neoplasm-Histologic Features Suggestive of Microsatellite Instability-High histologic grade (poorly differentiated) High histologic grade (poorly differentiated) Cervix-Infiltrating malignant neoplasm-Histologic type-Nonkeratinizing squamous cell carcinoma Nonkeratinizing squamous cell carcinoma Colon-Infiltrating malignant neoplasm-Histologic type-Small cell carcinoma Small cell carcinoma Colon-Infiltrating malignant neoplasm-Histologic type-Squamous cell carcinoma Squamous cell carcinoma Colon-Infiltrating malignant neoplasm-Histologic type-Adenosquamous carcinoma Adenosquamous carcinoma Colon-Infiltrating malignant neoplasm-Histologic type-Carcinoma, type cannot be determinedd Carcinoma, type cannot be determinedd Colon-Lesion-Histologic type-Active inflammatory bowel disease Active inflammatory bowel disease Colon-Lesion-Histologic type-Quiescent inflammatory bowel disease Quiescent inflammatory bowel disease Colon-Lesion-Histologic type-Dysplasia arising in inflammatory bowel disease Dysplasia arising in inflammatory bowel disease Colon-Lesion-Histologic type-Chronic ulcerative proctocolitis Chronic ulcerative proctocolitis Salivary gland-Infiltrating malignant neoplasm-Specimen size, largest dimension Specimen size, largest dimension Colon-Lesion-Histologic type-Crohn disease Crohn disease Colon-Lesion-Histologic type-Adenoma(s) Adenoma(s) Colon-Lesion-Histologic type-Other polyps (specify) Other polyps (specify) Endometrium-Infiltrating malignant neoplasm-Histologic type-Small cell carcinoma Small cell carcinoma Endometrium-Infiltrating malignant neoplasm-Histologic type-Mixed carcinoma (specify types and percentages) Mixed carcinoma (specify types and percentages) Endometrium-Infiltrating malignant neoplasm-Histologic type-Transitional cell carcinoma Transitional cell carcinoma Endometrium-Lesion-Histologic type-Simple hyperplasia without cytologic atypia Simple hyperplasia without cytologic atypia Endometrium-Lesion-Histologic type-Complex hyperplasia without cytologic atypia Complex hyperplasia without cytologic atypia Endometrium-Lesion-Histologic type-Simple atypical hyperplasia Simple atypical hyperplasia Endometrium-Lesion-Histologic type-Complex atypical hyperplasia Complex atypical hyperplasia Generic-Lesion-Histologic type Histologic type Salivary gland-Infiltrating malignant neoplasm-Histologic type Histologic type Endometrium-Lesion-Histologic type-Endometrial intraepithelial neoplasia (EIN) Endometrial intraepithelial neoplasia (EIN) Breast-Infiltrating malignant neoplasm-Histologic type-Invasive mucinous carcinoma Invasive mucinous carcinoma Breast-Infiltrating malignant neoplasm-Histologic type-Invasive medullary carcinoma Invasive medullary carcinoma Breast-Infiltrating malignant neoplasm-Histologic type-Invasive papillary carcinoma Invasive papillary carcinoma Breast-Infiltrating malignant neoplasm-Histologic type-Invasive micropapillary carcinoma Invasive micropapillary carcinoma Breast-Infiltrating malignant neoplasm-Histologic type-Invasive tubular carcinoma Invasive tubular carcinoma Breast-Infiltrating malignant neoplasm-Histologic type-Invasive cribriform carcinoma Invasive cribriform carcinoma Breast-In situ neoplasm-Histologic type-Ductal carcinoma in situ with microinvasion Ductal carcinoma in situ with microinvasion Breast-In situ neoplasm-Histologic type-Lobular carcinoma in situ with microinvasion Lobular carcinoma in situ with microinvasion Larynx-Infiltrating malignant neoplasm-Margins involvement Margins involvement Breast-In situ neoplasm-Histologic type-Ductal carcinoma in situ involving nipple skin (Paget disease) with microinvasion Ductal carcinoma in situ involving nipple skin (Paget disease) with microinvasion Breast-In situ neoplasm-Histologic type-Invasive carcinoma with ductal and lobular features (“mixed type carcinoma”) Invasive carcinoma with ductal and lobular features (“mixed type carcinoma”) Cervix-Lesion-Histologic type-Koilocytosis Koilocytosis Stomach-Infiltrating malignant neoplasm-Histologic type-Adenocarcinoma, diffuse type Adenocarcinoma, diffuse type Stomach-Infiltrating malignant neoplasm-Histologic type-Signet-ring cell carcinoma (greater than 50% signet-ring cells) Signet-ring cell carcinoma (greater than 50% signet-ring cells) Stomach-Infiltrating malignant neoplasm-Histologic type-Adenocarcinoma, intestinal type Adenocarcinoma, intestinal type Stomach-Lesion-Histologic type-Intestinal metaplasia Intestinal metaplasia Stomach-Lesion-Histologic type-Dysplasia Dysplasia Stomach-Lesion-Histologic type-Helicobacter pylori-type gastritis Helicobacter pylori-type gastritis Stomach-Lesion-Histologic type-Other gastritis (specify) Other gastritis (specify) Stomach-Lesion-Histologic type-Polyp(s) (specify) Polyp(s) (specify) Liver-Infiltrating malignant neoplasm-Histologic type-Fibrolamellar hepatocellular carcinoma Fibrolamellar hepatocellular carcinoma Liver-Infiltrating malignant neoplasm-Histologic type-Undifferentiated carcinoma Undifferentiated carcinoma Liver-Infiltrating malignant neoplasm-Histologic type-Carcinoma, type cannot be determinedd Carcinoma, type cannot be determinedd Liver-Lesion-Histologic type-Cirrhosis/severe fibrosis (Ishak score 5-6) (F1) Cirrhosis/severe fibrosis (Ishak score 5-6) (F1) Liver-Lesion-Histologic type-None to moderate fibrosis (Ishak score 0-4) (F2) None to moderate fibrosis (Ishak score 0-4) (F2) Liver-Lesion-Histologic type-Low-grade hepatocellular dysplastic nodule Low-grade hepatocellular dysplastic nodule Liver-Lesion-Histologic type-High-grade hepatocellular dysplastic nodule High-grade hepatocellular dysplastic nodule Liver-Lesion-Histologic type-Steatosis Steatosis Liver-Lesion-Histologic type-Iron overload Iron overload Larynx-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin Distance of lesion from closest uninvolved margin Liver-Lesion-Histologic type-Chronic hepatitis (specify) Chronic hepatitis (specify) Salivary gland-Infiltrating malignant neoplasm-Histologic type-Acinic cell carcinoma Acinic cell carcinoma Salivary gland-Infiltrating malignant neoplasm-Histologic type-Clear cell adenocarcinoma Clear cell adenocarcinoma Salivary gland-Infiltrating malignant neoplasm-Histologic type-Cystadenocarcinoma Cystadenocarcinoma Salivary gland-Infiltrating malignant neoplasm-Histologic type-Large cell carcinoma Large cell carcinoma Salivary gland-Infiltrating malignant neoplasm-Histologic type-Low-grade cribriform cystadenocarcinoma Low-grade cribriform cystadenocarcinoma Salivary gland-Infiltrating malignant neoplasm-Histologic type-Lymphoepithelial carcinoma Lymphoepithelial carcinoma Salivary gland-Infiltrating malignant neoplasm-Histologic type-Metastasizing pleomorphic adenoma Metastasizing pleomorphic adenoma Larynx-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin Distance of lesion from closest uninvolved margin Salivary gland-Infiltrating malignant neoplasm-Histologic type-Mucinous adenocarcinoma (colloid carcinoma) Mucinous adenocarcinoma (colloid carcinoma) Salivary gland-Infiltrating malignant neoplasm-Histologic type-Myoepithelial carcinoma (malignant myoepithelioma) Myoepithelial carcinoma (malignant myoepithelioma) Salivary gland-Infiltrating malignant neoplasm-Histologic type-Oncocytic carcinoma Oncocytic carcinoma Salivary gland-Infiltrating malignant neoplasm-Histologic type-Polymorphous low-grade adenocarcinoma Polymorphous low-grade adenocarcinoma Salivary gland-Infiltrating malignant neoplasm-Histologic type-Salivary duct carcinoma Salivary duct carcinoma Salivary gland-Infiltrating malignant neoplasm-Histologic type-Sebaceous lymphadenocarcinoma Sebaceous lymphadenocarcinoma Salivary gland-Infiltrating malignant neoplasm-Histologic type-Sialoblastoma Sialoblastoma Salivary gland-Infiltrating malignant neoplasm-Histologic type-Squamous cell carcinoma, primary Squamous cell carcinoma, primary Salivary gland-Infiltrating malignant neoplasm-Histologic type-Other Other Salivary gland-Infiltrating malignant neoplasm-Histologic type-Carcinoma, type cannot be determinedd Carcinoma, type cannot be determinedd Larynx-Infiltrating malignant neoplasm-Lymph-vascular invasion Lymph-vascular invasion Salivary gland-Lesion-Histologic type-Sialadenitis Sialadenitis Salivary gland-Lesion-Histologic type-Tumor associated lymphoid proliferation (TALP) Tumor associated lymphoid proliferation (TALP) Salivary gland-Lesion-Histologic type-Severe keratinizing dysplasia (carcinoma in situ) Severe keratinizing dysplasia (carcinoma in situ) Salivary gland-Lesion-Histologic type-Mild keratinizing dysplasia Mild keratinizing dysplasia Salivary gland-Lesion-Histologic type-Moderate keratinizing dysplasia Moderate keratinizing dysplasia Larynx-Infiltrating malignant neoplasm-Histologic type-Variants of Squamous Cell Carcinoma Variants of Squamous Cell Carcinoma Larynx-Infiltrating malignant neoplasm-Histologic type-Acantholytic squamous cell carcinoma Acantholytic squamous cell carcinoma Larynx-Infiltrating malignant neoplasm-Histologic type-Papillary squamous cell carcinoma Papillary squamous cell carcinoma Larynx-Infiltrating malignant neoplasm-Histologic type-Giant cell carcinoma Giant cell carcinoma Larynx-Infiltrating malignant neoplasm-Histologic type-Neuroendocrine Carcinoma Neuroendocrine Carcinoma Larynx-Infiltrating malignant neoplasm-Lymph node sampling Lymph node sampling Larynx-Infiltrating malignant neoplasm-Histologic type-Typical carcinoid tumor (well differentiated neuroendocrine carcinoma) Typical carcinoid tumor (well differentiated neuroendocrine carcinoma) Larynx-Infiltrating malignant neoplasm-Histologic type-Atypical carcinoid tumor (moderately differentiated neuroendocrine carcinoma) Atypical carcinoid tumor (moderately differentiated neuroendocrine carcinoma) Larynx-Infiltrating malignant neoplasm-Histologic type-Small cell carcinoma, neuroendocrine type (poorly differentiated neuroendocrine Small cell carcinoma, neuroendocrine type (poorly differentiated neuroendocrine Larynx-Infiltrating malignant neoplasm-Histologic type-carcinoma) carcinoma) Larynx-Infiltrating malignant neoplasm-Histologic type-Combined (or composite) small cell carcinoma, neuroendocrine type Combined (or composite) small cell carcinoma, neuroendocrine type Larynx-Infiltrating malignant neoplasm-Histologic type-Mucosal malignant melanoma Mucosal malignant melanoma Larynx-Infiltrating malignant neoplasm-Histologic type-Adenoid cystic carcinoma Adenoid cystic carcinoma Larynx-Infiltrating malignant neoplasm-Histologic type-Mucoepidermoid carcinoma Mucoepidermoid carcinoma Larynx-Infiltrating malignant neoplasm-Histologic type-Other carcinoma (specify) Other carcinoma (specify) Larynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma, type cannot be determinedd Carcinoma, type cannot be determinedd Larynx-Infiltrating malignant neoplasm-Extent Extent Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Acantholytic squamous cell carcinoma Acantholytic squamous cell carcinoma Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma cuniculatum Carcinoma cuniculatum Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Papillary squamous cell carcinoma Papillary squamous cell carcinoma Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Lymphoepithelial carcinoma (non-nasopharyngeal) Lymphoepithelial carcinoma (non-nasopharyngeal) Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Acinic cell carcinoma Carcinoma of Minor Salivary Glands: Acinic cell carcinoma Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Adenoid cystic carcinoma Carcinoma of Minor Salivary Glands: Adenoid cystic carcinoma Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Adenocarcinoma, not otherwise specified (NOS) Carcinoma of Minor Salivary Glands: Adenocarcinoma, not otherwise specified (NOS) Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Basal cell adenocarcinoma Carcinoma of Minor Salivary Glands: Basal cell adenocarcinoma Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Carcinoma ex pleomorphic adenoma (malignant mixed tumor) Carcinoma of Minor Salivary Glands: Carcinoma ex pleomorphic adenoma (malignant mixed tumor) Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Carcinoma, type cannot be determinedd Carcinoma of Minor Salivary Glands: Carcinoma, type cannot be determinedd Larynx-Infiltrating malignant neoplasm-Perineural invasion Perineural invasion Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Carcinosarcoma Carcinoma of Minor Salivary Glands: Carcinosarcoma Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Clear cell adenocarcinoma Carcinoma of Minor Salivary Glands: Clear cell adenocarcinoma Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Cystadenocarcinoma Carcinoma of Minor Salivary Glands: Cystadenocarcinoma Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Epithelial-myoepithelial carcinoma Carcinoma of Minor Salivary Glands: Epithelial-myoepithelial carcinoma Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Mucoepidermoid carcinoma Carcinoma of Minor Salivary Glands: Mucoepidermoid carcinoma Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Mucinous adenocarcinoma (colloid carcinoma) Carcinoma of Minor Salivary Glands: Mucinous adenocarcinoma (colloid carcinoma) Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Myoepithelial carcinoma (malignant myoepithelioma) Carcinoma of Minor Salivary Glands: Myoepithelial carcinoma (malignant myoepithelioma) Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Oncocytic carcinoma Carcinoma of Minor Salivary Glands: Oncocytic carcinoma Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Polymorphous low-grade adenocarcinoma Carcinoma of Minor Salivary Glands: Polymorphous low-grade adenocarcinoma Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Salivary duct carcinoma Carcinoma of Minor Salivary Glands: Salivary duct carcinoma Larynx-Infiltrating malignant neoplasm-Lymph node capsule involvement Lymph node capsule involvement Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Other Carcinoma of Minor Salivary Glands: Other Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Adenocarcinoma, Non-Salivary Gland Type: Adenocarcinoma, not otherwise specified (NOS) Adenocarcinoma, Non-Salivary Gland Type: Adenocarcinoma, not otherwise specified (NOS) Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Adenocarcinoma, Non-Salivary Gland Type: Other Adenocarcinoma, Non-Salivary Gland Type: Other Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Neuroendocrine Carcinoma Neuroendocrine Carcinoma Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Neuroendocrine Carcinoma: Typical carcinoid tumor (well differentiated neuroendocrine carcinoma) Neuroendocrine Carcinoma: Typical carcinoid tumor (well differentiated neuroendocrine carcinoma) Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Neuroendocrine Carcinoma: Atypical carcinoid tumor (moderately differentiated neuroendocrine carcinoma) Neuroendocrine Carcinoma: Atypical carcinoid tumor (moderately differentiated neuroendocrine carcinoma) Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Neuroendocrine Carcinoma: Small cell carcinoma (poorly differentiated neuroendocrine carcinoma) Neuroendocrine Carcinoma: Small cell carcinoma (poorly differentiated neuroendocrine carcinoma) Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Neuroendocrine Carcinoma: Combined (or composite) small cell carcinoma, neuroendocrine type Neuroendocrine Carcinoma: Combined (or composite) small cell carcinoma, neuroendocrine type Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Neuroendocrine Carcinoma: Other Neuroendocrine Carcinoma: Other Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Carcinoma, type cannot be determined Carcinoma, type cannot be determined Larynx-Infiltrating malignant neoplasm-Lesion site Lesion site Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type-Mucosal malignant melanoma Mucosal malignant melanoma Lip, oral cavity-Lesion-Histologic type-Severe keratinizing dysplasia (carcinoma in situ) Severe keratinizing dysplasia (carcinoma in situ) Lip, oral cavity-Lesion-Histologic type-Mild non-keratinizing dysplasia Mild non-keratinizing dysplasia Lip, oral cavity-Lesion-Histologic type-Moderate non-keratinizing dysplasia Moderate non-keratinizing dysplasia Lip, oral cavity-Lesion-Histologic type-Severe non-keratinizing dysplasia (carcinoma in situ) Severe non-keratinizing dysplasia (carcinoma in situ) Lip, oral cavity-Lesion-Histologic type-Inflammation (specify) Inflammation (specify) Lip, oral cavity-Lesion-Histologic type-Epithelial hyperplasia Epithelial hyperplasia Lip, oral cavity-Lesion-Histologic type-Fungal colonization Fungal colonization Lip, oral cavity-Lesion-Histologic type-Bacterial colonization Bacterial colonization Esophagus-Infiltrating malignant neoplasm-Histologic type-Small cell carcinoma Small cell carcinoma Larynx-Infiltrating malignant neoplasm-Lymph node site Lymph node site Esophagus-Infiltrating malignant neoplasm-Histologic type-Undifferentiated carcinoma Undifferentiated carcinoma Esophagus-Infiltrating malignant neoplasm-Histologic type-Carcinoma, type cannot be determinedd Carcinoma, type cannot be determinedd Esophagus-Lesion-Histologic type-Intestinal metaplasia (Barrett’s esophagus) Intestinal metaplasia (Barrett’s esophagus) Esophagus-Lesion-Histologic type-Low grade dysplasia Low grade dysplasia Esophagus-Lesion-Histologic type-High grade dysplasia High grade dysplasia Esophagus-Lesion-Histologic type-Esophagitis (specify) Esophagitis (specify) Esophagus-Lesion-Histologic type-Gastritis (specify) Gastritis (specify) Ovary-Infiltrating malignant neoplasm-Histologic type-Mucinous, borderline tumor, intestinal type Mucinous, borderline tumor, intestinal type Ovary-Infiltrating malignant neoplasm-Histologic type-Mucinous, borderline tumor, endocervical type (seromucinous type) Mucinous, borderline tumor, endocervical type (seromucinous type) Ovary-Infiltrating malignant neoplasm-Histologic type-Brenner tumor, malignant type Brenner tumor, malignant type Larynx-Infiltrating malignant neoplasm-Number of lymph nodes involved Number of lymph nodes involved Ovary-Infiltrating malignant neoplasm-Histologic type-Squamous cell carcinoma Squamous cell carcinoma Ovary-Infiltrating malignant neoplasm-Histologic type-Mixed epithelial borderline tumor (specify types and percentages) Mixed epithelial borderline tumor (specify types and percentages) Ovary-Infiltrating malignant neoplasm-Histologic type-Mixed epithelial carcinoma (specify types and percentages) Mixed epithelial carcinoma (specify types and percentages) Ovary-Infiltrating malignant neoplasm-Histologic type-Undifferentiated carcinoma Undifferentiated carcinoma Ovary-Infiltrating malignant neoplasm-Histologic type-Carcinosarcoma (Malignant müllerian mixed tumor) Carcinosarcoma (Malignant müllerian mixed tumor) Ovary-Infiltrating malignant neoplasm-Histologic type-Granulosa cell tumor Granulosa cell tumor Ovary-Lesion-Histologic type-Ovarian endometriosis Ovarian endometriosis Ovary-Lesion-Histologic type-Extraovarian endometriosis Extraovarian endometriosis Ovary-Lesion-Histologic type-Endosalpingiosis Endosalpingiosis Pancreas-Infiltrating malignant neoplasm-Histologic type-Undifferentiated (anaplastic) carcinoma Undifferentiated (anaplastic) carcinoma Larynx-Infiltrating malignant neoplasm-Number of lymph nodes examined Number of lymph nodes examined Pancreas-Infiltrating malignant neoplasm-Histologic type-Undifferentiated carcinoma with osteoclast-like giant cells Undifferentiated carcinoma with osteoclast-like giant cells Pancreas-Infiltrating malignant neoplasm-Histologic type-Mixed ductal-endocrine carcinoma Mixed ductal-endocrine carcinoma Pancreas-Infiltrating malignant neoplasm-Histologic type-Noninvasive mucinous cystic neoplasm Noninvasive mucinous cystic neoplasm Pancreas-Infiltrating malignant neoplasm-Histologic type-Noninvasive intraductal papillary-mucinous carcinoma Noninvasive intraductal papillary-mucinous carcinoma Pancreas-Infiltrating malignant neoplasm-Histologic type-Mixed acinar-endocrine carcinoma Mixed acinar-endocrine carcinoma Pancreas-Lesion-Histologic type-Pancreatic intraepithelial neoplasia Pancreatic intraepithelial neoplasia Skin (melanoma)-Infiltrating malignant neoplasm-Histologic type-Malignant melanoma Malignant melanoma Skin (melanoma)-Infiltrating malignant neoplasm-Histologic type-Melanoma, not otherwise classified Melanoma, not otherwise classified Skin (melanoma)-Infiltrating malignant neoplasm-Histologic type-Lentigo maligna melanoma Lentigo maligna melanoma Skin (melanoma)-Infiltrating malignant neoplasm-Histologic type-Acral-lentiginous melanoma Acral-lentiginous melanoma Skin (melanoma)-Infiltrating malignant neoplasm-Histologic type-Desmoplastic and/or desmoplastic neurotropic melanoma Desmoplastic and/or desmoplastic neurotropic melanoma Skin (melanoma)-Infiltrating malignant neoplasm-Histologic type-Melanoma arising from blue nevus Melanoma arising from blue nevus Skin (melanoma)-Infiltrating malignant neoplasm-Histologic type-Melanoma arising in a giant congenital nevus Melanoma arising in a giant congenital nevus Skin (melanoma)-Infiltrating malignant neoplasm-Histologic type-Melanoma of childhood Melanoma of childhood Skin (melanoma)-Infiltrating malignant neoplasm-Histologic type-Nevoid melanoma Nevoid melanoma Skin (melanoma)-Infiltrating malignant neoplasm-Histologic type-Persistent melanoma Persistent melanoma Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of the Oropharynx and Hypopharynx: Squamous cell carcinoma, conventional Carcinoma of the Oropharynx and Hypopharynx: Squamous cell carcinoma, conventional Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of the Oropharynx and Hypopharynx: Acantholytic squamous cell carcinoma Carcinoma of the Oropharynx and Hypopharynx: Acantholytic squamous cell carcinoma Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of the Oropharynx and Hypopharynx: Adenosquamous carcinoma Carcinoma of the Oropharynx and Hypopharynx: Adenosquamous carcinoma Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of the Oropharynx and Hypopharynx: Basaloid squamous cell carcinoma Carcinoma of the Oropharynx and Hypopharynx: Basaloid squamous cell carcinoma Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of the Oropharynx and Hypopharynx: Papillary squamous cell carcinoma Carcinoma of the Oropharynx and Hypopharynx: Papillary squamous cell carcinoma Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of the Oropharynx and Hypopharynx: Spindle cell squamous carcinoma Carcinoma of the Oropharynx and Hypopharynx: Spindle cell squamous carcinoma Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of the Oropharynx and Hypopharynx: Verrucous carcinoma Carcinoma of the Oropharynx and Hypopharynx: Verrucous carcinoma Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of the Oropharynx and Hypopharynx: Lymphoepithelial carcinoma (non-nasopharyngeal) Carcinoma of the Oropharynx and Hypopharynx: Lymphoepithelial carcinoma (non-nasopharyngeal) Pharynx-Infiltrating malignant neoplasm-Histologic type-Keratinizing squamous cell carcinoma (formerly WHO-1) of the Nasopharynx Keratinizing squamous cell carcinoma (formerly WHO-1) of the Nasopharynx Pharynx-Infiltrating malignant neoplasm-Histologic type-Nonkeratinizing carcinoma of the Nasopharynx Nonkeratinizing carcinoma of the Nasopharynx Pharynx-Infiltrating malignant neoplasm-Histologic type-Differentiated carcinoma (formerly WHO-2; transitional carcinoma) of the Nasopharynx Differentiated carcinoma (formerly WHO-2; transitional carcinoma) of the Nasopharynx Pharynx-Infiltrating malignant neoplasm-Histologic type-Undifferentiated carcinoma (formerly WHO-3; lymphoepithelioma) of the Nasopharynx Undifferentiated carcinoma (formerly WHO-3; lymphoepithelioma) of the Nasopharynx Pharynx-Infiltrating malignant neoplasm-Histologic type-Basaloid squamous cell carcinoma of the Nasopharynx Basaloid squamous cell carcinoma of the Nasopharynx Pharynx-Infiltrating malignant neoplasm-Histologic type-AdenoCarcinoma (Non-Salivary Gland Type): Nasopharyngeal papillary adenocarcinoma AdenoCarcinoma (Non-Salivary Gland Type): Nasopharyngeal papillary adenocarcinoma Larynx-Infiltrating malignant neoplasm-Lesion size, largest dimension Lesion size, largest dimension Pharynx-Infiltrating malignant neoplasm-Histologic type-AdenoCarcinoma (Non-Salivary Gland Type): Adenocarcinoma, not otherwise specified (NOS) AdenoCarcinoma (Non-Salivary Gland Type): Adenocarcinoma, not otherwise specified (NOS) Pharynx-Infiltrating malignant neoplasm-Histologic type-AdenoCarcinoma (Non-Salivary Gland Type): Other: AdenoCarcinoma (Non-Salivary Gland Type): Other: Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Acinic cell carcinoma Carcinoma of Minor Salivary Glands: Acinic cell carcinoma Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Adenoid cystic carcinoma Carcinoma of Minor Salivary Glands: Adenoid cystic carcinoma Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Adenocarcinoma, not otherwise specified (NOS) Carcinoma of Minor Salivary Glands: Adenocarcinoma, not otherwise specified (NOS) Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Basal cell adenocarcinoma Carcinoma of Minor Salivary Glands: Basal cell adenocarcinoma Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Carcinoma ex pleomorphic adenoma (malignant mixed tumor) Carcinoma of Minor Salivary Glands: Carcinoma ex pleomorphic adenoma (malignant mixed tumor) Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Carcinoma, type cannot be determinedd Carcinoma of Minor Salivary Glands: Carcinoma, type cannot be determinedd Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Clear cell adenocarcinoma Carcinoma of Minor Salivary Glands: Clear cell adenocarcinoma Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Cystadenocarcinoma Carcinoma of Minor Salivary Glands: Cystadenocarcinoma Larynx-Infiltrating malignant neoplasm-Specimen size, largest dimension Specimen size, largest dimension Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Epithelial-myoepithelial carcinoma Carcinoma of Minor Salivary Glands: Epithelial-myoepithelial carcinoma Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Mucoepidermoid carcinoma Carcinoma of Minor Salivary Glands: Mucoepidermoid carcinoma Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Mucinous adenocarcinoma (colloid carcinoma) Carcinoma of Minor Salivary Glands: Mucinous adenocarcinoma (colloid carcinoma) Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Myoepithelial carcinoma (malignant myoepithelioma) Carcinoma of Minor Salivary Glands: Myoepithelial carcinoma (malignant myoepithelioma) Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Oncocytic carcinoma Carcinoma of Minor Salivary Glands: Oncocytic carcinoma Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Polymorphous low-grade adenocarcinoma Carcinoma of Minor Salivary Glands: Polymorphous low-grade adenocarcinoma Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Salivary duct carcinoma Carcinoma of Minor Salivary Glands: Salivary duct carcinoma Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma of Minor Salivary Glands: Other Carcinoma of Minor Salivary Glands: Other Pharynx-Infiltrating malignant neoplasm-Histologic type-Neuroendocrine Carcinoma: Typical carcinoid tumor (well differentiated neuroendocrine carcinoma) Neuroendocrine Carcinoma: Typical carcinoid tumor (well differentiated neuroendocrine carcinoma) Pharynx-Infiltrating malignant neoplasm-Histologic type-Neuroendocrine Carcinoma: Atypical carcinoid tumor (moderately differentiated neuroendocrine carcinoma) Neuroendocrine Carcinoma: Atypical carcinoid tumor (moderately differentiated neuroendocrine carcinoma) Larynx-Infiltrating malignant neoplasm-Histologic type Histologic type Pharynx-Infiltrating malignant neoplasm-Histologic type-Neuroendocrine Carcinoma: Small cell carcinoma (poorly differentiated neuroendocrine carcinoma) Neuroendocrine Carcinoma: Small cell carcinoma (poorly differentiated neuroendocrine carcinoma) Pharynx-Infiltrating malignant neoplasm-Histologic type-Neuroendocrine Carcinoma: Combined (or composite) small cell carcinoma, neuroendocrine type Neuroendocrine Carcinoma: Combined (or composite) small cell carcinoma, neuroendocrine type Pharynx-Infiltrating malignant neoplasm-Histologic type-Mucosal malignant melanoma Mucosal malignant melanoma Pharynx-Infiltrating malignant neoplasm-Histologic type-Other carcinoma (specify) Other carcinoma (specify) Pharynx-Infiltrating malignant neoplasm-Histologic type-Carcinoma, type cannot be determinedd Carcinoma, type cannot be determinedd Pharynx-Lesion-Histologic type-Mild Keratinizing dysplasia Mild Keratinizing dysplasia Pharynx-Lesion-Histologic type-Moderate Keratinizing dysplasia Moderate Keratinizing dysplasia Pharynx-Lesion-Histologic type-Severe Keratinizing dysplasia (carcinoma in situ) Severe Keratinizing dysplasia (carcinoma in situ) Pharynx-Lesion-Histologic type-Mild Nonkeratinizing dysplasia Mild Nonkeratinizing dysplasia Pharynx-Lesion-Histologic type-Moderate Nonkeratinizing dysplasia Moderate Nonkeratinizing dysplasia Lip, oral cavity-Infiltrating malignant neoplasm-Margins involvement Margins involvement Pharynx-Lesion-Histologic type-Severe Nonkeratinizing dysplasia (carcinoma in situ) Severe Nonkeratinizing dysplasia (carcinoma in situ) Pharynx-Lesion-Histologic type-Inflammation (specify type) Inflammation (specify type) Pharynx-Lesion-Histologic type-Squamous metaplasia Squamous metaplasia Pharynx-Lesion-Histologic type-Epithelial hyperplasia Epithelial hyperplasia Pharynx-Lesion-Histologic type-Fungal Colonization Fungal Colonization Pharynx-Lesion-Histologic type-Bacterial Colonization Bacterial Colonization Lung-Infiltrating malignant neoplasm-Histologic type-Carcinoma, type cannot be determinedd Carcinoma, type cannot be determinedd Lung-Infiltrating malignant neoplasm-Histologic type-Non-small cell carcinoma, subtype cannot be determined Non-small cell carcinoma, subtype cannot be determined Lung-Infiltrating malignant neoplasm-Histologic type-Combined small cell carcinoma (small cell carcinoma and non-small cell component) Combined small cell carcinoma (small cell carcinoma and non-small cell component) Lung-Infiltrating malignant neoplasm-Histologic type-Squamous cell carcinoma Squamous cell carcinoma Lip, oral cavity-Infiltrating malignant neoplasm-Margins involvement Margins involvement Lung-Infiltrating malignant neoplasm-Histologic type-Squamous cell carcinoma, papillary variant Squamous cell carcinoma, papillary variant Lung-Infiltrating malignant neoplasm-Histologic type-Squamous cell carcinoma, clear cell variant Squamous cell carcinoma, clear cell variant Lung-Infiltrating malignant neoplasm-Histologic type-Squamous cell carcinoma, small cell variant Squamous cell carcinoma, small cell variant Lung-Infiltrating malignant neoplasm-Histologic type-Squamous cell carcinoma, basaloid variant Squamous cell carcinoma, basaloid variant Lung-Infiltrating malignant neoplasm-Histologic type-Adenocarcinoma, mixed subtype Adenocarcinoma, mixed subtype Lung-Infiltrating malignant neoplasm-Histologic type-Acinar adenocarcinoma Acinar adenocarcinoma Lung-Infiltrating malignant neoplasm-Histologic type-Papillary adenocarcinoma Papillary adenocarcinoma Lung-Infiltrating malignant neoplasm-Histologic type-Bronchioloalveolar carcinoma Bronchioloalveolar carcinoma Lung-Infiltrating malignant neoplasm-Histologic type-Bronchioloalveolar carcinoma, nonmucinous Bronchioloalveolar carcinoma, nonmucinous Lung-Infiltrating malignant neoplasm-Histologic type-Bronchioloalveolar carcinoma, mucinous Bronchioloalveolar carcinoma, mucinous Lip, oral cavity-Infiltrating malignant neoplasm-Margins involvement Margins involvement Lung-Infiltrating malignant neoplasm-Histologic type-Bronchioloalveolar carcinoma, mixed nonmucinous and mucinous Bronchioloalveolar carcinoma, mixed nonmucinous and mucinous Lung-Infiltrating malignant neoplasm-Histologic type-Solid adenocarcinoma Solid adenocarcinoma Lung-Infiltrating malignant neoplasm-Histologic type-Fetal adenocarcinoma Fetal adenocarcinoma Lung-Infiltrating malignant neoplasm-Histologic type-Mucinous (colloid) adenocarcinoma Mucinous (colloid) adenocarcinoma Lung-Infiltrating malignant neoplasm-Histologic type-Mucinous cystadenocarcinoma Mucinous cystadenocarcinoma Lung-Infiltrating malignant neoplasm-Histologic type-Signet ring adenocarcinoma Signet ring adenocarcinoma Lung-Infiltrating malignant neoplasm-Histologic type-Clear cell adenocarcinoma Clear cell adenocarcinoma Lung-Infiltrating malignant neoplasm-Histologic type-Large cell neuroendocrine carcinoma Large cell neuroendocrine carcinoma Lung-Infiltrating malignant neoplasm-Histologic type-Combined large cell neuroendocrine carcinoma (specify type of other non-small cell carcinoma component) Combined large cell neuroendocrine carcinoma (specify type of other non-small cell carcinoma component) Lung-Infiltrating malignant neoplasm-Histologic type-Basaloid carcinoma Basaloid carcinoma Lip, oral cavity-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin Distance of lesion from closest uninvolved margin Lung-Infiltrating malignant neoplasm-Histologic type-Lymphoepithelioma-like carcinoma Lymphoepithelioma-like carcinoma Lung-Infiltrating malignant neoplasm-Histologic type-Clear cell carcinoma Clear cell carcinoma Lung-Infiltrating malignant neoplasm-Histologic type-Large cell carcinoma with rhabdoid phenotype Large cell carcinoma with rhabdoid phenotype Lung-Infiltrating malignant neoplasm-Histologic type-Pleomorphic carcinoma Pleomorphic carcinoma Lung-Infiltrating malignant neoplasm-Histologic type-Spindle cell carcinoma Spindle cell carcinoma Lung-Infiltrating malignant neoplasm-Histologic type-Giant cell carcinoma Giant cell carcinoma Lung-Infiltrating malignant neoplasm-Histologic type-Carcinosarcoma Carcinosarcoma Lung-Infiltrating malignant neoplasm-Histologic type-Pulmonary blastoma Pulmonary blastoma Lung-Infiltrating malignant neoplasm-Histologic type-Atypical carcinoid tumor Atypical carcinoid tumor Lung-Infiltrating malignant neoplasm-Histologic type-Mucoepidermoid carcinoma Mucoepidermoid carcinoma Lip, oral cavity-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin Distance of lesion from closest uninvolved margin Lung-Infiltrating malignant neoplasm-Histologic type-Adenoid cystic carcinoma Adenoid cystic carcinoma Lung-Infiltrating malignant neoplasm-Histologic type-Epithelial-myoepithelial carcinoma Epithelial-myoepithelial carcinoma Lung-Lesion-Histologic type-Atelectasis Extends to the hilar region but does not involve entire lung Atelectasis Extends to the hilar region but does not involve entire lung Lung-Lesion-Histologic type-Atelectasis involves entire lung Atelectasis involves entire lung Lung-Lesion-Histologic type-Obstructive Pneumonitis extends to the hilar region but does not involve entire lung Obstructive Pneumonitis extends to the hilar region but does not involve entire lung Lung-Lesion-Histologic type-Obstructive Pneumonitis involves entire lung Obstructive Pneumonitis involves entire lung Lung-Lesion-Histologic type-Atypical adenomatous hyperplasia Atypical adenomatous hyperplasia Lung-Lesion-Histologic type-Squamous dysplasia Squamous dysplasia Lung-Lesion-Histologic type-Metaplasia (specify) Metaplasia (specify) Lung-Lesion-Histologic type-Diffuse neuroendocrine hyperplasia Diffuse neuroendocrine hyperplasia Lip, oral cavity-Infiltrating malignant neoplasm-Lymph-vascular invasion Lymph-vascular invasion Lung-Lesion-Histologic type-Inflammation Inflammation Prostate-Lesion-Histologic type-High-grade prostatic intraepithelial neoplasia (PIN) High-grade prostatic intraepithelial neoplasia (PIN) Prostate-Lesion-Histologic type-Atypical adenomatous hyperplasia (adenosis) Atypical adenomatous hyperplasia (adenosis) Prostate-Lesion-Histologic type-Nodular prostatic hyperplasia Nodular prostatic hyperplasia Prostate-Lesion-Histologic type-Inflammation Inflammation Kidney-Infiltrating malignant neoplasm-Histologic type-Multilocular clear cell renal cell carcinoma Multilocular clear cell renal cell carcinoma Kidney-Infiltrating malignant neoplasm-Histologic type-Papillary renal cell carcinoma Papillary renal cell carcinoma Kidney-Infiltrating malignant neoplasm-Histologic type-Translocation carcinoma (Xp11 or others) Translocation carcinoma (Xp11 or others) Kidney-Infiltrating malignant neoplasm-Histologic type-Carcinoma associated with neuroblastoma Carcinoma associated with neuroblastoma Kidney-Infiltrating malignant neoplasm-Histologic type-Mucinous tubular and spindle cell carcinoma Mucinous tubular and spindle cell carcinoma Lip, oral cavity-Infiltrating malignant neoplasm-Extent Extent Kidney-Infiltrating malignant neoplasm-Histologic type-Tubulocystic renal cell carcinoma Tubulocystic renal cell carcinoma Kidney-Infiltrating malignant neoplasm-Histologic type-Renal cell carcinoma, unclassified Renal cell carcinoma, unclassified Kidney-Lesion-Histologic type-Glomerular disease (specify) Glomerular disease (specify) Kidney-Lesion-Histologic type-Tubulointerstitial disease (specify) Tubulointerstitial disease (specify) Kidney-Lesion-Histologic type-Vascular disease (specify) Vascular disease (specify) Kidney-Lesion-Histologic type-Cyst(s) (specify) Cyst(s) (specify) Kidney-Lesion-Histologic type-Tubular (papillary) adenoma(s) Tubular (papillary) adenoma(s) Breast-In situ neoplasm-Histologic type-DCIS Comedo DCIS Comedo Breast-In situ neoplasm-Histologic type-DCIS Paget disease (DCIS involving nipple skin) DCIS Paget disease (DCIS involving nipple skin) Breast-In situ neoplasm-Histologic type-DCIS Cribriform DCIS Cribriform Lip, oral cavity-Infiltrating malignant neoplasm-Perineural invasion Perineural invasion Breast-In situ neoplasm-Histologic type-DCIS Micropapillary DCIS Micropapillary Breast-In situ neoplasm-Histologic type-DCIS Papillary DCIS Papillary Breast-In situ neoplasm-Histologic type-DCIS Solid DCIS Solid Testis-Lesion-Histologic type-Intratubular germ cell neoplasia Intratubular germ cell neoplasia Thyroid-Lesion-Histologic type-Adenoma Adenoma Thyroid-Lesion-Histologic type-Adenomatoid nodule(s) Adenomatoid nodule(s) Thyroid-Lesion-Histologic type-Nodular follicular disease (eg, nodular hyperplasia,goitrous thyroid) Nodular follicular disease (eg, nodular hyperplasia,goitrous thyroid) Thyroid-Lesion-Histologic type-Diffuse hyperplasia (Graves’ disease) Diffuse hyperplasia (Graves’ disease) Thyroid-Lesion-Histologic type-Advanced thyroiditis Advanced thyroiditis Thyroid-Lesion-Histologic type-Focal (nonspecific) thyroiditis Focal (nonspecific) thyroiditis Lip, oral cavity-Infiltrating malignant neoplasm-Lymph node capsule involvement Lymph node capsule involvement Thyroid-Lesion-Histologic type-Parathyroid gland(s) within normal limits Parathyroid gland(s) within normal limits Thyroid-Lesion-Histologic type-Hypercellular parathyroid gland(s) Hypercellular parathyroid gland(s) Thyroid-Lesion-Histologic type-C-cell hyperplasia C-cell hyperplasia Urinary bladder-Lesion-Histologic type-Inflammation/regenerative changes Inflammation/regenerative changes Urinary bladder-Lesion-Histologic type-Therapy-related changes Therapy-related changes Urinary bladder-Lesion-Histologic type-Cautery artifact Cautery artifact Urinary bladder-Lesion-Histologic type-Cystitis cystica glandularis Cystitis cystica glandularis Urinary bladder-Lesion-Histologic type-Keratinizing squamous metaplasia Keratinizing squamous metaplasia Urinary bladder-Lesion-Histologic type-Intestinal metaplasia Intestinal metaplasia Colon-Infiltrating malignant neoplasm-Macroscopic type-Tubular adenoma Tubular adenoma Lip, oral cavity-Infiltrating malignant neoplasm-Lymph node site Lymph node site Colon-Infiltrating malignant neoplasm-Macroscopic type-Villous adenoma Villous adenoma Colon-Infiltrating malignant neoplasm-Macroscopic type-Tubulovillous adenoma Tubulovillous adenoma Colon-Infiltrating malignant neoplasm-Macroscopic type-Traditional serrated adenoma Traditional serrated adenoma Colon-Infiltrating malignant neoplasm-Macroscopic type-Sessile serrated adenoma Sessile serrated adenoma Colon-Infiltrating malignant neoplasm-Macroscopic type-Hamartomatous polyp Hamartomatous polyp Colon-Infiltrating malignant neoplasm-Macroscopic type-Indeterminate Indeterminate Colon-Lesion-Macroscopic type-Pedunculated polyp with stalk (Stalk length: cm) Pedunculated polyp with stalk (Stalk length: cm) Colon-Lesion-Macroscopic type-Sessile polyp Sessile polyp Salivary gland-Infiltrating malignant neoplasm-Macroscopic type-Encapsulated/circumscribed lesion Encapsulated/circumscribed lesion Lip, oral cavity-Infiltrating malignant neoplasm-Number of lymph nodes involved Number of lymph nodes involved Salivary gland-Infiltrating malignant neoplasm-Macroscopic type-Invasive lesion Invasive lesion Salivary gland-Infiltrating malignant neoplasm-Macroscopic type-Solid lesion Solid lesion Salivary gland-Infiltrating malignant neoplasm-Macroscopic type-Cystic lesion Cystic lesion Salivary gland-Infiltrating malignant neoplasm-Macroscopic type-Epithelial-myoepithelial carcinoma Epithelial-myoepithelial carcinoma Larynx-Infiltrating malignant neoplasm-Macroscopic type-Sessile lesion Sessile lesion Larynx-Infiltrating malignant neoplasm-Macroscopic type-Polypoid lesion Polypoid lesion Larynx-Infiltrating malignant neoplasm-Macroscopic type-Exophytic lesion Exophytic lesion Larynx-Infiltrating malignant neoplasm-Macroscopic type-Endophytic lesion Endophytic lesion Larynx-Infiltrating malignant neoplasm-Macroscopic type-Ulcerated lesion Ulcerated lesion Larynx-Infiltrating malignant neoplasm-Macroscopic type-Mild keratinizing dysplasia Mild keratinizing dysplasia Lip, oral cavity-Infiltrating malignant neoplasm-Number of lymph nodes examined Number of lymph nodes examined Larynx-Infiltrating malignant neoplasm-Macroscopic type-Moderate keratinizing dysplasia Moderate keratinizing dysplasia Larynx-Infiltrating malignant neoplasm-Macroscopic type-Severe keratinizing dysplasia (carcinoma in situ) Severe keratinizing dysplasia (carcinoma in situ) Larynx-Infiltrating malignant neoplasm-Macroscopic type-Mild non-keratinizing dysplasia Mild non-keratinizing dysplasia Larynx-Infiltrating malignant neoplasm-Macroscopic type-Moderate non-keratinizing dysplasia Moderate non-keratinizing dysplasia Larynx-Infiltrating malignant neoplasm-Macroscopic type-Severe non-keratinizing dysplasia (carcinoma in situ) Severe non-keratinizing dysplasia (carcinoma in situ) Larynx-Infiltrating malignant neoplasm-Macroscopic type-Inflammation (specify) Inflammation (specify) Larynx-Infiltrating malignant neoplasm-Macroscopic type-Squamous metaplasia Squamous metaplasia Larynx-Infiltrating malignant neoplasm-Macroscopic type-Epithelial hyperplasia Epithelial hyperplasia Larynx-Infiltrating malignant neoplasm-Macroscopic type-Fungal colonization Fungal colonization Larynx-Infiltrating malignant neoplasm-Macroscopic type-Bacterial colonization Bacterial colonization Pharynx-Infiltrating malignant neoplasm-Macroscopic type-Polypoid lesion Polypoid lesion Pharynx-Infiltrating malignant neoplasm-Macroscopic type-Exophytic lesion Exophytic lesion Pharynx-Infiltrating malignant neoplasm-Macroscopic type-Endophytic lesion Endophytic lesion Pharynx-Infiltrating malignant neoplasm-Macroscopic type-Ulcerated lesion Ulcerated lesion Pharynx-Infiltrating malignant neoplasm-Macroscopic type-Sessile lesion Sessile lesion Urinary bladder-Infiltrating malignant neoplasm-Macroscopic type-Papillary Papillary Urinary bladder-Infiltrating malignant neoplasm-Macroscopic type-Solid/nodule Solid/nodule Urinary bladder-Infiltrating malignant neoplasm-Macroscopic type-Flat Flat Urinary bladder-Infiltrating malignant neoplasm-Macroscopic type-Ulcerated Ulcerated Urinary bladder-Infiltrating malignant neoplasm-Macroscopic type-Indeterminate Indeterminate Lip, oral cavity-Infiltrating malignant neoplasm-pN pN Cervix-In situ neoplasm-Histologic type- Intraepithelial neoplasia Prostate-Infiltrating malignant neoplasm-Histologic type-Signet-ring cell carcinoma Signet-ring cell carcinoma Prostate-Infiltrating malignant neoplasm-Histologic type-Adenosquamous carcinoma Adenosquamous carcinoma Prostate-Infiltrating malignant neoplasm-Histologic type-Small cell carcinoma Small cell carcinoma Prostate-Infiltrating malignant neoplasm-Histologic type-Sarcomatoid carcinoma Sarcomatoid carcinoma Prostate-Infiltrating malignant neoplasm-Histologic type-Undifferentiated carcinoma, not otherwise specified Undifferentiated carcinoma, not otherwise specified Testis-Infiltrating malignant neoplasm-Histologic type-Seminoma with associated scar Seminoma with associated scar Testis-Infiltrating malignant neoplasm-Histologic type-Seminoma with syncytiotrophoblastic cells Seminoma with syncytiotrophoblastic cells Testis-Infiltrating malignant neoplasm-Histologic type-Embryonal carcinoma Embryonal carcinoma Testis-Infiltrating malignant neoplasm-Histologic type-Choriocarcinoma, biphasic Choriocarcinoma, biphasic Testis-Infiltrating malignant neoplasm-Histologic type-Choriocarcinoma, monophasic Choriocarcinoma, monophasic Testis-Infiltrating malignant neoplasm-Histologic type-Placental site trophoblastic tumor Placental site trophoblastic tumor Testis-Infiltrating malignant neoplasm-Histologic type-Teratoma with a secondary somatic-type malignant component (specify type) Teratoma with a secondary somatic-type malignant component (specify type) Testis-Infiltrating malignant neoplasm-Histologic type-Monodermal teratoma, carcinoid Monodermal teratoma, carcinoid Testis-Infiltrating malignant neoplasm-Histologic type-Monodermal teratoma, primitive neuroectodermal tumor Monodermal teratoma, primitive neuroectodermal tumor Testis-Infiltrating malignant neoplasm-Histologic type-Monodermal teratoma, Other Monodermal teratoma, Other Testis-Infiltrating malignant neoplasm-Histologic type-Spermatocytic seminoma Spermatocytic seminoma Testis-Infiltrating malignant neoplasm-Histologic type-Spermatocytic seminoma with a sarcomatous component Spermatocytic seminoma with a sarcomatous component Testis-Infiltrating malignant neoplasm-Histologic type-Mixed germ cell-sex cord-stromal tumor, gonadoblastoma Mixed germ cell-sex cord-stromal tumor, gonadoblastoma Testis-Infiltrating malignant neoplasm-Histologic type-Mixed germ cell-sex cord-stromal tumor, others (specify) Mixed germ cell-sex cord-stromal tumor, others (specify) Lip, oral cavity-Infiltrating malignant neoplasm-pT mucosal malignant melanoma pT mucosal malignant melanoma Testis-Infiltrating malignant neoplasm-Histologic type-Testicular scar with intratubular germ cell neoplasia Testicular scar with intratubular germ cell neoplasia Testis-Infiltrating malignant neoplasm-Histologic type-Sex cord-stromal tumor: Leydig cell tumor Sex cord-stromal tumor: Leydig cell tumor Testis-Infiltrating malignant neoplasm-Histologic type-Sex cord-stromal tumor: Classic Sertoli cell tumor Sex cord-stromal tumor: Classic Sertoli cell tumor Testis-Infiltrating malignant neoplasm-Histologic type-Sex cord-stromal tumor: Sclerosing Sertoli cell tumor Sex cord-stromal tumor: Sclerosing Sertoli cell tumor Testis-Infiltrating malignant neoplasm-Histologic type-Sex cord-stromal tumor: Large cell calcifying Sertoli cell tumor Sex cord-stromal tumor: Large cell calcifying Sertoli cell tumor Testis-Infiltrating malignant neoplasm-Histologic type-Sex cord-stromal tumor: Adult-type Granulosa cell tumor Sex cord-stromal tumor: Adult-type Granulosa cell tumor Testis-Infiltrating malignant neoplasm-Histologic type-Sex cord-stromal tumor: Juvenile-type Granulosa cell tumor Sex cord-stromal tumor: Juvenile-type Granulosa cell tumor Testis-Infiltrating malignant neoplasm-Histologic type-Sex cord-stromal tumor: Mixed, with components Sex cord-stromal tumor: Mixed, with components Testis-Infiltrating malignant neoplasm-Histologic type-Sex cord-stromal tumor: Unclassified Sex cord-stromal tumor: Unclassified Testis-Infiltrating malignant neoplasm-Histologic type-Malignant neoplasm, type cannot be determined Malignant neoplasm, type cannot be determined Lip, oral cavity-Infiltrating malignant neoplasm-Lymph node metastasis size Lymph node metastasis size Testis-Lesion-Histologic type-Hemosiderin-laden macrophages Hemosiderin-laden macrophages Testis-Lesion-Histologic type-Atrophy Atrophy Urinary bladder-Infiltrating malignant neoplasm-Histologic type-Urothelial (transitional cell) carcinoma with squamous differentiation Urothelial (transitional cell) carcinoma with squamous differentiation Urinary bladder-Infiltrating malignant neoplasm-Histologic type-Urothelial (transitional cell) carcinoma with glandular differentiation Urothelial (transitional cell) carcinoma with glandular differentiation Urinary bladder-Infiltrating malignant neoplasm-Histologic type-Urothelial (transitional cell) carcinoma with variant histology - Specify Urothelial (transitional cell) carcinoma with variant histology - Specify Urinary bladder-Infiltrating malignant neoplasm-Histologic type-Squamous cell carcinoma, typical Squamous cell carcinoma, typical Urinary bladder-Infiltrating malignant neoplasm-Histologic type-Squamous cell carcinoma, variant histology - Specify Squamous cell carcinoma, variant histology - Specify Urinary bladder-Infiltrating malignant neoplasm-Histologic type-Adenocarcinoma, typical Adenocarcinoma, typical Urinary bladder-Infiltrating malignant neoplasm-Histologic type-Adenocarcinoma, variant histology - Specify Adenocarcinoma, variant histology - Specify Urinary bladder-Infiltrating malignant neoplasm-Histologic type-Undifferentiated carcinoma - Specify Undifferentiated carcinoma - Specify Lip, oral cavity-Infiltrating malignant neoplasm-Lesion size, largest dimension Lesion size, largest dimension Urinary bladder-Infiltrating malignant neoplasm-Histologic type-Mixed cell type - Specify Mixed cell type - Specify Pancreas-Lesion-Histologic type-Chronic pancreatitis Chronic pancreatitis Pancreas-Lesion-Histologic type-Acute pancreatitis Acute pancreatitis Lip, oral cavity-Infiltrating malignant neoplasm-Specimen size, largest dimension Specimen size, largest dimension Lip, oral cavity-Infiltrating malignant neoplasm-Histologic type Histologic type Skin (melanoma)-Infiltrating malignant neoplasm-Margins involvement Margins involvement Esophagus-Infiltrating malignant neoplasm-Margins involvement Margins involvement Esophagus-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin Distance of lesion from closest uninvolved margin Esophagus-Infiltrating malignant neoplasm-Lymph-vascular invasion Lymph-vascular invasion Esophagus-Infiltrating malignant neoplasm-Extent Extent Esophagus-Infiltrating malignant neoplasm-Perineural invasion Perineural invasion Esophagus-Infiltrating malignant neoplasm-Lesion site Lesion site Esophagus-Infiltrating malignant neoplasm-Margin site Margin site Esophagus-Infiltrating malignant neoplasm-Number of lymph nodes involved Number of lymph nodes involved Esophagus-Infiltrating malignant neoplasm-Number of lymph nodes examined Number of lymph nodes examined Esophagus-Infiltrating malignant neoplasm-pN pN Esophagus-Infiltrating malignant neoplasm-pT pT Esophagus-Infiltrating malignant neoplasm-Lesion size, largest dimension Lesion size, largest dimension Esophagus-Infiltrating malignant neoplasm-Histologic type Histologic type Ovary-Infiltrating malignant neoplasm-Extent Extent Ovary-Infiltrating malignant neoplasm-Histologic grade of ovary mucinous carcinoma Histologic grade of ovary mucinous carcinoma Ovary-Infiltrating malignant neoplasm-Histologic grade (FIGO) Histologic grade (FIGO) Ovary-Infiltrating malignant neoplasm-Histologic grade of ovarry immature teratoma Histologic grade of ovarry immature teratoma Ovary-Infiltrating malignant neoplasm-Lymph node site Lymph node site Ovary-Infiltrating malignant neoplasm-pN pN Ovary-Infiltrating malignant neoplasm-pT pT Ovary-Infiltrating malignant neoplasm-Lymph-vascular invasion Lymph-vascular invasion Ovary-Infiltrating malignant neoplasm-Lymph node sampling Lymph node sampling Ovary-Infiltrating malignant neoplasm-Number of lymph nodes involved Number of lymph nodes involved Ovary-Infiltrating malignant neoplasm-Number of lymph nodes examined Number of lymph nodes examined Ovary-Infiltrating malignant neoplasm-Lesion size, largest dimension Lesion size, largest dimension Ovary-Infiltrating malignant neoplasm-Histologic type Histologic type Generic-Infiltrating malignant neoplasm-Specimen size, additional dimension Specimen size, additional dimension Pancreas-Infiltrating malignant neoplasm-Margins involvement Margins involvement Pancreas-Infiltrating malignant neoplasm-Margins involvement Margins involvement Pancreas-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin Distance of lesion from closest uninvolved margin Pancreas-Infiltrating malignant neoplasm-Lymph-vascular invasion Lymph-vascular invasion Pancreas-Infiltrating malignant neoplasm-Extent Extent Pancreas-Infiltrating malignant neoplasm-Perineural invasion Perineural invasion Pancreas-Infiltrating malignant neoplasm-Lesion site Lesion site Pancreas-Infiltrating malignant neoplasm-Margin site Margin site Pancreas-Infiltrating malignant neoplasm-Number of lymph nodes involved Number of lymph nodes involved Pancreas-Infiltrating malignant neoplasm-Number of lymph nodes examined Number of lymph nodes examined Generic-Infiltrating malignant neoplasm-Histologic grade (WHO) Histologic grade (WHO) Pancreas-Infiltrating malignant neoplasm-pN pN Pancreas-Infiltrating malignant neoplasm-pT pT Pancreas-Infiltrating malignant neoplasm-Lesion size, largest dimension Lesion size, largest dimension Pancreas-Infiltrating malignant neoplasm-Histologic type Histologic type Skin (melanoma)-Infiltrating malignant neoplasm-Margins involvement Margins involvement Skin (melanoma)-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin Distance of lesion from closest uninvolved margin Skin (melanoma)-Infiltrating malignant neoplasm-Lymph-vascular invasion Lymph-vascular invasion Skin (melanoma)-Infiltrating malignant neoplasm-Lymph node sampling Lymph node sampling Skin (melanoma)-Infiltrating malignant neoplasm-Perineural invasion Perineural invasion Skin (melanoma)-Infiltrating malignant neoplasm-Lymph node capsule involvement Lymph node capsule involvement Skin (melanoma)-Infiltrating malignant neoplasm-Lesion site Lesion site Skin (melanoma)-Infiltrating malignant neoplasm-Margin site Margin site Skin (melanoma)-Infiltrating malignant neoplasm-Number of lymph nodes involved Number of lymph nodes involved Skin (melanoma)-Infiltrating malignant neoplasm-Number of lymph nodes examined Number of lymph nodes examined Skin (melanoma)-Infiltrating malignant neoplasm-pN pN Skin (melanoma)-Infiltrating malignant neoplasm-pT pT Skin (melanoma)-Infiltrating malignant neoplasm-Lymph node metastasis size Lymph node metastasis size Skin (melanoma)-Infiltrating malignant neoplasm-Lesion size, largest dimension Lesion size, largest dimension Skin (melanoma)-Infiltrating malignant neoplasm-Specimen size, largest dimension Specimen size, largest dimension Skin (melanoma)-Infiltrating malignant neoplasm-Histologic type Histologic type Skin (melanoma)-Infiltrating malignant neoplasm-Lesion ulceration Lesion ulceration Pharynx-Infiltrating malignant neoplasm-Margins involvement Margins involvement Pharynx-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin Distance of lesion from closest uninvolved margin Pharynx-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin Distance of lesion from closest uninvolved margin Pharynx-Infiltrating malignant neoplasm-Lymph-vascular invasion Lymph-vascular invasion Pharynx-Infiltrating malignant neoplasm-Extent Extent Pharynx-Infiltrating malignant neoplasm-Perineural invasion Perineural invasion Pharynx-Infiltrating malignant neoplasm-Lymph node capsule involvement Lymph node capsule involvement Pharynx-Infiltrating malignant neoplasm-Lesion site Lesion site Pharynx-Infiltrating malignant neoplasm-Lymph node site Lymph node site Pharynx-Infiltrating malignant neoplasm-Number of lymph nodes involved Number of lymph nodes involved Pharynx-Infiltrating malignant neoplasm-Number of lymph nodes examined Number of lymph nodes examined Pharynx-Infiltrating malignant neoplasm-pN hypopharynx carcinoma pN hypopharynx carcinoma Pharynx-Infiltrating malignant neoplasm-pN nasopharynx carcinoma pN nasopharynx carcinoma Colon-Infiltrating malignant neoplasm-Tumor deposits Tumor deposits Pharynx-Infiltrating malignant neoplasm-pN mucosal malignant melanoma pN mucosal malignant melanoma Pharynx-Infiltrating malignant neoplasm-pT hypopharynx carcinoma pT hypopharynx carcinoma Pharynx-Infiltrating malignant neoplasm-pT nasopharynx carcinoma pT nasopharynx carcinoma Pharynx-Infiltrating malignant neoplasm-pT mucosal malignant melanoma pT mucosal malignant melanoma Pharynx-Infiltrating malignant neoplasm-Lymph node metastasis size Lymph node metastasis size Pharynx-Infiltrating malignant neoplasm-Lesion size, largest dimension Lesion size, largest dimension Pharynx-Infiltrating malignant neoplasm-Specimen size, largest dimension Specimen size, largest dimension Pharynx-Infiltrating malignant neoplasm-Histologic type Histologic type Lung-Infiltrating malignant neoplasm-Margins involvement Margins involvement Generic-Infiltrating malignant neoplasm-Extent Extent Lung-Infiltrating malignant neoplasm-Margins involvement Margins involvement Lung-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin Distance of lesion from closest uninvolved margin Lung-Infiltrating malignant neoplasm-Lymph-vascular invasion Lymph-vascular invasion Lung-Infiltrating malignant neoplasm-Extent Extent Lung-Infiltrating malignant neoplasm-Perineural invasion Perineural invasion Lung-Infiltrating malignant neoplasm-Lymph node capsule involvement Lymph node capsule involvement Lung-Infiltrating malignant neoplasm-Lymph node site Lymph node site Lung-Infiltrating malignant neoplasm-Margin site Margin site Lung-Infiltrating malignant neoplasm-Number of lymph nodes involved Number of lymph nodes involved Lung-Infiltrating malignant neoplasm-Number of lymph nodes examined Number of lymph nodes examined Lung-Infiltrating malignant neoplasm-pN pN Lung-Infiltrating malignant neoplasm-pT pT Lung-Infiltrating malignant neoplasm-Lesion size, largest dimension Lesion size, largest dimension Lung-Infiltrating malignant neoplasm-Lesion size, largest dimension Lesion size, largest dimension Lung-Infiltrating malignant neoplasm-Histologic type Histologic type Prostate-Infiltrating malignant neoplasm-Margins involvement Margins involvement Prostate-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin Distance of lesion from closest uninvolved margin Prostate-Infiltrating malignant neoplasm-Lymph-vascular invasion Lymph-vascular invasion Generic-Infiltrating malignant neoplasm-Number of lymph nodes examined Number of lymph nodes examined Prostate-Infiltrating malignant neoplasm-Lymph node sampling Lymph node sampling Prostate-Infiltrating malignant neoplasm-Extent Extent Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Primary (Predominant) Pattern) Histologic grade (Gleason-Primary (Predominant) Pattern) Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Secondary (Worst Remaining) Pattern) Histologic grade (Gleason-Secondary (Worst Remaining) Pattern) Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Tertiary Pattern) Histologic grade (Gleason-Tertiary Pattern) Prostate-Infiltrating malignant neoplasm-Histologic grade (Gleason-Total Gleason Score) Histologic grade (Gleason-Total Gleason Score) Prostate-Infiltrating malignant neoplasm-Perineural invasion Perineural invasion Prostate-Infiltrating malignant neoplasm-Lesion site Lesion site Prostate-Infiltrating malignant neoplasm-Number of lymph nodes involved Number of lymph nodes involved Prostate-Infiltrating malignant neoplasm-Number of lymph nodes examined Number of lymph nodes examined Generic-Infiltrating malignant neoplasm-Number of lymph nodes involved Number of lymph nodes involved Prostate-Infiltrating malignant neoplasm-pN pN Prostate-Infiltrating malignant neoplasm-Specimen weight Specimen weight Prostate-Infiltrating malignant neoplasm-pT pT Prostate-Infiltrating malignant neoplasm-Lymph node metastasis size Lymph node metastasis size Prostate-Infiltrating malignant neoplasm-Specimen size, largest dimension Specimen size, largest dimension Prostate-Infiltrating malignant neoplasm-Histologic type Histologic type Kidney-Infiltrating malignant neoplasm-Margins involvement Margins involvement Kidney-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin Distance of lesion from closest uninvolved margin Generic-Specimen-Specimen integrity Specimen integrity Breast-Infiltrating malignant neoplasm-Number of lymph nodes with isolated tumor cells (< = 0.2 mm and < = 200 cells) Number of lymph nodes with isolated tumor cells (< = 0.2 mm and < = 200 cells) Kidney-Infiltrating malignant neoplasm-Lymph-vascular invasion Lymph-vascular invasion Kidney-Infiltrating malignant neoplasm-Extent Extent Kidney-Infiltrating malignant neoplasm-Histologic grade (Fuhrman Nuclear Grade) Histologic grade (Fuhrman Nuclear Grade) Kidney-Infiltrating malignant neoplasm-Lesion site Lesion site Kidney-Infiltrating malignant neoplasm-Margin site Margin site Kidney-Infiltrating malignant neoplasm-Number of lymph nodes involved Number of lymph nodes involved Kidney-Infiltrating malignant neoplasm-Number of lymph nodes examined Number of lymph nodes examined Kidney-Infiltrating malignant neoplasm-pN pN Breast-Infiltrating malignant neoplasm-Number of lymph nodes with macrometastases (>0.2 cm) Number of lymph nodes with macrometastases (>0.2 cm) Kidney-Infiltrating malignant neoplasm-pT pT Kidney-Infiltrating malignant neoplasm-Lesion size, largest dimension Lesion size, largest dimension Kidney-Infiltrating malignant neoplasm-Histologic type Histologic type Margins involvement Breast-In situ neoplasm-Margins involvement Breast-Margins involvement Breast-In situ neoplasm-Distance of lesion from closest uninvolved margin Distance of lesion from closest uninvolved margin Lymph-vascular invasion Breast-Infiltrating malignant neoplasm-Lymph-vascular invasion Breast-Lymph-vascular invasion Lymph node sampling Breast-Infiltrating malignant neoplasm-Lymph node sampling Breast-Lymph node sampling Breast-In situ neoplasm-Histologic grade of ductal carcinoma in situ (DCIS) Histologic grade of ductal carcinoma in situ (DCIS) Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham Histologic Score-Glandular (Acinar)/Tubular Differentiation) Histologic grade (Nottingham Histologic Score-Glandular (Acinar)/Tubular Differentiation) Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham Histologic Score-Mitotic Count) Histologic grade (Nottingham Histologic Score-Mitotic Count) Breast-Infiltrating malignant neoplasm-Number of lymph nodes with micrometastases (>0.2 mm to 0.2 cm and/or >200 cells): Number of lymph nodes with micrometastases (>0.2 mm to 0.2 cm and/or >200 cells): Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham Histologic Score-Nuclear Pleomorphism) Histologic grade (Nottingham Histologic Score-Nuclear Pleomorphism) Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham) Histologic grade (Nottingham) Lesion site Breast-Infiltrating malignant neoplasm-Lesion site Breast-Lesion site Lymph node site Breast-Infiltrating malignant neoplasm-Lymph node site Breast-Lymph node site Margin site Breast-Infiltrating malignant neoplasm-Margin site Breast-Margin site Number of lymph nodes involved Breast-Infiltrating malignant neoplasm-Number of lymph nodes involved Breast-Number of lymph nodes involved Number of lymph nodes examined Breast-Infiltrating malignant neoplasm-Number of lymph nodes examined Breast-Number of lymph nodes examined pN Breast-Infiltrating malignant neoplasm-pN Breast-Infiltrating malignant neoplasm-pN Larynx-Infiltrating malignant neoplasm-Lymph node metastasis size Lymph node metastasis size pT Breast-Infiltrating malignant neoplasm-pT Breast-Infiltrating malignant neoplasm-pT Breast-Infiltrating malignant neoplasm-Progesterone receptor Progesterone receptor Breast-Infiltrating malignant neoplasm-Estrogen receptor Estrogen receptor Breast-Infiltrating malignant neoplasm-HER2/neu (FISH method) HER2/neu (FISH method) Breast-Infiltrating malignant neoplasm-HER2/neu (immunoperoxidase study) Specimen size, largest dimension Breast-In situ neoplasm-Lesion size, largest dimension Lesion size, largest dimension Histologic type Breast-In situ neoplasm-Histologic type Breast-Histologic type Histologic type Breast-Infiltrating malignant neoplasm-Histologic type Breast-Histologic type Testis-Infiltrating malignant neoplasm-Margins involvement Margins involvement Testis-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin Distance of lesion from closest uninvolved margin Cervix-Infiltrating malignant neoplasm-Lymph node capsule involvement Lymph node capsule involvement Testis-Infiltrating malignant neoplasm-Lymph-vascular invasion Lymph-vascular invasion Testis-Infiltrating malignant neoplasm-Extent Extent Testis-Infiltrating malignant neoplasm-Margin site Margin site Testis-Infiltrating malignant neoplasm-Number of lymph nodes involved Number of lymph nodes involved Testis-Infiltrating malignant neoplasm-Number of lymph nodes examined Number of lymph nodes examined Testis-Infiltrating malignant neoplasm-pN pN Testis-Infiltrating malignant neoplasm-pT pT Testis-Infiltrating malignant neoplasm-Lesion size, largest dimension Lesion size, largest dimension Generic-Infiltrating malignant neoplasm-Lymph node site Lymph node site Testis-Infiltrating malignant neoplasm-Histologic type Histologic type Thyroid-Infiltrating malignant neoplasm-Margins involvement Margins involvement Thyroid-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin Distance of lesion from closest uninvolved margin Thyroid-Infiltrating malignant neoplasm-Lymph-vascular invasion Lymph-vascular invasion Thyroid-Infiltrating malignant neoplasm-Extent Extent Thyroid-Infiltrating malignant neoplasm-Perineural invasion Perineural invasion Thyroid-Infiltrating malignant neoplasm-Lymph node capsule involvement Lymph node capsule involvement Thyroid-Infiltrating malignant neoplasm-Lesion site Lesion site Thyroid-Infiltrating malignant neoplasm-Number of lymph nodes involved Number of lymph nodes involved Thyroid-Infiltrating malignant neoplasm-Number of lymph nodes examined Number of lymph nodes examined Thyroid-Infiltrating malignant neoplasm-pN pN Thyroid-Infiltrating malignant neoplasm-Specimen weight Specimen weight Thyroid-Infiltrating malignant neoplasm-pT anaplasic carcinoma pT anaplasic carcinoma Thyroid-Infiltrating malignant neoplasm-pT exept anaplasic carcinoma pT exept anaplasic carcinoma Thyroid-Infiltrating malignant neoplasm-Lesion size, largest dimension Lesion size, largest dimension Thyroid-Infiltrating malignant neoplasm-Lesion size, largest dimension Lesion size, largest dimension Thyroid-Infiltrating malignant neoplasm-Specimen size, largest dimension Specimen size, largest dimension Thyroid-Infiltrating malignant neoplasm-Histologic type Histologic type Colon-Infiltrating malignant neoplasm-Margins involvement Margins involvement Urinary bladder-Infiltrating malignant neoplasm-Margins involvement Margins involvement Urinary bladder-Infiltrating malignant neoplasm-Margins involvement Margins involvement Urinary bladder-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin Distance of lesion from closest uninvolved margin Urinary bladder-Infiltrating malignant neoplasm-Lymph-vascular invasion Lymph-vascular invasion Urinary bladder-Infiltrating malignant neoplasm-Extent Extent Urinary bladder-Infiltrating malignant neoplasm-Histologic grade (WHO 2004) Histologic grade (WHO 2004) Urinary bladder-Infiltrating malignant neoplasm-Lesion site Lesion site Urinary bladder-Infiltrating malignant neoplasm-Margin site Margin site Urinary bladder-Infiltrating malignant neoplasm-Number of lymph nodes involved Number of lymph nodes involved Urinary bladder-Infiltrating malignant neoplasm-Number of lymph nodes examined Number of lymph nodes examined Urinary bladder-Infiltrating malignant neoplasm-pN pN Urinary bladder-Infiltrating malignant neoplasm-pT pT Urinary bladder-Infiltrating malignant neoplasm-Lesion size, largest dimension Lesion size, largest dimension Urinary bladder-Infiltrating malignant neoplasm-Histologic type Histologic type Histologic grade (WHO) Cervix-Infiltrating malignant neoplasm-Histologic grade (WHO) Cervix-Histologic grade (WHO) Margin site Cervix-Infiltrating malignant neoplasm-Margin site Cervix-Margin site pM Cervix-Infiltrating malignant neoplasm-pM Cervix-Infiltrating malignant neoplasm-pM Margins involvement Breast-Infiltrating malignant neoplasm-Margins involvement Breast-Margins involvement Lesion site Cervix-Lesion-Lesion site Cervix-Lesion site Lesion site Cervix-In situ neoplasm-Lesion site Cervix-Lesion site Colon-Infiltrating malignant neoplasm-Microsatellite instability Microsatellite instability Colon-Infiltrating malignant neoplasm-Mismatch Repair Proteins-MLH1 (Immunohistochemistry Study) Mismatch Repair Proteins-MLH1 (Immunohistochemistry Study) Colon-Infiltrating malignant neoplasm-Mismatch Repair Proteins-MLH2 (Immunohistochemistry Study) Mismatch Repair Proteins-MLH2 (Immunohistochemistry Study) Colon-Infiltrating malignant neoplasm-Mismatch Repair Proteins-MLH6 (Immunohistochemistry Study) Mismatch Repair Proteins-MLH6 (Immunohistochemistry Study) Colon-Infiltrating malignant neoplasm-BRAF V600E mutational analysis BRAF V600E mutational analysis Colon-Infiltrating malignant neoplasm-KRAS mutational analysis KRAS mutational analysis Colon-Infiltrating malignant neoplasm-Mismatch Repair Proteins-PMS2 (Immunohistochemistry Study) Mismatch Repair Proteins-PMS2 (Immunohistochemistry Study) Esophagus-Infiltrating malignant neoplasm-Margins involvement Margins involvement Cervix-Specimen-Target site-Col utérin Cervix Cervix-Specimen-Specimen collection procedure-Radical hysterectomy Radical hysterectomy Cervix-Infiltrating malignant neoplasm-Cytologic type-Invasive carcinoma Invasive carcinoma Cervix-Infiltrating malignant neoplasm-Histologic type-Endocervical type Mucinous Adenocarcinoma Endocervical type Mucinous Adenocarcinoma Cervix-Infiltrating malignant neoplasm-Histologic type-Intestinal type Mucinous Adenocarcinoma Intestinal type Mucinous Adenocarcinoma Esophagus-Infiltrating malignant neoplasm-Margins involvement Margins involvement Cervix-Infiltrating malignant neoplasm-Histologic type-Other Mucinous Adenocarcinoma Other Mucinous Adenocarcinoma Cervix-Infiltrating malignant neoplasm-Histologic type-Endometrioid Adenocarcinoma Endometrioid Adenocarcinoma Cervix-Infiltrating malignant neoplasm-Histologic type-Clear cell Adenocarcinoma Clear cell Adenocarcinoma Cervix-Infiltrating malignant neoplasm-Histologic grade (FIGO)-FIGO grade 1 FIGO grade 1 Esophagus-Infiltrating malignant neoplasm-Margins involvement Margins involvement Cervix-Infiltrating malignant neoplasm-Histologic grade (FIGO)-FIGO grade 2 FIGO grade 2 Cervix-Infiltrating malignant neoplasm-Histologic grade (FIGO)-FIGO grade 3 FIGO grade 3 Cervix-Infiltrating malignant neoplasm-pT-pT1 [I]: Cervical carcinoma confined to uterus (extension to corpus should be disregarded) pT1 [I]: Cervical carcinoma confined to uterus (extension to corpus should be disregarded) Cervix-Infiltrating malignant neoplasm-pT-pT1a [IA]: Invasive carcinoma diagnosed by microscopy only. All macroscopically visible lesions (even with superficial invasion) are pT1b/1B. pT1a [IA]: Invasive carcinoma diagnosed by microscopy only. All macroscopically visible lesions (even with superficial invasion) are pT1b/1B. Cervix-Infiltrating malignant neoplasm-pT-pT1a1 [IA1]: Stromal invasion < =3.0 mm in depth and horizontal spread < =7.0 mm pT1a1 [IA1]: Stromal invasion < =3.0 mm in depth and horizontal spread < =7.0 mm Cervix-Infiltrating malignant neoplasm-pT-pT1a2 [IA2]: Stromal invasion >3.0 mm but not more than 5.0 mm in depth and horizontal spread 􀀁7.0 mm pT1a2 [IA2]: Stromal invasion >3.0 mm but not more than 5.0 mm in depth and horizontal spread 􀀁7.0 mm Cervix-Infiltrating malignant neoplasm-pT-pT1b [IB]: Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a2/IA2 pT1b [IB]: Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a2/IA2 Cervix-Infiltrating malignant neoplasm-pT-pT1b1 [IB1]: Clinically visible lesion 􀀁4.0 cm in greatest dimension pT1b1 [IB1]: Clinically visible lesion 􀀁4.0 cm in greatest dimension Cervix-Infiltrating malignant neoplasm-pT-pT1b2 [IB2]: Clinically visible lesion >4.0 cm in greatest dimension pT1b2 [IB2]: Clinically visible lesion >4.0 cm in greatest dimension Cervix-Infiltrating malignant neoplasm-pT-pT2 [II]: Tumor invades beyond the uterus but not to pelvic wall or to lower third of vagina pT2 [II]: Tumor invades beyond the uterus but not to pelvic wall or to lower third of vagina Generic-Infiltrating malignant neoplasm-Margins involvement Margins involvement Cervix-Infiltrating malignant neoplasm-pT-pT2a [IIA]: Tumor without parametrial invasion pT2a [IIA]: Tumor without parametrial invasion Cervix-Infiltrating malignant neoplasm-pT-pT2a1 [IIA1]: Clinically visible lesion 􀀁4.0 cm in greatest dimension pT2a1 [IIA1]: Clinically visible lesion 􀀁4.0 cm in greatest dimension Cervix-Infiltrating malignant neoplasm-pT-pT2a2 [IIA2] Clinically visible lesion >4.0 cm in greatest dimension pT2a2 [IIA2] Clinically visible lesion >4.0 cm in greatest dimension Cervix-Infiltrating malignant neoplasm-pT-pT2b [IIB]: Tumor with parametrial invasion pT2b [IIB]: Tumor with parametrial invasion Cervix-Infiltrating malignant neoplasm-pT-pT3 [III]: Tumor extends to the pelvic wall and/or involves the lower third of the vagina and/or causes hydronephrosis or non-functioning kidney pT3 [III]: Tumor extends to the pelvic wall and/or involves the lower third of the vagina and/or causes hydronephrosis or non-functioning kidney Cervix-Infiltrating malignant neoplasm-pT-pT3a [IIIA]: Tumor involves lower third of vagina, but not pelvic wall pT3a [IIIA]: Tumor involves lower third of vagina, but not pelvic wall Cervix-Infiltrating malignant neoplasm-pT-pT3b [IIIB]: Tumor extends to pelvic wall and/or causes hydronephrosis or non-functioning kidney pT3b [IIIB]: Tumor extends to pelvic wall and/or causes hydronephrosis or non-functioning kidney Cervix-Infiltrating malignant neoplasm-pT-pT4 [IVA]: Tumor invades the mucosa of bladder or rectum and/or extends beyond true pelvis (bullous edema is not sufficient evidence to classify a tumor as pT4) pT4 [IVA]: Tumor invades the mucosa of bladder or rectum and/or extends beyond true pelvis (bullous edema is not sufficient evidence to classify a tumor as pT4) Cervix-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis pN0: No regional lymph node metastasis Cervix-Infiltrating malignant neoplasm-pN-pN1: Regional lymph node metastasis pN1: Regional lymph node metastasis Cervix-Specimen-Target site-Uterine corpus Uterine corpus Endometrium-Specimen-Specimen collection procedure-Supracervical hysterectomy Supracervical hysterectomy Endometrium-Specimen-Specimen collection procedure-Radical hysterectomy Radical hysterectomy Endometrium-Infiltrating malignant neoplasm-Histologic type-Endometrioid adenocarcinoma, not otherwise characterized Endometrioid adenocarcinoma, not otherwise characterized Endometrium-Infiltrating malignant neoplasm-Histologic type-Mucinous adenocarcinoma Mucinous adenocarcinoma Endometrium-Infiltrating malignant neoplasm-Histologic type-Serous adenocarcinoma Serous adenocarcinoma Endometrium-Infiltrating malignant neoplasm-Histologic type-Clear cell adenocarcinoma Clear cell adenocarcinoma Endometrium-Infiltrating malignant neoplasm-Histologic type-Squamous cell carcinoma Squamous cell carcinoma Endometrium-Infiltrating malignant neoplasm-Histologic type-Undifferentiated carcinoma Undifferentiated carcinoma Endometrium-Infiltrating malignant neoplasm-Histologic type-Carcinosarcoma (malignant müllerian mixed tumor) Carcinosarcoma (malignant müllerian mixed tumor) Endometrium-Infiltrating malignant neoplasm-Histologic type-Endometrioid adenocarcinoma, variant (specify) Endometrioid adenocarcinoma, variant (specify) Endometrium-Infiltrating malignant neoplasm-Histologic type-Endometrioid adenocarcinoma, variant (specify) Endometrioid adenocarcinoma, variant (specify) Endometrium-Infiltrating malignant neoplasm-Histologic type-Endometrioid adenocarcinoma, variant (specify) Endometrioid adenocarcinoma, variant (specify) Endometrium-Infiltrating malignant neoplasm-Histologic grade (FIGO)-FIGO grade 1 FIGO grade 1 Endometrium-Infiltrating malignant neoplasm-Histologic grade (FIGO)-FIGO grade 2 FIGO grade 2 Endometrium-Infiltrating malignant neoplasm-Histologic grade (FIGO)-FIGO grade 3 FIGO grade 3 Generic-Infiltrating malignant neoplasm-Histologic grade (WHO)-G1: Well differentiated G1: Well differentiated Generic-Infiltrating malignant neoplasm-Histologic grade (WHO)-G2: Moderately differentiated G2: Moderately differentiated Generic-Infiltrating malignant neoplasm-Histologic grade (WHO)-G3: Poorly differentiated" G3: Poorly differentiated" Endometrium-Infiltrating malignant neoplasm-Lymph node site-Pelvic lymph nodes Pelvic lymph nodes Endometrium-Infiltrating malignant neoplasm-Lymph node site-Para-aortic lymph nodes Para-aortic lymph nodes Endometrium-Infiltrating malignant neoplasm-pT-pT0 [--]: No evidence of primary tumor pT0 [--]: No evidence of primary tumor Endometrium-Infiltrating malignant neoplasm-pT-pT1a [IA]: Tumor limited to endometrium or invades less than one-half of the myometrium pT1a [IA]: Tumor limited to endometrium or invades less than one-half of the myometrium Endometrium-Infiltrating malignant neoplasm-pT-pT1b [IB]: Tumor invades greater than or equal to one-half of the myometrium pT1b [IB]: Tumor invades greater than or equal to one-half of the myometrium Endometrium-Infiltrating malignant neoplasm-pT-pT2 [II]: Tumor invades stromal connective tissue of the cervix, but does not extend beyond uterus pT2 [II]: Tumor invades stromal connective tissue of the cervix, but does not extend beyond uterus Endometrium-Infiltrating malignant neoplasm-pT-pT3a [IIIA]: Tumor involves serosa and/or adnexa (direct extension or metastasis) pT3a [IIIA]: Tumor involves serosa and/or adnexa (direct extension or metastasis) Endometrium-Infiltrating malignant neoplasm-pT-pT3b [IIIB]: Vaginal involvement (direct extension or metastasis) or parametrial involvement pT3b [IIIB]: Vaginal involvement (direct extension or metastasis) or parametrial involvement Endometrium-Infiltrating malignant neoplasm-pT-pT4 [IVA]: Tumor invades bladder mucosa and/or bowel mucosa (bullous edema is not sufficient to classify a tumor as T4) pT4 [IVA]: Tumor invades bladder mucosa and/or bowel mucosa (bullous edema is not sufficient to classify a tumor as T4) Endometrium-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis pN0: No regional lymph node metastasis Endometrium-Infiltrating malignant neoplasm-pN-pN1 [IIIC1]: Regional lymph node metastasis to pelvic lymph nodes pN1 [IIIC1]: Regional lymph node metastasis to pelvic lymph nodes Endometrium-Infiltrating malignant neoplasm-pN-pN2 [IIIC2]: Regional lymph node metastasis to para-aortic lymph nodes, with or without positive pelvic lymph nodes pN2 [IIIC2]: Regional lymph node metastasis to para-aortic lymph nodes, with or without positive pelvic lymph nodes Cervix-Specimen-Target site-Ovary (qualifier : right, left) Ovary (qualifier : right, left) Ovary-Specimen-Specimen collection procedure-Oophorectomy Oophorectomy Ovary-Specimen-Specimen collection procedure-Salpingo-oophorectomy Salpingo-oophorectomy Generic-Lesion-Lesion site Lesion site Generic-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin Distance of lesion from closest uninvolved margin Ovary-Specimen-Specimen collection procedure-Omentectomy Omentectomy Ovary-Infiltrating malignant neoplasm-Histologic type-Serous, borderline tumor Serous, borderline tumor Ovary-Infiltrating malignant neoplasm-Histologic type-Serous, carcinoma Serous, carcinoma Ovary-Infiltrating malignant neoplasm-Histologic type-Mucinous carcinoma Mucinous carcinoma Ovary-Infiltrating malignant neoplasm-Histologic type-Endometrioid borderline tumor Endometrioid borderline tumor Ovary-Infiltrating malignant neoplasm-Histologic type-Endometrioid carcinoma Endometrioid carcinoma Ovary-Infiltrating malignant neoplasm-Histologic type-Clear cell borderline tumor Clear cell borderline tumor Ovary-Infiltrating malignant neoplasm-Histologic type-Clear cell carcinoma Clear cell carcinoma Generic-In situ neoplasm-Distance of lesion from closest uninvolved margin Distance of lesion from closest uninvolved margin Ovary-Infiltrating malignant neoplasm-Histologic type-Transitional cell borderline tumor Transitional cell borderline tumor Ovary-Infiltrating malignant neoplasm-Histologic type-Transitional cell carcinoma Transitional cell carcinoma Ovary-Infiltrating malignant neoplasm-Histologic type-Other sex cord-stromal tumor (specify type) Other sex cord-stromal tumor (specify type) Ovary-Infiltrating malignant neoplasm-Histologic type-Malignant germ cell tumor (specify types and percentages) Malignant germ cell tumor (specify types and percentages) Generic-Infiltrating malignant neoplasm-Lymph-vascular invasion Lymph-vascular invasion Generic-Infiltrating malignant neoplasm-Histologic grade (Two-Tier Grading System)-High grade High grade Generic-Infiltrating malignant neoplasm-Histologic grade (Two-Tier Grading System)-Low grade Low grade Generic-Infiltrating malignant neoplasm-Perineural invasion Perineural invasion Ovary-Infiltrating malignant neoplasm-pT-pT0 [--]: No evidence of primary tumor pT0 [--]: No evidence of primary tumor Ovary-Infiltrating malignant neoplasm-pT-pT1a [IA]: Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings pT1a [IA]: Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings Ovary-Infiltrating malignant neoplasm-pT-pT1b [IB]: Tumor limited to both ovaries; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings pT1b [IB]: Tumor limited to both ovaries; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings Ovary-Infiltrating malignant neoplasm-pT-pT1c [IC]: Tumor limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washings pT1c [IC]: Tumor limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washings Ovary-Infiltrating malignant neoplasm-pT-pT2a [IIA]: Extension and/or implants on uterus and/or tube(s). No malignant cells in ascites or peritoneal washings pT2a [IIA]: Extension and/or implants on uterus and/or tube(s). No malignant cells in ascites or peritoneal washings Ovary-Infiltrating malignant neoplasm-pT-pT2b [IIB]: Extension to other pelvic tissues. No malignant cells in ascites or peritoneal washings pT2b [IIB]: Extension to other pelvic tissues. No malignant cells in ascites or peritoneal washings Ovary-Infiltrating malignant neoplasm-pT-pT2c [IIC]: Pelvic extension and/or implants (T2a or T2b / IIa or IIb) with malignant cells in ascites or peritoneal washings pT2c [IIC]: Pelvic extension and/or implants (T2a or T2b / IIa or IIb) with malignant cells in ascites or peritoneal washings Ovary-Infiltrating malignant neoplasm-pT-pT3a [IIIA]: Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor) pT3a [IIIA]: Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor) Ovary-Infiltrating malignant neoplasm-pT-pT3b [IIIB]: Macroscopic peritoneal metastasis beyond pelvis ≤ 2 cm in greatest dimension pT3b [IIIB]: Macroscopic peritoneal metastasis beyond pelvis ≤ 2 cm in greatest dimension Ovary-Infiltrating malignant neoplasm-pT-pT3c [IIIC]: Peritoneal metastasis beyond pelvis > 2 cm in greatest dimension and/or regional lymph node metastasis pT3c [IIIC]: Peritoneal metastasis beyond pelvis > 2 cm in greatest dimension and/or regional lymph node metastasis Generic-Infiltrating malignant neoplasm-pT pT Ovary-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis pN0: No regional lymph node metastasis Ovary-Infiltrating malignant neoplasm-pN-pN1 [IIIC]: Regional lymph node metastasis pN1 [IIIC]: Regional lymph node metastasis Breast-Specimen-Target site-Total breast (including nipple and skin) Total breast (including nipple and skin) Generic-Infiltrating malignant neoplasm-pN pN Breast-Specimen-Specimen collection procedure-Total mastectomy (including nipple and skin) Total mastectomy (including nipple and skin) Breast-Infiltrating malignant neoplasm-Lesion site-Upper outer quadrant Upper outer quadrant Breast-Infiltrating malignant neoplasm-Lesion site-Lower outer quadrant Lower outer quadrant Breast-Infiltrating malignant neoplasm-Lesion site-Upper inner quadrant Upper inner quadrant Breast-Infiltrating malignant neoplasm-Lesion site-Lower inner quadrant Lower inner quadrant Generic-Infiltrating malignant neoplasm-pM pM Breast-Infiltrating malignant neoplasm-Lesion site-Nipple Nipple Breast-Infiltrating malignant neoplasm-Lesion site-Central Central Generic-Infiltrating malignant neoplasm-Treatment effect Treatment effect Breast-Infiltrating malignant neoplasm-Histologic type-Invasive ductal carcinoma (no special type or not otherwise specified) Invasive ductal carcinoma (no special type or not otherwise specified) Breast-Infiltrating malignant neoplasm-Histologic type-Invasive lobular carcinoma Invasive lobular carcinoma Generic-In situ neoplasm-Margins involvement Margins involvement Breast-Infiltrating malignant neoplasm-Histologic type-Invasive Carcinoma, type cannot be determinedd Invasive Carcinoma, type cannot be determinedd Generic-Infiltrating malignant neoplasm-Lesion site Lesion site Breast-Infiltrating malignant neoplasm-Distance of lesion from closest uninvolved margin Distance of lesion from closest uninvolved margin Breast-Infiltrating malignant neoplasm-Margin site-Superior Superior Breast-Infiltrating malignant neoplasm-Margin site-Inferior Inferior Breast-Infiltrating malignant neoplasm-Margin site-Medial Medial Breast-Infiltrating malignant neoplasm-Margin site-Lateral Lateral Breast-Infiltrating malignant neoplasm-Margin site-Anterior Anterior Breast-Infiltrating malignant neoplasm-Margin site-Posterior Posterior Breast-Infiltrating malignant neoplasm-Lymph node site-Intramammary lymph nodes) Intramammary lymph nodes) Breast-Infiltrating malignant neoplasm-Lymph node site-Sentinel lymph node(s) Sentinel lymph node(s) Breast-Infiltrating malignant neoplasm-pT-pT0: No evidence of primary tumor pT0: No evidence of primary tumor Breast-Infiltrating malignant neoplasm-pT-pTis (DCIS): Ductal carcinoma in situ pTis (DCIS): Ductal carcinoma in situ Breast-Infiltrating malignant neoplasm-pT-pTis (LCIS): Lobular carcinoma in situ pTis (LCIS): Lobular carcinoma in situ Breast-Infiltrating malignant neoplasm-pT-pTis (Paget): Paget disease of the nipple not associated with invasive carcinoma and/or carcinoma in situ (DCIS and/or LCIS) in the underlying breast parenchyma pTis (Paget): Paget disease of the nipple not associated with invasive carcinoma and/or carcinoma in situ (DCIS and/or LCIS) in the underlying breast parenchyma Breast-Infiltrating malignant neoplasm-pT-pT1: Tumor < =20 mm in greatest dimension pT1: Tumor < =20 mm in greatest dimension Breast-Infiltrating malignant neoplasm-pT-pT1mi: Tumor < =1 mm in greatest dimension (microinvasion) pT1mi: Tumor < =1 mm in greatest dimension (microinvasion) Breast-Infiltrating malignant neoplasm-pT-pT1a: Tumor >1 mm but < = 5 mm in greatest dimension pT1a: Tumor >1 mm but < = 5 mm in greatest dimension Breast-Infiltrating malignant neoplasm-pT-pT1b: Tumor >5 mm but < = 10 mm in greatest dimension pT1b: Tumor >5 mm but < = 10 mm in greatest dimension Breast-Infiltrating malignant neoplasm-pT-pT1c: Tumor >10 mm but < = 20 mm in greatest dimension pT1c: Tumor >10 mm but < = 20 mm in greatest dimension Breast-Infiltrating malignant neoplasm-pT-pT2: Tumor >20 mm but < = 50 mm in greatest dimension pT2: Tumor >20 mm but < = 50 mm in greatest dimension Breast-Infiltrating malignant neoplasm-pT-pT3: Tumor >50 mm in greatest dimension pT3: Tumor >50 mm in greatest dimension Skin (melanoma)-Infiltrating malignant neoplasm-Histologic grade (Clark) Histologic grade (Clark) Breast-Infiltrating malignant neoplasm-pT-pT4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules). Note: Invasion of the dermis alone does not qualify as pT4. pT4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules). Note: Invasion of the dermis alone does not qualify as pT4. Breast-Infiltrating malignant neoplasm-pT-pT4a: Extension to chest wall, not including only pectoralis muscle adherence/invasion pT4a: Extension to chest wall, not including only pectoralis muscle adherence/invasion Breast-Infiltrating malignant neoplasm-pT-pT4b: Ulceration and/or ipsilateral satellite nodules and/or edema (including peau d’orange) of the skin which do not meet the criteria for inflammatory carcinoma pT4b: Ulceration and/or ipsilateral satellite nodules and/or edema (including peau d’orange) of the skin which do not meet the criteria for inflammatory carcinoma Breast-Infiltrating malignant neoplasm-pT-pT4c: Both T4a and T4b pT4c: Both T4a and T4b Breast-Infiltrating malignant neoplasm-pT-pT4d: Inflammatory carcinoma pT4d: Inflammatory carcinoma Breast-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis identified histologically Note: Isolated tumor cell (ITC) clusters are defined as small clusters of cells not greater than 0.2 mm or single tumor cells, or a cluster of fewer than 200 cells in a single histologic cross-section. ITCs may be detected by routine histology or by immunohistochemical (IHC) methods. Nodes containing only ITCs are excluded from the total positive node count for purposes of N classification but should be included in the total number of nodes evaluated. pN0: No regional lymph node metastasis identified histologically Note: Isolated tumor cell (ITC) clusters are defined as small clusters of cells not greater than 0.2 mm or single tumor cells, or a cluster of fewer than 200 cells in a single histologic cross-section. ITCs may be detected by routine histology or by immunohistochemical (IHC) methods. Nodes containing only ITCs are excluded from the total positive node count for purposes of N classification but should be included in the total number of nodes evaluated. Breast-Infiltrating malignant neoplasm-pN-pN0 (i-): No regional lymph node metastases histologically, negative IHC pN0 (i-): No regional lymph node metastases histologically, negative IHC Breast-Infiltrating malignant neoplasm-pN-pN0 (i+): Malignant cells in regional lymph node(s) no greater than 0.2 mm and no more than 200 cells (detected by H&E or IHC including ITC) pN0 (i+): Malignant cells in regional lymph node(s) no greater than 0.2 mm and no more than 200 cells (detected by H&E or IHC including ITC) Breast-Infiltrating malignant neoplasm-pN-pN0 (mol-): No regional lymph node metastases histologically, negative molecular findings (reverse transcriptase polymerase chain reaction [RT-PCR]) pN0 (mol-): No regional lymph node metastases histologically, negative molecular findings (reverse transcriptase polymerase chain reaction [RT-PCR]) Breast-Infiltrating malignant neoplasm-pN-pN0 (mol+): Positive molecular findings (RT-PCR), but no regional lymph node metastases detected by histology or IHC pN0 (mol+): Positive molecular findings (RT-PCR), but no regional lymph node metastases detected by histology or IHC Cervix-Infiltrating malignant neoplasm-Histologic grade (FIGO) Histologic grade (FIGO) Breast-Infiltrating malignant neoplasm-pN-pN1mi: Micrometastases (greater than 0.2 mm and/or more than 200 cells, but none greater than 2.0 mm). pN1mi: Micrometastases (greater than 0.2 mm and/or more than 200 cells, but none greater than 2.0 mm). Breast-Infiltrating malignant neoplasm-pN-pN1a: Metastases in 1 to 3 axillary lymph nodes, at least 1 metastasis greater than 2.0 mm pN1a: Metastases in 1 to 3 axillary lymph nodes, at least 1 metastasis greater than 2.0 mm Breast-Infiltrating malignant neoplasm-pN-pN2a: Metastases in 4 to 9 axillary lymph nodes (at least 1 tumor deposit greater than 2.0 mm) pN2a: Metastases in 4 to 9 axillary lymph nodes (at least 1 tumor deposit greater than 2.0 mm) Breast-Infiltrating malignant neoplasm-pN-pN3a: Metastases in 10 or more axillary lymph nodes (at least 1 tumor deposit greater than 2.0 mm) pN3a: Metastases in 10 or more axillary lymph nodes (at least 1 tumor deposit greater than 2.0 mm) Generic-Infiltrating malignant neoplasm-Treatment effect-No residual tumor (complete response, grade 0) No residual tumor (complete response, grade 0) Generic-Infiltrating malignant neoplasm-Treatment effect-Moderate response (grade 2) Moderate response (grade 2) Generic-Infiltrating malignant neoplasm-Treatment effect-No definite response identified (grade 3, poor or no response) No definite response identified (grade 3, poor or no response) Breast-Infiltrating malignant neoplasm-Progesterone receptor-No immunoreactive tumor cells present No immunoreactive tumor cells present Breast-Infiltrating malignant neoplasm-HER2/neu (FISH method)-Amplified (HER2 gene copy >6.0 or ratio >2.2) Amplified (HER2 gene copy >6.0 or ratio >2.2) Breast-Infiltrating malignant neoplasm-HER2/neu (FISH method)-Not amplified (HER2 gene copy <4.0 or ratio <1.8) Not amplified (HER2 gene copy <4.0 or ratio <1.8) Breast-In situ neoplasm-Histologic grade of ductal carcinoma in situ (DCIS)-Grade I (low) Grade I (low) Breast-In situ neoplasm-Histologic grade of ductal carcinoma in situ (DCIS)-Grade II (intermediate) Grade II (intermediate) Breast-In situ neoplasm-Histologic grade of ductal carcinoma in situ (DCIS)-Grade III (high) Grade III (high) Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham Histologic Score-Glandular (Acinar)/Tubular Differentiation)-Score 1: >75% of tumor area forming glandular/tubular structures Score 1: >75% of tumor area forming glandular/tubular structures Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham Histologic Score-Glandular (Acinar)/Tubular Differentiation)-Score 2: 10% to 75% of tumor area forming glandular/tubular structures Score 2: 10% to 75% of tumor area forming glandular/tubular structures Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham Histologic Score-Glandular (Acinar)/Tubular Differentiation)-Score 3: <10% of tumor area forming glandular/tubular structures Score 3: <10% of tumor area forming glandular/tubular structures Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham Histologic Score-Nuclear Pleomorphism)-Score 1: Nuclei small with little increase in size in comparison with normal breast Score 1: Nuclei small with little increase in size in comparison with normal breast Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham Histologic Score-Nuclear Pleomorphism)-epithelial cells, regular outlines, uniform nuclear chromatin, little variation in size epithelial cells, regular outlines, uniform nuclear chromatin, little variation in size Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham Histologic Score-Nuclear Pleomorphism)-Score 2: Cells larger than normal with open vesicular nuclei, visible nucleoli, and Score 2: Cells larger than normal with open vesicular nuclei, visible nucleoli, and Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham Histologic Score-Mitotic Count)-Score 1 Score 1 Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham Histologic Score-Mitotic Count)-Score 2 Score 2 Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham Histologic Score-Mitotic Count)-Score 3 Score 3 Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham)-moderate variability in both size and shape moderate variability in both size and shape Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham)-Score 3: Vesicular nuclei, often with prominent nucleoli, exhibiting marked variation Score 3: Vesicular nuclei, often with prominent nucleoli, exhibiting marked variation Breast-Infiltrating malignant neoplasm-Histologic grade (Nottingham)-in size and shape, occasionally with very large and bizarre forms in size and shape, occasionally with very large and bizarre forms Esophagus-Specimen-Target site-Esophagus Esophagus Esophagus-Infiltrating malignant neoplasm-Lesion site-Cervical (proximal) esophagus Cervical (proximal) esophagus Esophagus-Infiltrating malignant neoplasm-Lesion site-Esophagogastric junction (EGJ) Esophagogastric junction (EGJ) Esophagus-Infiltrating malignant neoplasm-Histologic type-Squamous cell carcinoma Squamous cell carcinoma Esophagus-Infiltrating malignant neoplasm-Histologic type-Adenocarcinoma Adenocarcinoma Esophagus-Infiltrating malignant neoplasm-Histologic type-Adenosquamous carcinoma Adenosquamous carcinoma Esophagus-Infiltrating malignant neoplasm-Margin site-Proximal Margin Proximal Margin Esophagus-Infiltrating malignant neoplasm-Margin site-Distal Margin Distal Margin Esophagus-Infiltrating malignant neoplasm-pT-pT0: No evidence of primary tumor pT0: No evidence of primary tumor Esophagus-Infiltrating malignant neoplasm-pT-pTis: High-grade dysplasia pTis: High-grade dysplasia Esophagus-Infiltrating malignant neoplasm-pT-pT1: Tumor invades lamina propria, muscularis mucosae, or submucosa pT1: Tumor invades lamina propria, muscularis mucosae, or submucosa Esophagus-Infiltrating malignant neoplasm-pT-pT1a: Tumor invades lamina propria or muscularis mucosae pT1a: Tumor invades lamina propria or muscularis mucosae Esophagus-Infiltrating malignant neoplasm-pT-pT1b: Tumor invades submucosa pT1b: Tumor invades submucosa Esophagus-Infiltrating malignant neoplasm-pT-pT2: Tumor invades muscularis propria pT2: Tumor invades muscularis propria Esophagus-Infiltrating malignant neoplasm-pT-pT3: Tumor invades adventitia pT3: Tumor invades adventitia Esophagus-Infiltrating malignant neoplasm-pT-pT4: Tumor invades adjacent structures (specify) pT4: Tumor invades adjacent structures (specify) Esophagus-Infiltrating malignant neoplasm-pT-pT4a: Resectable tumor invading pleura, pericardium, or diaphragm pT4a: Resectable tumor invading pleura, pericardium, or diaphragm Esophagus-Infiltrating malignant neoplasm-pT-pT4b: Unresectable tumor invading other adjacent structures, such as aorta, vertebral body, trachea, etc pT4b: Unresectable tumor invading other adjacent structures, such as aorta, vertebral body, trachea, etc Esophagus-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis pN0: No regional lymph node metastasis Esophagus-Infiltrating malignant neoplasm-pN-pN1: Regional lymph node metastasis involving 1 to 2 nodes pN1: Regional lymph node metastasis involving 1 to 2 nodes Esophagus-Infiltrating malignant neoplasm-pN-pN2: 3 to 6 nodes involved pN2: 3 to 6 nodes involved Esophagus-Infiltrating malignant neoplasm-pN-pN3: 7 or more nodes involved pN3: 7 or more nodes involved Generic-Specimen-Specimen integrity -Intact specimen(s) (Unopened, Capsule intact, Single intact specimen, Multiple intact, designated specimens (margins can be evaluated)) Intact specimen(s) (Unopened, Capsule intact, Single intact specimen, Multiple intact, designated specimens (margins can be evaluated)) Generic-Specimen-Specimen integrity -Non intact specimen (Open, Capsule ruptured specimen, Multiple non designated specimens (Fragmented, Morcellated)(margins cannot be evaluated with certainty) Non intact specimen (Open, Capsule ruptured specimen, Multiple non designated specimens (Fragmented, Morcellated)(margins cannot be evaluated with certainty) Generic-Lesion-Lesion focality-Single focus (Solitary - Unifocal) Single focus (Solitary - Unifocal) Generic-Lesion-Lesion focality Lesion focality Generic-Lesion-Lesion focality-Multiple foci (Multifocal - (Ipsilateral – Bilateral))(specify location) Multiple foci (Multifocal - (Ipsilateral – Bilateral))(specify location) Generic-Infiltrating malignant neoplasm-Lesion focality-Single focus (Solitary - Unifocal) Single focus (Solitary - Unifocal) Generic-Infiltrating malignant neoplasm-Lesion focality-Multiple foci (Multifocal - (Ipsilateral – Bilateral))(specify location) Multiple foci (Multifocal - (Ipsilateral – Bilateral))(specify location) Pancreas-Specimen-Target site-Stomach Stomach Stomach-Specimen-Specimen collection procedure-Total gastrectomy Total gastrectomy Stomach-Specimen-Specimen collection procedure-Partial gastrectomy, proximal Partial gastrectomy, proximal Stomach-Specimen-Specimen collection procedure-Partial gastrectomy, distal Partial gastrectomy, distal Stomach-Specimen-Specimen collection procedure-Endoscopic resection Endoscopic resection Larynx-Infiltrating malignant neoplasm-pN mucosal malignant melanoma pN mucosal malignant melanoma Stomach-Infiltrating malignant neoplasm-Histologic type-Tubular adenocarcinoma Tubular adenocarcinoma Stomach-Infiltrating malignant neoplasm-Histologic type-Papillary adenocarcinoma Papillary adenocarcinoma Stomach-Infiltrating malignant neoplasm-Histologic type-Mucinous adenocarcinoma (greater than 50% mucinous) Mucinous adenocarcinoma (greater than 50% mucinous) Larynx-Infiltrating malignant neoplasm-pN carcinoma pN carcinoma Stomach-Infiltrating malignant neoplasm-Histologic type-Carcinoma, not otherwise specified Carcinoma, not otherwise specified Stomach-Infiltrating malignant neoplasm-Margin site-Proximal Margin Proximal Margin Stomach-Infiltrating malignant neoplasm-Margin site-Distal Margin Distal Margin Stomach-Infiltrating malignant neoplasm-pT-pT0: No evidence of primary tumor pT0: No evidence of primary tumor Stomach-Infiltrating malignant neoplasm-pT-pTis: Carcinoma in situ pTis: Carcinoma in situ Stomach-Infiltrating malignant neoplasm-pT-pT1: Tumor invades lamina propria, muscularis mucosae, or submucosa pT1: Tumor invades lamina propria, muscularis mucosae, or submucosa Stomach-Infiltrating malignant neoplasm-pT-pT1a: Tumor invades lamina propria or muscularis mucosae pT1a: Tumor invades lamina propria or muscularis mucosae Stomach-Infiltrating malignant neoplasm-pT-pT1b: Tumor invades submucosa pT1b: Tumor invades submucosa Stomach-Infiltrating malignant neoplasm-pT-pT2: Tumor invades muscularis propria pT2: Tumor invades muscularis propria Stomach-Infiltrating malignant neoplasm-pT-pT3: Tumor invades subserosal connective tissue, without involvement of visceral peritoneum or adjacent structures pT3: Tumor invades subserosal connective tissue, without involvement of visceral peritoneum or adjacent structures Stomach-Infiltrating malignant neoplasm-pT-pT4: Tumor involves serosa (visceral peritoneum) or adjacent structures pT4: Tumor involves serosa (visceral peritoneum) or adjacent structures Stomach-Infiltrating malignant neoplasm-pT-pT4a: Tumor invades serosa (visceral peritoneum) pT4a: Tumor invades serosa (visceral peritoneum) Stomach-Infiltrating malignant neoplasm-pT-pT4b: Tumor invades adjacent structures pT4b: Tumor invades adjacent structures Stomach-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis pN0: No regional lymph node metastasis Stomach-Infiltrating malignant neoplasm-pN-pN1: Metastasis in 1 to 2 perigastric lymph nodes pN1: Metastasis in 1 to 2 perigastric lymph nodes Stomach-Infiltrating malignant neoplasm-pN-pN2: Metastasis in 3 to 6 perigastric lymph nodes pN2: Metastasis in 3 to 6 perigastric lymph nodes Stomach-Infiltrating malignant neoplasm-pN-pN3: Metastasis in 7 or more perigastric lymph nodes pN3: Metastasis in 7 or more perigastric lymph nodes Stomach-Infiltrating malignant neoplasm-pN-pN3a: Metastasis in 7 to 15 perigastric lymph nodes pN3a: Metastasis in 7 to 15 perigastric lymph nodes Stomach-Infiltrating malignant neoplasm-pN-pN3b: Metastassis in 16 or more perigastric lymph nodes pN3b: Metastassis in 16 or more perigastric lymph nodes Lip, oral cavity-Infiltrating malignant neoplasm-pT carcinoma pT carcinoma Colon-Infiltrating malignant neoplasm-Lesion site-Right (ascending) colon Right (ascending) colon Colon-Infiltrating malignant neoplasm-Lesion site-Hepatic flexure Hepatic flexure Colon-Infiltrating malignant neoplasm-Lesion site-Transverse colon Transverse colon Colon-Infiltrating malignant neoplasm-Lesion site-Splenic flexure Splenic flexure Colon-Infiltrating malignant neoplasm-Lesion site-Left (descending) colon Left (descending) colon Colon-Infiltrating malignant neoplasm-Lesion site-Sigmoid colon Sigmoid colon Cervix-Specimen-Target site-Rectum Rectum Colon-Infiltrating malignant neoplasm-Histologic type-Adenocarcinoma Adenocarcinoma Colon-Infiltrating malignant neoplasm-Histologic type-Mucinous adenocarcinoma Mucinous adenocarcinoma Larynx-Infiltrating malignant neoplasm-pT glottis carcinoma pT glottis carcinoma Colon-Infiltrating malignant neoplasm-Histologic type-Signet-ring cell carcinoma Signet-ring cell carcinoma Colon-Infiltrating malignant neoplasm-Histologic type-Medullary carcinoma Medullary carcinoma Colon-Infiltrating malignant neoplasm-Histologic type-Undifferentiated carcinoma Undifferentiated carcinoma Colon-Infiltrating malignant neoplasm-Margin site-Proximal Margin Proximal Margin Colon-Infiltrating malignant neoplasm-Margin site-Distal Margin Distal Margin Colon-Infiltrating malignant neoplasm-pT-pT0: No evidence of primary tumor pT0: No evidence of primary tumor Colon-Infiltrating malignant neoplasm-pT-pTis: Carcinoma in situ, intraepithelial (no invasion) pTis: Carcinoma in situ, intraepithelial (no invasion) Colon-Infiltrating malignant neoplasm-pT-pTis: Carcinoma in situ, invasion of lamina propria pTis: Carcinoma in situ, invasion of lamina propria Larynx-Infiltrating malignant neoplasm-pT supra glottis carcinoma pT supra glottis carcinoma Colon-Infiltrating malignant neoplasm-pT-pT1: Tumor invades submucosa pT1: Tumor invades submucosa Colon-Infiltrating malignant neoplasm-pT-pT2: Tumor invades muscularis propria pT2: Tumor invades muscularis propria Colon-Infiltrating malignant neoplasm-pT-pT3: Tumor invades through the muscularis propria into pericolorectal tissues pT3: Tumor invades through the muscularis propria into pericolorectal tissues Colon-Infiltrating malignant neoplasm-pT-pT4a: Tumor penetrates the visceral peritoneum pT4a: Tumor penetrates the visceral peritoneum Colon-Infiltrating malignant neoplasm-pT-pT4b: Tumor directly invades or is adherent to other organs or structures pT4b: Tumor directly invades or is adherent to other organs or structures Colon-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis pN0: No regional lymph node metastasis Colon-Infiltrating malignant neoplasm-pN-pN1a: Metastasis in 1 regional lymph node pN1a: Metastasis in 1 regional lymph node Colon-Infiltrating malignant neoplasm-pN-pN1b: Metastasis in 2 to 3 regional lymph nodes pN1b: Metastasis in 2 to 3 regional lymph nodes Colon-Infiltrating malignant neoplasm-pN-pN1c: Tumor deposit(s) in the subserosa, or non-peritonealized pericolic or perirectal tissues without regional lymph node metastasis pN1c: Tumor deposit(s) in the subserosa, or non-peritonealized pericolic or perirectal tissues without regional lymph node metastasis Colon-Infiltrating malignant neoplasm-pN-pN2a: Metastasis in 4 to 6 regional lymph nodes pN2a: Metastasis in 4 to 6 regional lymph nodes Larynx-Infiltrating malignant neoplasm-pT sub glottis carcinoma pT sub glottis carcinoma Colon-Infiltrating malignant neoplasm-pN-pN2b: Metastasis in 7 or more regional lymph nodes pN2b: Metastasis in 7 or more regional lymph nodes Liver-Infiltrating malignant neoplasm-Lesion site-Liver Liver Liver-Specimen-Specimen collection procedure-Total hepatectomy Total hepatectomy Liver-Infiltrating malignant neoplasm-Histologic type-Hepatocellular carcinoma Hepatocellular carcinoma Generic-Infiltrating malignant neoplasm-Lesion focality Lesion focality Liver-Infiltrating malignant neoplasm-pT-pT0: No evidence of primary tumor pT0: No evidence of primary tumor Liver-Infiltrating malignant neoplasm-pT-pT1: Solitary tumor without vascular invasion pT1: Solitary tumor without vascular invasion Liver-Infiltrating malignant neoplasm-pT-pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm Liver-Infiltrating malignant neoplasm-pT-pT3a: Multiple tumors more than 5 cm pT3a: Multiple tumors more than 5 cm Larynx-Infiltrating malignant neoplasm-pT mucosal malignant melanoma pT mucosal malignant melanoma Liver-Infiltrating malignant neoplasm-pT-pT3b: Single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic veins pT3b: Single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic veins Liver-Infiltrating malignant neoplasm-pT-pT4: Tumor(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum pT4: Tumor(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum Liver-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis pN0: No regional lymph node metastasis Liver-Infiltrating malignant neoplasm-pN-pN1: Regional lymph node metastasis pN1: Regional lymph node metastasis Pancreas-Specimen-Specimen collection procedure-Partial pancreatectomy, pancreatic tail Partial pancreatectomy, pancreatic tail Pancreas-Specimen-Specimen collection procedure-Pancreaticoduodenectomy (Whipple resection), total pancreatectomy Pancreaticoduodenectomy (Whipple resection), total pancreatectomy Pancreas-Specimen-Specimen collection procedure-Partial pancreatectomy, pancreatic body Partial pancreatectomy, pancreatic body Pancreas-Infiltrating malignant neoplasm-Lesion site-Pancreatic head Pancreatic head Pancreas-Infiltrating malignant neoplasm-Lesion site-Uncinate process Uncinate process Pancreas-Infiltrating malignant neoplasm-Lesion site-Pancreatic body Pancreatic body Pancreas-Infiltrating malignant neoplasm-Lesion site-Pancreatic tail Pancreatic tail Pancreas-Infiltrating malignant neoplasm-Histologic type-Ductal adenocarcinoma Ductal adenocarcinoma Pancreas-Infiltrating malignant neoplasm-Histologic type-Mucinous noncystic carcinoma Mucinous noncystic carcinoma Pancreas-Infiltrating malignant neoplasm-Histologic type-Signet-ring cell carcinoma Signet-ring cell carcinoma Pancreas-Infiltrating malignant neoplasm-Histologic type-Acinar cell carcinoma Acinar cell carcinoma Pancreas-Infiltrating malignant neoplasm-Histologic type-Serous cystadenocarcinoma Serous cystadenocarcinoma Pancreas-Infiltrating malignant neoplasm-Histologic type-Invasive mucinous cystic neoplasm Invasive mucinous cystic neoplasm Pancreas-Infiltrating malignant neoplasm-Histologic type-Acinar cell cystadenocarcinoma Acinar cell cystadenocarcinoma Pancreas-Infiltrating malignant neoplasm-Histologic type-Adenosquamous carcinoma Adenosquamous carcinoma Pancreas-Infiltrating malignant neoplasm-Histologic type-Invasive intraductal papillary-mucinous carcinoma Invasive intraductal papillary-mucinous carcinoma Pancreas-Infiltrating malignant neoplasm-Margin site-Proximal pancreatic margin Proximal pancreatic margin Pancreas-Infiltrating malignant neoplasm-Margin site-Common bile duct margin Common bile duct margin Pancreas-Infiltrating malignant neoplasm-Margin site-Distal pancreatic margin Distal pancreatic margin Pancreas-Infiltrating malignant neoplasm-Margin site-Posterior retroperitoneal surface of pancreas (Uncinate process (retroperitoneal) margin (nonperitonealized surface of the uncinate process) Posterior retroperitoneal surface of pancreas (Uncinate process (retroperitoneal) margin (nonperitonealized surface of the uncinate process) Pancreas-Infiltrating malignant neoplasm-pT-pT0: No evidence of primary tumor pT0: No evidence of primary tumor Pancreas-Infiltrating malignant neoplasm-pT-pTis: Carcinoma in situ pTis: Carcinoma in situ Lesion size, largest dimension Breast-Infiltrating malignant neoplasm-Lesion size, largest dimension Breast-Lesion size, largest dimension Pancreas-Infiltrating malignant neoplasm-pT-pT1: Tumor limited to the pancreas, 2 cm or less in greatest dimension pT1: Tumor limited to the pancreas, 2 cm or less in greatest dimension Pancreas-Infiltrating malignant neoplasm-pT-pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension Pancreas-Infiltrating malignant neoplasm-pT-pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery Pancreas-Infiltrating malignant neoplasm-pT-pT4: Tumor involves the celiac axis or the superior mesenteric artery pT4: Tumor involves the celiac axis or the superior mesenteric artery Lung-Infiltrating malignant neoplasm-Lesion site-Lung Lung Lung-Specimen-Specimen collection procedure-Pneumonectomy Pneumonectomy Lung-Specimen-Specimen collection procedure-Lobectomy Lobectomy Lung-Specimen-Specimen collection procedure-Bilobectomy Bilobectomy Lung-Specimen-Specimen collection procedure-Segmentectomy Segmentectomy Lung-Infiltrating malignant neoplasm-Margin site-Parenchymal Margin Parenchymal Margin Lung-Infiltrating malignant neoplasm-Histologic type-Adenocarcinoma Adenocarcinoma Lung-Infiltrating malignant neoplasm-Histologic type-Large cell carcinoma Large cell carcinoma Lung-Infiltrating malignant neoplasm-Histologic type-Small cell carcinoma Small cell carcinoma Lung-Infiltrating malignant neoplasm-Histologic type-Adenosquamous carcinoma Adenosquamous carcinoma Endometrium-Infiltrating malignant neoplasm-Lesion ulceration Lesion ulceration Lung-Infiltrating malignant neoplasm-Histologic type-Sarcomatoid carcinoma Sarcomatoid carcinoma Lung-Infiltrating malignant neoplasm-Histologic type-Typical carcinoid tumor Typical carcinoid tumor Lung-Infiltrating malignant neoplasm-Margin site-Bronchial Margin Bronchial Margin Lung-Infiltrating malignant neoplasm-Margin site-Vascular Margin Vascular Margin Breast-Infiltrating malignant neoplasm-Microinvasion (DCIS) Microinvasion (DCIS) Lung-Infiltrating malignant neoplasm-pT-pT0: No evidence of primary tumor pT0: No evidence of primary tumor Lung-Infiltrating malignant neoplasm-pT-pTis: Carcinoma in situ pTis: Carcinoma in situ Lung-Infiltrating malignant neoplasm-pT-pT1a: Tumor 2 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus (ie, not in the main bronchus); or Superficial spreading tumor of any size with its invasive component limited to the bronchial wall, which may extend proximally to the main bronchus pT1a: Tumor 2 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus (ie, not in the main bronchus); or Superficial spreading tumor of any size with its invasive component limited to the bronchial wall, which may extend proximally to the main bronchus Lung-Infiltrating malignant neoplasm-pT-pT1b: Tumor greater than 2 cm, but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus (ie, not in the main bronchus) pT1b: Tumor greater than 2 cm, but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus (ie, not in the main bronchus) Lung-Infiltrating malignant neoplasm-pT-pT2a: Tumor greater than 3 cm, but 5 cm or less in greatest dimension surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus (ie, not in the main bronchus); or Tumor 5 cm or less in greatest dimension with any of the following features of extent: involves main bronchus, 2 cm or more distal to the carina; invades the visceral pleura; associated with atelectasi or obstructive pneumonitis that extends to the hilar region but does not involve the entire lung pT2a: Tumor greater than 3 cm, but 5 cm or less in greatest dimension surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus (ie, not in the main bronchus); or Tumor 5 cm or less in greatest dimension with any of the following features of extent: involves main bronchus, 2 cm or more distal to the carina; invades the visceral pleura; associated with atelectasi or obstructive pneumonitis that extends to the hilar region but does not involve the entire lung Lung-Infiltrating malignant neoplasm-pT-pT2b: Tumor greater than 5 cm, but 7 cm or less in greatest dimension pT2b: Tumor greater than 5 cm, but 7 cm or less in greatest dimension Lung-Infiltrating malignant neoplasm-pT-pT3: Tumor greater than 7 cm in greatest dimension; or Tumor of any size that directly invades any of the following: chest wall (including superior sulcus tumors), diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium; or Tumor of any size in the main bronchus less than 2 cm distal to the carina but without involvement of the carina; or Tumor of any size associated with atelectasis or obstructive pneumonitis of the entire lung; or Tumors of any size with separate tumor nodule(s) in same lobe pT3: Tumor greater than 7 cm in greatest dimension; or Tumor of any size that directly invades any of the following: chest wall (including superior sulcus tumors), diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium; or Tumor of any size in the main bronchus less than 2 cm distal to the carina but without involvement of the carina; or Tumor of any size associated with atelectasis or obstructive pneumonitis of the entire lung; or Tumors of any size with separate tumor nodule(s) in same lobe Lung-Infiltrating malignant neoplasm-pT-pT4: Tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina; or Tumor of any size with separate tumor nodule(s) in a different lobe of ipsilateral lung pT4: Tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina; or Tumor of any size with separate tumor nodule(s) in a different lobe of ipsilateral lung Lung-Infiltrating malignant neoplasm-pN-pN0: No regional lymph node metastasis pN0: No regional lymph node metastasis Lung-Infiltrating malignant neoplasm-pN-pN1: Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes, and intrapulmonary nodes, including involvement by direct extension pN1: Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes, and intrapulmonary nodes, including involvement by direct extension Lung-Infiltrating malignant neoplasm-pN-pN2: Metastasis in ipsilateral mediastinal and/or subcarinal lymph node(s) pN2: Metastasis in ipsilateral mediastinal and/or subcarinal lymph node(s) Lung-Infiltrating malignant neoplasm-pN-pN3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph node(s) pN3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph node(s) Prostate-Specimen-Target site-Prostate Prostate Prostate-Specimen-Specimen collection procedure-Needle Biopsy Needle Biopsy Prostate-Specimen-Specimen collection procedure-Radical prostatectomy Radical prostatectomy Not classified owl:Thing Christel Daniel David Ouagne PATHLEX